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ABSTRACT 
 
Tryptamine (1H-indole-3-ethyleneamine) Schiff bases were prepared by the condensation 
reaction of ethanolic solution of tryptamine with: salicylaldehyde (TS), 5-
chlorosalicylaldehyde (TCS), 5-nitrosalicylaldehyde (TNS), 3,5-di-tert-butyl-2-hydroxy 
benzaldehyde (TTET) and the ketones: 2-hydroxyacetophenone (THAP), 5-methyl-2-
hydroxyacetophenone (TMeHAP), 5-methoxy-2-hydroxyacetophenone (TOMeHAP), 5-
chloro-2-hydroxyacetophenone (TClHAP) and 5-bromo-2-hydroxyacetophenone 
(TBrHAP). The ligands were coordinated to Zn(II), Cu(II) and Ni(II) by the reaction of 
metal acetates with the corresponding ligand in a 1 : 2 metal to ligand ratio. The solid 
products formed were collected, washed with ethanol and recrystallized from a suitable 
solvent. All the ligands and complexes prepared have been characterized by 
spectroscopic methods using IR, 1H and 13C {1H} NMR spectroscopies, and UV-Visible 
spectrophotomerty. Single crystal X-ray structure analysis was carried out for TNS, 
(TS)2Zn complex, (TS)2Ni complex, (TCS)2Zn complex, (TTET)2Zn complex and 
(THAP)2Zn complex. Metal content was determined using atomic absorption 
spectroscopy. X-ray diffraction crystallography for (TNS) shows that it was exists in the 
zwitterionic form with the phenol H atom transferred to the imine group. Adjacent 
zwitterions are linked into a linear chain running along the axis by an indole–hydroxy 
N—H···O hydrogen bond. For zinc complexes the zinc atom is N, O-chelated by two 
deprotonated Schiff base monoanionic ligands in tetrahedral coordination geometry. In 
the case of nickel complex, Bis{2-[2-(1H-indol-3-yl)ethyliminomethyl] phenolato 
k2N,O}nickel(II) N,N-dimethylformamide disolvate the nickel atom lies on a twofold 
rotation axis. It is N, O-chelated by the deprotonated Schiff base in a square-planar 
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coordination environment. The molecule is linked to a solvent molecule by an indole–
dimethylformamide NH···O hydrogen bond. 
Anti-ulcerogenic activities of the ligands and complexes have been investigated with 
Cimetidine as a standard drug. The screening was done on high and low doses (60 mg/kg 
and 30 mg/kg) respectively on six albino Sprague-Dawley rats in which ulcer was 
induced after dosing by absolute ethanol. The ulcer lesion of the stomachs were identified 
and counted, and then correlation between the different compound effects has been made. 
(TS)2Zn complex proved to be more effective in ulcer inhibition than its nickel and 
copper congeners. 
The anti-oxidant properties for the prepared ligands and complexes have been evaluated 
against vitamin C and BHT as standard drugs. The complexes show comparable 
scavenging activity against DPPH radical than do the ligands. Copper complexes reveal 
the strongest radical scavenging activity among the compounds. However, none of the 
compounds were found to be better than vitamin C or BHT. (TTET)2Zn, (TTET)2Cu 
complexes and TOMeHAP ligand exhibit better ferric reducing abilities than BHT in the 
FRAP assay. Acute toxicity studies proved that most of the prepared compounds were 
non-toxic and can be considered as safe.  
 
 v 
Abstrak 
 
Sebatian bes Schiff bagi triptamina (1H-indol-3-etilamina) telah disediakan melalui 
tindak balas kondensasi yang dilakukan di dalam larutan etanol yang setiap satunya 
mengandungi triptamina dan sebatian aldehid seperti salisilaldehid (TS), 5-
klorosalisilaldehid (TCS), 5-nitrosalisilaldehid (TNS), 3,5-di-tert-butil-2-
hidroksibenzaldehid (TTET) dan sebatian keton seperti 2-hidroksiasetofenon (THAP), 5-
metil-2-hidroksiasetofenon (TMeHAP), 5-metoksi-2-hidroksiasetofenon (TOMeHAP), 5-
kloro-2-hidroksiasetofenon (TClHAP) and 5-bromo-2-hidroksiasetofenon (TBrHAP). 
Semua ligan telah ditindakbalaskan dengan sebatian asetat logam Zn(II), Cu(II) dan 
Ni(II) dengan nisbah 1 asetat logam dan 2 ligan. Produk yang diperoleh telah 
dikumpulkan, dicuci dengan menggunakan etanol dan dilakukan pengkristalan semula 
dalam pelarut yang sesuai. Ligan dan kompleks telah dicirikan melalui kaedah-kaedah 
spektroskopi seperti IR, 1H dan 13C NMR dan UV-Vis. Analisis struktur bagi TNS, 
kompleks Zn(TS)2, Ni(TS)2, Zn(TCS)2, Zn(TTET)2 and Zn(THAP)2 telah dijalankan 
dengan menggunakan kaedah X-ray kristal tunggal. Kandungan logam pula telah 
ditentukan melalui kaedah spektroskopi penyerapan atom. Kristalografi pembelauan X-
ray menunjukkan bahawa TNS wujud sebagai zwitterions dengan atom H daripada fenol 
dipindahkan kepada kumpulan imina. Zwitterion bersebelahan pula dihubungkan dalam 
rantai linear melalui ikatan hidrogen indol-hidroksi N - H····· O. Sementara itu, atom zink 
terikat kepada N dan O pada dua bes Schiff monoanion dan menghasilkan bentuk 
tetrahedral. Atom nikel bagi kompleks bis{2-[2-(1H-indol-3-yl)] fenolato κ2N, O} 
nikel(II) N,N-dimetilformamida tersolvat berada pada paksi putaran twofold. Atom 
 vi 
tersebut terikat pada N, O yang ternyahproton pada sebatian bes Schiff secara koordinasi 
satah empat segi-sama.  Molekul tersebut dihubungkan kepada molekul pelarut melalui 
ikatan hidrogen indol - dimetilformamida NH····· O. 
 
Aktiviti anti-ulser bagi semua ligan dan kompleks telah dikaji dengan menggunakan 
cimetidine sebagai sebatian kawalan. Ujian terhadap enam ekor tikus albino Sprague - 
Dawley telah dijalankan dengan menggunakan dos tinggi dan rendah (60 mg/kg dan 30 
mg/kg) yang mana yang tikus - tikus tersebut telah diberikan etanol mutlak selepas 
sebatian ujian diberikan. Luka ulser di perut tikus telah dikenalpasti, dikira dan korelasi 
kesan yang ditunjukkan antara sebatian yang berbeza telah dikenalpasti. Kompleks 
(TS)2Zn didapati lebih efektif dalam merencatkan pembentukan ulser daripada kompleks 
nikel dan kuprum yang sepadan dengannya. 
 
Sifat antioksidan bagi ligan dan kompleks yang telah disediakan juga telah dikaji dengan 
menggunakan Vitamin C dan BHT sebagai sebatian kawalan eksperimen. Sebatian 
kompleks menunjukkan aktiviti pemerangkapan radikal DPPH yang memberangsangkan 
berbanding aktiviti yang ditunjukkan oleh sebatian ligan. Sebatian-sebatian kompleks 
kuprum telah menunjukkan kesan aktiviti pemerangkapan radikal yang terkuat. Walau 
bagaimanapun, aktiviti bagi semua sebatian yang disintesis tidak mengatasi aktiviti 
Vitamin C atau BHT. (TTET)2Zn, (TTET)2Cu dan TOMeHAP menunjukkan keupayaan 
menurunkan kadar ferik berbanding BHT dalam ujian FRAP. Toksisiti akut juga telah 
membuktikan bahawa kebanyakan sebatian yang disediakan adalah tidak toksik dan 
boleh dipertimbangkan sebagai sebatian yang selamat untuk digunakan. 
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CHAPTER ONE 
 
 
 
INTRODUCTION  
 1 
1. Introduction 
1.1 General and historical aspects:  
The condensation of primary amines with carbonyl compounds was first reported in 1864 
by Schiff [1, 2] and the condensation products are often referred to as Schiff bases. The 
experimental conditions depend on the nature of the amine and especially of the carbonyl 
compound which determine the position of the equilibrium:  
                
R-CO-R/ + R//-NH2 C
NR//
R/R + H2O  
 
Aromatic aldehydes react smoothly under mild conditions and at relatively low 
temperature in a suitable solvent. In condensation of aromatic amines with aromatic 
aldehydes, electron attracting substituents in the para position of the amine decrease the 
rate of the reaction, while increasing it when on the aldehyde [3]. With ketones, 
especially aromatic ketones higher temperatures, longer reaction times and catalyst are 
usually required in addition to the removal of the water as it is formed, and the reaction is 
acid catalyzed [4]. 
The most characteristic respect in which compounds containing the C=N bond show 
basic properties in the formation of complexes is with metals. These complexes provide 
some very characteristic series of co-ordination compounds, and consequently a large 
number of them have been prepared and their properties were examined and compared 
[5-7]. The basic strength of the C=N group is insufficient by itself to permit for the 
formation of stable complexes by simple co-ordination of the lone pair to a metal ion. 
Therefore in order the stable compounds should be formed, it is necessary that there 
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should also be a molecule with a functional group with a replaceable hydrogen atom is 
present, preferably a hydroxyl group, near enough to the C=N group to permit the 
formation of a five or six membered ring by chelation to the metal atom. 
Among the simplest compounds which meet this requirement are salicylaldimines 
[Fig1.1a] and their N-hydroxy derivative, salicyldoxime [Fig1.1b] and by far the most 
intensive studies have been made on the metal complexes of the former and their 
derivatives.  
 
     
C N
H
H
OH                               
C
H
N
OH
OH       
 
              a                                                                               b 
 
Figure 1.1:  Salicylaldimine (a) and Salicyldoxime (b) 
The compounds formed with metals by these and other Schiff bases and known up to 
1960’s have been listed and their properties discussed in details by Holm, Everett and 
Chakravorthy [8] whilst some of the salicylaldimine complexes have formed the subject 
of reviews by Sacconi [9].  
In 1840 Jorgensen and Werner Ettling [10-11] isolated a dark green crystalline product 
from the reaction of cupric acetate salicylaldehyde and aqueous ammonia. In 1869 Schiff 
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isolated the corresponding phenyl derivative as well as 1:2 metal – ligand stoichiometry 
[12 - 13].  
The salicylaldimine complexes of the general type [ Fig 1.2a ] and [ Fig 1.2b] can often 
be made by the direct interaction between the metal ion and the appropriate Schiff base in 
alcoholic or aqueous alcoholic solution and in the presence of a base such as sodium 
hydroxide or sodium acetate. 
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H
N
2
M (II)
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                            a                                                                       b 
Figure 1.2: Salicylaldimine complexes  
 Under these conditions the N-alkylsalicylaldimines tend to hydrolyse, however, so a 
more general useful method of preparation is to reflux the salicylaldehyde complex of the 
metal with a slight excess of the primary amine in a non aqueous solvent. This procedure 
was originally used by Schiff [12] who prepared a number of these compounds and 
proved their compositions. 
The co-ordination complexes formed with divalent metal ions (Fig 1.2a) are of 
considerable interest as they vary in structure from coplanar to tetrahedral not only in 
dependence of the nature of the divalent metal, but also on the nature of the substituent 
on the nitrogen atom and the substituents on the aromatic ring of the salicylaldimine 
molecule. 
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A number of reasons make complexes of the first row transition metals with 
salicylaldehyde Schiff bases of significant importance, among them are a large variety of 
co-ordination geometries, and the complexes often exist in many crystalline 
modifications, besides the stereochemistry of these complexes is often labile so that very 
often the molecular configurations in solution are different from those in the solid state 
and conformational equilibria between different forms takes place. 
It has been shown that the lability of the geometry of many metal complexes with Schiff 
bases also occurs in the solid state, giving rise to cases of anomalous isomorphism [14-
15]. This phenomenon has been particularly investigated in complexes of 3d metals from 
Mn(II) to Zn(II) with N-methylsalicylaldimines having the general formula:  
 
                                             
O
NHC
CH3
X
M
2  
 
The Ni(II) complex was the first example of the magnetically anomalous complexes 
reported in the literature [16]. It exists in two planar diamagnetic forms the α-form 
(orthorhombic) and the β-form (monoclinic). Above 180oC both forms transform to the γ- 
paramagnetic form. This form is insoluble in all inert solvents. For this reason a 
polymeric structure involving the sharing of oxygen atoms by the nickel atoms has been 
attributed to it. 
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The copper complex exists in three crystalline modifications, α- and γ- both orthorhombic 
and β- form which is monoclinic. The forms α- and β- are isomorphous with the 
corresponding forms of the nickel derivative. In these complexes the copper has planar 
co-ordination geometry [5]. 
The Mn(II), Co(II) and Zn(II) complexes with N-methyl salicylaldimine are mutually 
isomorphous. They exist as dimers in the solid state. The metal ion which is bound to 
three oxygen and two nitrogen atoms has a co-ordination number of five in a distorted 
trigonl bipyramidal environment [17]. 
Moreover, a significant amount of information related to the characterization of Schiff 
bases and their metal complexes with several metals has appeared in the literature [18-19] 
The spectroscopic properties of salicylaldimines and α-hydroxy naphthaldimines with 
copper(II), nickel(II) and iron(III) complexes were studied previously [20]. NMR results 
have shown the presence of keto-amine versus enol-imine equilibria: 
 
C
H
N
R
H
O-
C
H
N
R
H
O
C
H
N
R
H
O
+
enol-imine keto-imine
 
Recently in 1986 M.G Martin Reyes, P. Gili and co-workers [21] have synthesized and 
characterized for the first time the Schiff base 1H-Indole-3-ethylene salicylaldimine from 
the coupling reaction of tryptamine and salicylaldehyde. The Cu(II), Ni(II) and Co(II) 
complexes were also studied. The results indicate that the ligands were co-ordinated 
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through oxygen and nitrogen atoms with the metal ions in different stereochemistry. The 
electronic spectra of the compounds revealed that the energy of the π – π* transition of the 
chelate ring of the ligand is characteristic of Schiff bases which exhibit delocalized 
systems with an intramolecular hydrogen bonding [22]. It was also been suggested that 
for the Cu(II) complex the position of UV bands at high wavelengths indicates the 
presence of a square planar environment around the copper ion in solution, shifted 
towards a pseudotetrahedral geometry in the solid state [23]. 
In 1989 P. Gili and co-workers extend the work and synthesized and characterized a 
Schiff bases: 3- and 5-methoxysalicylaldimine-3-ethlene-1H Indole and their Co(II), 
Ni(II) and Cu(II) complexes. X-ray structure for the Cu(II) complex indicates co-
ordination of the Cu(II) complex is trans planar (CuO2N2) geometry [24] and also the two 
Ni(II) complexes (NiO2N2). The magnetic data for bis(1H-Indole-3-ethylene-5-
methoxysalicylaldimine) Co(II) complex is consistent with an octahedral environment 
around the metal. 
In 1990 P. Martin Zarza et al has extended the work further through the condensation 
reaction of tryptamine with 2-hydroxyacetophenone and other diketones [25]. They also 
prepared and characterized their Cu(II) complexes. The electronic diffuse reflectance 
spectra of the bidentate ligand complexes indicate a distorted pseudotetrahedral 
disposition around the Cu(II) ion attributed to the substitution of the hydrogen atom on 
the iminic carbon by methyl groups. 
P. Gili extended his work in 1990 for related compounds with different substituents in 
order to study how the nature and position of the alkoxy group in the ligand and 
complexes affect their properties. Thus he described a new nickel complex of the ligand: 
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1H-Indole-3-ethylene-3-ethoxysalicylaldimine. He discovered that the geometry around 
the Ni atom is a square planar with the metal atom lying at the center of symmetry. There 
is an intermolecular hydrogen bonding between the nitrogen atom of the indole group and 
the phenolic oxygen of the ethoxysalicylaldiminate moiety. The six-membered chelate 
ring is observed puckered while in related compounds the equivalent rings are nearly 
planar probably due to the accommodation of the larger ethoxy groups in order to avoid 
steric hindrance [26] 
Similar complexes of Cu(II) and Ni(II) with the ligand N-[2-(3-ethyl indole) 
pyridoxaldimine prepared by the condensation reaction of tryptamine with pyridoxal have 
been synthesized and characterized [27]. X-ray diffraction analysis for Ni(II) complex 
indicate that the co-ordination of the Ni(II) complex is trans planar NiN2O2 species and 
the spectroscopic data for the Cu(II) complexes suggest the same  chromophore group 
CuN2O2 with a trans configuration in the solid phase. The nickel atom is lying at the 
center of symmetry and is four co-ordinated to the phenolic oxygen atoms and the imine 
nitrogen atoms of the two Schiff base units. The crystal structure can be described in 
terms of chains of complex units along the crystallographic b-axis. The complex units in 
the chains are held together by intermolecular hydrogen bonding. Each hydrogen bond is 
formed between the nitrogen atom of the indole group and the pyridine nitrogen atom of 
the pyridoxaldiminate group.  
In 1997 manganous complexes containing Mn(II) and Mn(III) species have been 
introduced with the Schiff base: N-[2-(3-ethylindole )]  pyridoxaldimine previously stated 
[28]. The compounds have been characterized by spectroscopic methods as well as 
magnetic measurements, thermogravimetric and calorimetric studies. The spectroscopic 
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and magnetic data indicate a tetrahedral co-ordination for the Mn(II) complex and a five 
co-ordination for the Mn(III) complex. Square pyramidal geometry was favored by such 
bulky ligands. However the observed geometries are usually intermediate between 
trigonal bipyramidal and square pyramidal. The steriochemical non-rigidity is common 
for penta co-ordinate complexes which thus can easily exhibit distorted geometries. 
Lanthanide complexes of salicylaldehyde Schiff bases with salicyled hydrazide and 
anthranilic acid were synthesized and characterized [29]. Proton NMR spectra and infra 
red studies for the complexes reveal the bidentate binding of both Schiff base ligands to 
the lanthanide ion. Electronic spectra along with the conductance data for the complexes 
indicate a coordination number of six for the lanthanide ion in the complexes of both the 
Schiff bases.  
1.2 Biological activities of Schiff bases and their metal complexes:  
A great deal of information regarding the properties of synthetic Schiff bases of potential 
biological interest has arisen during the last few years [30-32]. Several of these 
compounds were characterized and used as models for a series of systems including 
nickel which has been found in few biological systems, but has recently been detected in 
very low amounts in jack-bean urease [33] and in some hydrogenases [34-35]. 
Also it is well known that several metalloproteins and metaloenzymes play important 
roles in natural biological systems. These functions are related to catalytic activity in 
reactions such as hydrogen exchange, hydrolysis of esters, carboxylation or 
decarboxilation. The functions of a metal ion in a metalloprotein are determined by 
structural characteristics which include, among others, the nature of its co-ordination 
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sphere. These functions also depend on the structural arrangement in the vicinity of the 
metallic ion but outside its co-ordination sphere [36-37]. 
Schiff base complexes are known to be dioxygen carriers and have been studied as 
potential reagents for oxygen separation and transportation. [2, 38-40]. The Co(II) 
complexes of Schiff bases such as bis(salicylaldehyde) ethylenediamine and its analogues 
have been the first and extensively investigated. Dian Chen et al [41] has synthesized a 
series of Co(II) Schiff base complexes and their oxygen affinities have been tested 
against the effect of substituents in the benzene ring. The substitution of methyl groups 
on the Schiff bases (α-substitution, acetophenone derivatives) increases the affinity for 
oxygen but also increasing the rate of degradation. Flourine substitution on the aromatic 
rings of the Schiff bases increasing the affinity for dioxygen by promoting 2:1 (binuclear) 
dioxygen complex formation. Sulphonation of the aromatic rings of the Schiff base 
increase the rate of degradation of the Co(II) complexes studied. Methoxy groups on the 
aromatic rings of the Schiff bases tends to increase the affinity of the Co(II) complex for 
dioxygen and favor 1:1 dioxygen complex formation. Combination of dioxygen with the 
Co(II) complexes of the pentadentate Schiff bases seems to be partially inhibited by steric 
effects, which are relieved by hydrogenation of the ligands. The Co(II) complexes of 
reduced ligands have much higher affinities for dioxygen than do the complexes of the 
corresponding Schiff bases.  
The first report that a low molecular weight Cu(II) complex was effective against 
rheumatoid arthritis appears as early as 1941 [42]. Sorenson and Hangarter reviewed the 
treatment of some 1500 patients since then with a variety of copper Schiff base 
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compounds. Cupraline (formula (I), Figure1.3), alcuprin (formula (II), Figure 1.3) and 
dicuprene (formula (III), Figure 1.3) [43]. 
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Figure 1.3:  Cupraline(I) , Alcuprin(II) and Dicuprene (III) 
 
 These preparations all bring about marked reductions in inflammation and particularly 
show very few toxic reactions. Indeed they exhibit an antiulcer activity [44-45] which is 
significant because gastrointestinal irritation commonly necessitates treatment by many 
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antiarthritic drugs to be abandoned [46]. This in line with the role of copper in generally 
preventing gastrointestinal damage by acidic anti-inflammatory agents [47]. 
P.K Parashar et al studied the anti-inflammatory and anti ulcer activities of Schiff bases 
derived from salicylaldehydes and 2-substituted aniline and their metal chelates with 
Cu(II), Ni(II), and Co(II) [48]. The compound salicylidene anthranilic acid was found to 
possess antiflammatory and antiulcer activity, while the copper complexes showed an 
increased antiulcer activity. Similar study was carried out by K. D Rainsford and co-
workers on a number of Cu(II) complexes [49]. Results show that Cu(II) preparations 
which are highly irritating outside the stomach, caused no ulceration when applied intra 
gastric, but always elicited a copious mucus effusion  into the stomach. This non ulcerant 
effect was confirmed by light microscopic observations of formaline-fixed tissues stained 
with periodic acid Schiff reagent, Alcian blue (pH 2.5) or the haematoxylin and eosin 
stains. 
Mucus discharge from the superficial and gastric pit mucous cells was clearly evident 
after administering CuCl2 and those Cu(II) complexes which elicited a visible mucus 
effusion. Some disruption of parietal cells was also seen specially after giving high doses 
of Cu(II) compounds [49]. 
L.Araya and J.Vargas [36] studied a series of Cu(II) complexes derived from substituted 
anilines and bromosalicylaldehydes. They realize that biological and catalytic response of 
the complex may be increased or diminished by small changes in the ligand structure and 
this may be attributed to the redox activity and an interesting problem in bioinorganic 
chemistry has been the quantitative evaluation of the effect on the redox potential of 
changing the ligand structure.  
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Jan Vanco et al [50] recently described copper and zinc complexes with a tridentate ONO 
donor Schiff base derived from salicylaldehyde and β-alanine. Their biological activities 
have been evaluated by the anti-peroxynitrite activity assay and alloxan induced diabetes 
model. Significant antioxidant and anti-diabetic activities have been found in the case of 
Cu(II) complexes, but not significant in the case of Zn(II) complex. The biological results 
sets the potential use of Cu(II) complexes as nutritional supplements with biological 
activities relevant in prevention of diseases connected with progression of oxidative 
stress-like diabetes mellitus. 
Pt(II) complexes with Schiff bases derived from salicylaldehyde and phenylene diamine 
have been studied along with their biological activities as anti-microbials [40] The results 
revealed that the complexes are more microbial toxic than the ligands. Chelation to the 
metal ion reduces the polarity of the metal mainly because of partial sharing of its 
positive charge with the donor groups and possible π-electron delocalization within the 
whole chelate ring. Also chelation increases the lipophelic nature of the central atom 
which subsequently favors its permeation through the lipid layer of the cell membrane.  
Schiff bases derived from the reaction of salicylaldehyde and 2-amino-3-carboxy ethyl -
4, 5 dimethyl thiophene and their metal complexes with Mn(II), Fe(II), Co(II), Ni(II), 
Cu(II) and Zn(II) have also been studied and screened for their anti bacterial activities 
[51] It has been observed that the antibacterial activity of the ligand increased on 
chelation with the metal ions. Metal chelates of salicylaldimines derived from 
heterocyclic systems, which have known to be unstable, can be stabilized by suitable 
substitutions at the remaining positions of the thiophene ring by an ester group and two 
methyl groups. The resulting compound 2-amino-3-carboxyethyl-4, 5 dimethyl thiophene 
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has been condensed with salicylaldehyde to form a potentially tridentate Schiff base: (N-
salicylidene)-3-carboxyethyl-4, 5 dimethyl thiophene containing an ONO doner 
sequence. It is also found that introduction of carboxyethyl group at position 3 of the 
thiophene ring has provided further scope of reactivity and a new coordination site. In 
addition highly substituted thiophenes have shown extensive potential in pharmaceutical 
industry, besides the structural diversities, bonding interactions, bioisosteric relationship 
of thiophene to benzene has lead to several structures of drug analogs in which benzene 
rings have been replaced by thiophene rings and the vivid applications of thiphene 
derivatives as important therapeutic agents which have been documented in literature 
[52]. It is expected that metal chelates containing thiophene ring system would carry 
bioisosteric relationship and therapeutic values thus introducing another class of metal-
based thiophene derivatives.  
The antibacterial property can be thought of as a result of geometry and charge 
distribution around the molecule [53]. If the geometry and charge distribution around the 
molecule are incompatible with those around the holes of the bacterial cell wall, 
penetration through the wall by the toxic agent cannot takes place and this in turn prevent 
the toxic reaction within the pores. The presence of co-ligand also plays a decisive role in 
determining the antibacterial property of metal complexes. The mode of action of the 
complexes also indulges in the formation of hydrogen-bonded interaction through the 
coordinated anion and the azomethine group, with the active centers of the cell 
constituents resulting in interference with the normal cell processes.  
It has been also shown that Schiff base complexes derived from 4-
hydroxysalicylaldehyde and amines have strong anticancer activity e.g. Ehrlich ascites 
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carcinoma as well as antifungal activity [54]. N-4-hydroxysalicylidene-glycylglycine, 
and its Mn(II), Co(II), Ni(II) and Cu(II) complexes have been synthesized, characterized 
and screened for antifungal activity towards Candida albicans and Cryptococcus 
neoformans. The results show that the ligand and its complexes exhibit strong inhibition 
towards Cryptococcus neoformans under the test conditions. All of the compounds have 
strong inhibitory action towards Candida albicans when the concentration is 
comparatively high. When the concentration of the compounds is 200 ppm the ligand N-
4-hydroxysalicylidene-glycylglycine and its complexes exhibit strong antifungal activity 
to the two selected fungi except for copper complex.   
Schiff base ligands containing cyclobutane and thiazole rings have been studied together 
with their Co(II), Cu(II), Ni(II) and Zn(II) complexes [55]. Anti microbial activities of 
the ligands and their complexes have been tested against eight different microorganisms. 
The ligands with the nitrogen and oxygen donor system might have inhibited enzyme 
production, since enzymes which require a free hydroxyl group for their activity appear 
to be especially susceptible to deactivation by the ions of the complexes. Chelation 
reduces the polarity of the central ion mainly because of the partial sharing of its positive 
charge with the donor groups and possible π-electron delocalization within the whole 
chelate ring. This chelation increases the liophilic nature of the central atom which favors 
its permeation through the lipid layer of the membrane.  
To wide the scope of investigation on the coordination behavior of Schiff base ligands in 
biological systems towards organotin complexes, Han Dong et al [56] has reported six 
diorganotin(IV) derivatives of salicylaldehyde isonicontinylhydrazone. X-ray studies of 
the ligand and its di-tert-butyl Sn(IV) complex show that the Schiff base ligand is a 
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tridentate planar ligand, the tin atom lies in this plane and formed a five-membered  and 
six-membered chelate ring with the ligand.         
In 2006, Hapipah Mohd Ali et al [57] has introduced Ni(II) and Cd(II) complexes of 
Schiff base ligand derived from 4-nitrobenzhydrazide and 5-chloro-2-
hydroxyacetophenone as well as their anti cancer activity. IR and UV spectra of the 
ligand and complexes indicate coordination of the ligand to the metal centers. The nickel 
complex is a square planar which changed to octahedral geometry in pyridine solution 
due to coordinated solvent molecules. The Schiff base ligand is more sensitive towards 
human breast cancer cells (MCF-7) than the unsubstituted ligand. However upon 
coordination to nickel the activity have been reduced to the same level as the positive 
control drug tamoxifen. The anti-oxidant properties of the Schiff base ligand exhibited 
higher activity than vitamin-E or quercetine. However the activity is lower than the 
unsubstiuted Schiff base ligand or the commercial anti-oxidant agent butylated 
hydroxytoluene (BHT). 
1.3 The objectives of this work:  
In this work we report the synthesis, characterization, anti ulcerogenic and antioxidant 
activities of Schiff bases derived from the condensation reaction of tryptamine with the 
aldehydes: salicylaldehyde, 5-chlorosalicylaldehyde, 5-nitrosalicylaldehyde, 3,5-di-tert-
butyl-2-hydroxy benzaldehyde, and the ketones: 2-hydroxyacetophenone, 5-chloro-2-
hydroxyacetophenone, 5-bromo-2-hydroxyacetophenone, 5-methyl-2-
hydroxyacetophenone, and 5-methoxy-2-hydroxyacetophenone, together with their 
Zn(II), Ni(II) and Cu(II) complexes. All the prepared compounds were characterized by 
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spectroscopic methods including IR, 1H and 13C NMR, UV-Visible and X-ray diffraction 
whenever possible and applicable, as well as AAS for metal analysis.  
The prepared compounds were screened for anti-ulcer test, the screening involved high 
(60 mg/kg) and low (30 mg/kg) dosage of compound onto a minimum number of 6 adult 
male and female albino Sprague-Dawley rats to determine the best dosage needed for the 
ulcer treatment. Rats were fasting for two days but were allowed to access to water. The 
rats were fed with synthetic compound in 10% Tween-20 and after 30 minutes absolute 
ethanol were administrated. They were left for another 30 minutes before sacrifice. The 1 
day screening process includes negative control (10% Tween-20) and positive control 
(Cimetidine). After the rats sacrificed, the stomachs are removed, incised along its greater 
curvature and gastric juices as well as the mucus were collected. The stomachs were 
preserved in 10% formalin for gastric lesions measurement to determine mucosal erosion. 
The sum of the areas was expressed as ulcer index (mm2). The mucus was weighted and 
juices were measured for pH. Values were expressed as mean ± S.E.M. 
Acute toxicity studies for the ligands were checked and assessed in terms of LD50. 
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2. Experimental 
 
2.1 Preparation of the ligands:  
 
2.1.1 Preparation of: 1H-Indole-3-ethylenesalicylaldimine (TS): 
 
              
N
N C
H
OH
H  
 
Tryptamine (0.3g, 1.87 mmol.) was dissolved in 50 ml of acidified ethanol (pH 4.5) and 
added to (0.228g, 1.86 mmol.) of salicylaldehyde in 50 ml acidified ethanol (pH 4.5). The 
mixture was stirred under reflux for 2 hours. The solid product was formed, filtered and 
recrystallized from hot ethanol (yield 71%). 
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2.1.2 Preparation of: 1H-Indole-3-ethylene-5-chlorosalicylaldimine (TCS):  
 
              
N
N C
H
OH
H
Cl
 
 
Tryptamine (0.3g, 1.87 mmol.) was dissolved in 50 ml of acidified ethanol (pH 4.5) and 
added to (0.29g, 1.80 mmol.) of 5-chlorosalicylaldehyde in 50 ml acidified ethanol (pH 
4.5). The mixture was stirred under reflux for 2 hours. A solid product was formed, 
filtered and recrystallized from hot ethanol (yield 79%). 
 
2.1.3 Preparation of: 1H-Indole-3-ethylene-5-nitrosalicylaldimine (TNS):  
 
                  
N
N C
H
OH
H
NO2
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Tryptamine (0.3g, 1.87 mmol.) was dissolved in 50 ml of acidified ethanol (pH 4.5) and 
added to (0.33g 1.9 mmol.) of 5-nitrosalisylaldehyde in 50 ml of acidified ethanol (pH 
4.5). The mixture was stirred for 2 hours under reflux. A solid product was formed, 
filtered, and recrystallized from hot THF (yield 54%).  
 
2.1.4 Preparation of: 1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldimine (TTET):  
 
               
N
N C
H
OH
H
But-t
But-t
 
 
Tryptamine (0.5g, 3.12 mmol.) was dissolved in 50 ml of acidified ethanol and added to 
(0.73g, 3.12 mmol.) of 3, 5 ditertiarybutyl-2-hydroxybenzaldehyde in 50 ml acidified 
ethanol. The mixture was refluxed for 2 hours in a water bath. The product was collected 
after the evaporation of ethanol at room temperature, and recrystallized from hot ethanol 
(yield is 80%).  
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2.1.5 Preparation of: 2-{1-[2-(1H-Indole-3-yl)ethylimino]-ethyl}phenol (THAP):  
 
                  
N
N
OH
H
CH3
 
 
Tryptamine (0.5g, 3.12 mmol.) in 50 ml acidified ethanol was added to (0.426g, 3.13 
mmol.) of 2-hydroxyacetophenone in 50 ml of acidified ethanol. The mixture was 
refluxed in a water bath for 2 hours. The solvent was reduced in a rotary evaporator, and 
the yellow product was collected by filtration, recrystallized from hot ethanol (yield is 
79.4%). 
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2.1.6 Preparation of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methyl phenol 
(TMeHAP): 
 
            
N
N
OH
H
CH3
CH3
 
 
Tryptamine (0.5g, 3.12 mmol.) was dissolved in 50 ml of acidified ethanol, and added to 
(0.468g, 3.11 mmol.) of 5-methyl-2-hydroxyacetophenone in 50 ml of acidified ethanol. 
The reaction mixture was refluxed for 2 hours in a water bath.  A solid product was 
formed, filtered and recrystallized from hot ethyl acetate (yield is 70%).  
 
2.1.7 Preparation of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy phenol 
(TOMeHAP): 
 
                    
 
 
 
N
N
OH
H
CH3
OCH3
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Tryptamine (1g, 6.24 mmol.) was dissolved in 50 ml of acidified ethanol, and added to 
(1.04g, 6.25 mmol.) of 5-methoxy-2-hydroxyacetophenone in 50 ml of ethanol. The 
reaction mixture was refluxed for 2 hours. The yellow product was formed after reduction 
of the solvent, filtered and recrystallized from hot ethyl acetate (percentage yield 72.2%).  
 
2.1.8 Preparation of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-chloro phenol 
(TClHAP): 
 
               
N
N
OH
H
CH3
Cl
 
 
Tryptamine (1g, 6.24 mmol.) was dissolved in 50 ml of acidified ethanol at pH 4.5, and 
added to (1.06g, 6.21 mmol.) of 5-chloro-2-hydroxyacetophenone in 50 ml of acidified 
ethanol. The reaction mixture was refluxed in a water bath for 2 hours. After the 
reduction of the solvent, the yellow crystalline product was filtered, washed with ethanol, 
and dried at room temperature (percentage yield 81.2%).  
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2.1.9 Preparation of: 4-Bromo-2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-phenol 
(TBrHAP): 
 
                
N
N
OH
H
CH3
Br
 
 
Tryptamine (1g, 6.24 mmol.) was dissolved in 50 ml of acidified ethanol, and added to 
(1.34g, 6.23 mmol.) of 5-bromo-2-hydroxyaceophenone in 50 ml acidified ethanol. The 
mixture was refluxed for 2 hours. A cotton yellow product was formed filtered and 
recrystallized from boiling ethanol (percentage yield 91.6 %).  
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2.2 Preparation of the complexes:  
 
2.2.1 Preparation of: bis(1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Zn(II): (TS)2Zn:  
 
                 
HC N
Zn
O
O
CHN
HN
HN
 
 
TS (0.5g, 1.89 mmol.) in 50 ml of ethanol and (0.21g, 0.956 mmol.) of zinc acetate 
dihydrate  in 10 mls of ethanol  was stirred and refluxed for 5 hours in the presence of 
few drops of triethylamine. The solid product formed was filtered and recrystallized from 
DMF (yield 0.458g, 82%). 
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2.2.2 Preparation of: bis(1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Ni(II): (TS)2Ni:  
 
                   
HC N
Ni
O
O
CHN
HN
HN
 
 
TS (0.506g, 1.91 mmol.) in 50 ml of ethanol and (0.231g, 0.930 mmol.) of nickel acetate 
tetrahydrate in 10 mls of ethanol  was stirred and refluxed for 5 hours in the presence of 
few drops of triethylamine. The solid product formed was filtered and recrystallized from 
DMF (yield 0.464g, 82.8%).  
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2.2.3 Preparation of: bis(1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Cu(II): (TS)2Cu:  
 
TS (0.505g, 1.91 mmol.) in 50 ml of ethanol and (0.189g, 0.951 mmol.) of copper(II) 
acetate monohydrate in 10 mls of ethanol was stirred and refluxed for 5 hours in the 
presence of few drops of triethylamine. The solid product formed was filtered and 
recrystallized from DMF (yield 0.481g, 85%).   
 
 
                    
HC N
Cu
O
O
CHN
HN
HN
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2.2.4 Preparation of: bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl] 
phenolato-κ2N, O} zinc(II): (TCS)2Zn: 
 
TCS (0.5g, 1.67 mmol.) in 50 ml of ethanol and (0.18g, 0.835 mmol.) of zinc acetate 
dihydrae in 10 mls of ethanol  was stirred and refluxed for 5 hours in the presence of few 
drops of triethylamine. The solid product formed was filtered, and recrystallized from 
DMF (yield 0.321g, 58%). 
 
 
             
HC N
Zn
O
O
CHN
HN
HN
Cl
Cl
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2.2.5 Preparation of: bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl] 
phenolato-κ2N, O} nickel(II): (TCS)2Ni: 
 
TCS (0.501g 1.67 mmol.) in 50 ml of ethanol and (0.207g, 8.35mmol.) of nickel acetate 
tetrahydrate in 10 mls of ethanol  was stirred and refluxed for 5 hours in the presence of 
few drops of triethylamine. The solid product formed was filtered and recrystallized from 
DMF (yield 0.321g, 70%). 
 
             
HC N
Ni
O
O
CHN
HN
HN
Cl
Cl
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2.2.6 Preparation of: bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl] 
phenolato-κ2N, O} copper(II): (TCS)2Cu: 
 
TCS (0.505g, of 1.69 mmol.) in 50 ml of ethanol and (0.168g, 8.41 mmol.) of copper 
acetate monohydrate in 10 mls of ethanol  was stirred and refluxed for 5 hours in the 
presence of few drops of triethylamine. The solid product formed was filtered and 
recrystallized from DMF (yield 0.474g, 85%). 
 
            
HC N
Cu
O
O
CHN
HN
HN
Cl
Cl
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2.2.7 Preparation of the complex: bis{4-nitro-2-[2-(1H-indol-3-yl)ethyliminomethyl] 
phenolato-κ2N, O} zinc(II): (TNS)2Zn: 
 
TNS (0.502g, 1.62 mmol.) in 50 ml of THF and (0.192g, 0.876 mmol.) of zinc acetate 
dihydrate in 10 mls of ethanol  was stirred and refluxed for 5 hours in the presence of few 
drops of triethylamine. The solid product formed was filtered and recrystallized from 
DMF (yield 0.326g, 59%).  
 
 
         
HC
N
Zn
O
O
CH
N
NHHN
O2N
NO2  
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2.2.8 Preparation of: bis{4-nitro-2-[2-(1H-indol-3-yl)ethyliminomethyl] 
phenolato-κ2N, O} nickel(II): (TNS)2Ni: 
 
         
HC
N
Ni
O
O
CH
N
NHHN
O2N
NO2  
 
TNS (0.505g, 1.63 mmol.) in 50 ml of ethanol and (0.203g, 8.15 mmol.) of nickel acetate 
tetrahydrate in 10 mls of ethanol  was stirred and refluxed for 5 hours in the presence of 
few drops of triethylamine. The solid product formed was filtered and recrystallized from 
DMF (yield 0.423g, 76.7%). 
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2.2.9 Preparation of: bis{4-nitro-2-[2-(1H-indol-3-yl)ethyliminomethyl] 
phenolato-κ2N, O} copper(II): (TNS)2Cu: 
 
         
HC
N
Cu
O
O
CH
N
NHHN
O2N
NO2  
 
TNS (0.505g, 1.62 mmol.) in 50 ml of THF and (0.181g, 0.91 mmol.) of copper acetate 
monohydrate in 10 mls of ethanol  was stirred and refluxed for 5 hours in the presence of 
few drops of triethylamine. The solid product formed was filtered and recrystallized from 
DMF (yield 0.423g, 76.2%). 
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2.2.10 Preparation of: bis(1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Zn(II): (TTET)2Zn: 
 
TTET (0.5g, 1.33 mmol) was dissolved in 50 ml of ethanol; and 20 ml (0.15g, 0.664 
mmol.) of zinc acetate dihydrate was added to the solution. Few drops of triethylamine 
were then added, and the mixture was refluxed in a water bath for 5 hours. The pale 
yellow product formed was collected through a filter paper, and recrystallized from 
DMSO. (yield 0.31g, 71.9%).  
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N
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2.2.11 Preparation of: bis(1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Ni(II): (TTET)2Ni: 
 
TTET (0.5g, 1.33 mmol.) was dissolved in 50 ml of ethanol; 20 ml (0.165g, 0.663 mmol.) 
of nickel acetate tetrahydrate was then added together with few drops of triethylamine. 
The mixture was refluxed for 5 hours. The sticky product formed was treated with n-
hexane whereby a brownish yellow precipitate was separated, filtered and washed several 
times with n-hexane (yield 0.126g, 23.46%). 
 
        
HC
N
Ni
O
O
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N
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But-t
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2.2.12 Preparation of: bis(1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Cu(II): (TTET)2Cu: 
 
TTET (0.5g, 1.33 mmol.) in 50 ml of ethanol was mixed with (0.13g, 0.651 mmol.) of 
copper acetate monohydrate in 20 ml of ethanol. Few drops of triethylamine were 
introduced to the reaction vesicle, and the mixture was refluxed for 5 hours. After the 
reduction of the solvent, a sticky product was formed, treated with n-hexane whereby a 
black precipitate was separated, filtered and washed with n-hexane. 
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N
Cu
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2.2.13 Preparation of:  
dichloridobis(2-{1-[2-(1H-indol-3-yl)-ethyliminio]ethyl}phenolate-kO)zinc(II): 
(THAP)2Zn:  
 
    
C
N
Zn
O
O
C
N
NHHN
Cl
Cl
CH3
H3C
 
 
THAP (0.5g, 1.8 mmol.) was dissolved in 50 ml of ethanol, and added to (0.122g, 0.895 
mmol.) of unhydrous zinc chloride in 20 ml of dry ethanol; 0.024g of sodium hydride 
was then added. The reaction mixture was brought into a vacuum line, evacuated from air 
and refluxed for 5 hours under nitrogen. The product formed was collected and 
recrystallized from hot ethanol.  
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2.2.14 Preparation of:  
bis(2-{1-[2-(1H-indol-3-yl)- ethyliminio]ethyl}phenolato-k2N, O)Ni(II): (THAP)2Ni: 
 
THAP (0.5g, 1.8 mmol.) in 20 ml of ethanol, 0.06g of NaH and (0.224g, 0.90 mmol.) of 
nickel acetate tetrahydrate in 20 ml of ethanol were mixed and refluxed for 3 hours in a 
water bath. After which the reaction volume was reduced to the third, then distilled water 
was added. The green precipitate formed was filtered, washed with water and ethanol and 
dried in the oven at 50 0C.  
 
           
C
N
Ni
O
O
C
N
NHHN
H3C
CH3
 
 
2.2.15 Preparation of:  
bis(2-{1-[2-(1H-indol-3-yl)-ethyliminio]ethyl}phenolato-k2N, O)Cu(II): (THAP)2Cu: 
 
THAP (0.5g, 1.8 mmol.) in 50 ml of ethanol, and (0.177g, 0.88 mmol.) of copper acetate 
monohydrate in 20 ml of ethanol were mixed. Few drops of triethylamine were added to 
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the reaction mixture, and the reaction was refluxed for 5 hours in a water bath. A brown 
product was formed, filtered, washed with ethanol and dried at room temperature. 
(percentage yield 28.4%).  
 
               
C
N
Cu
O
O
C
N
NHHN
H3C
CH3
 
 
2.2.16 Preparation of:  
bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methylphenolato-k2N,O}Cu(II): 
(TMeHAP)2Cu: 
 
 40 
           
C
N
Cu
O
O
C
N
NHHN
H3C
CH3
H3C
CH3  
 
TMeHAP (0.5g, 1.71 mmol.) was dissolved in 50 ml of ethanol, and added to (0.173g, 
0.866 mmol.) of copper acetate monohydrate in ethanol followed by few drops of 
triethylamine to make the reaction mixture slightly basic. The mixture was refluxed for 5 
hours and the brown product formed was filtered, washed with ethanol and dried at room 
temperature (yield 34.6 %).  
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2.2.17 Preparation of:  
bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxyphenolato-k2N,O}Ni(II): 
(TOMeHAP)2Ni: 
 
             
C
N
Ni
O
O
C
N
NHHN
H3C
CH3
H3CO
OCH3  
 
TOMeHAP (0.5g, 1.62 mmol.) was dissolved in 20 ml of ethanol, and added to (0.2g, 
0.80 mmol.) of nickel acetate tetrahydrate in 20 ml of ethanol. 0.06g of NaH was 
introduced to the reaction mixture. The mixture was refluxed for 5 hours in a water bath 
after which time the volume of the reaction was reduced to the third. Distilled water was 
then added. A yellow product was separated, filtered, washed with water, ethanol and 
dried at 50 0C at the oven.  
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2.2.18 Preparation of:  
bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxyphenolato-k2N,O}Cu(II): 
(TOMeHAP)2Cu: 
 
TOMeHAP (0.5g, 1.62 mmol.) was dissolved in 50 ml of ethanol, and added to (0.16g, 
0.80 mmol.) of copper acetate monohydrate in 20 ml of ethanol. Few drops of 
triethylamine were then added. The mixture was refluxed in a water bath for 5 hours. The 
brown precipitate formed was then filtered, washed with ethanol and dried at room 
temperature (percentage yield 19.1%)  
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2.2.19 Preparation of:  
bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-chlorophenolato-k2N,O}Ni(II): 
(TClHAP)2Ni: 
 
The ligand (0.5g, 1.68 mmol.) was dissolved in 20 ml of ethanol, and added to (0.2g, 0.80 
mmol.) of nickel acetate tetrahydrate in 20 ml of ethanol. 0.06g of NaH was then added. 
The mixture was refluxed for 3 hours after which the volume was reduced and water was 
added. A solid product was formed, filtered, washed with ethanol and water and dried in 
the oven at 50 0C.  
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2.2.20 Preparation of:  
bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-chlorophenolato-k2N,O}Cu(II): 
(TClHAP)2Cu: 
 
The ligand (0.5g, 1.68 mmol.) was dissolved in 50 ml of ethanol and added to (0.16g, 
0.80 mmol.) of copper acetate monohydrate in 20 ml of ethanol. Few drops of 
triethylamine were then added. The mixture was refluxed for 5 hours. A brown solid was 
formed, filtered, washed with ethanol and dried at room temperature.  
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2.2.21 Preparation of:  
bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-bromophenolato-k2N,O}Cu(II): 
(TBrHAP)2Cu: 
 
            
C
N
Cu
O
O
C
N
NHHN
H3C
CH3
Br
Br  
 
The ligand (0.5g, 1.40 mmol.) was dissolved in 50 ml of ethanol and added to 20 ml 
(0.137g, 0.68 mmol.) of copper acetate monohydrate in ethanol. Few drops of 
triethylamine were then added. The reaction mixture was refluxed for 5 hours. A brown 
solid was formed, filtered, washed with ethanol and dried at room temperature 
(percentage yield 41%).  
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2.3 Metal analysis by atomic absorption spectroscopy (AAS):  
 
An accurately weighted amount (see table 2.1) of the complex sample was taken and 
digested with 10 mls of concentrated nitric acid in a hot plate heater, after the evolution 
of the brown nitrogen dioxide gas has ceased, 10 mls of concentrated sulphuric acid was 
then added and the heating continued until all the brown vapors of nitrogen dioxide was 
completely stopped and the solution becomes clear. The solution was then cooled, diluted 
with distilled water to 100 ml volumetric flask. From this solution, 0.4 ml was taken and 
diluted further to 10 ml volumetric flask. Concentration measurements was carried out   
and the results were summarized in table (2.1) 
 
Experimental percentage has been calculated according to the formula:  
 
               %age of copper = conc. (ppm) × 0.25 / weight of sample taken   
 
Table (2.1): Results of Cu analysis by AAS: 
 
No. Name of complex Weight 
taken (g) 
Conc. Value 
(ppm) 
Experimental 
percentage 
Theoretical 
percentage 
1 (TS)2Cu 0.0463 1.8963 10.24 10.77 
2 (TCS)2Cu 0.0518 2.0650 9.96 9.65 
3 (TNS)2Cu 0.0534 1.8892 8.84 9.35 
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Table 2.1 contiued 
No. Name of complex Weight 
taken (g) 
Conc. Value 
(ppm) 
Experimental 
percentage 
Theoretical 
percentage 
4 (TTET)2Cu 0.0643 1.9235 7.48 7.80 
5 (THAP)2Cu 0.0487 2.0142 10.33 10.27 
6 (TMeHAP)2Cu 0.0506 2.0136 9.94 9.83 
7 (TOMeHAP)2Cu 0.0534 1.9172 8.97 9.36 
8 (TClHAP)2Cu 0.0544 1.9645 9.03 9.24 
9 (TBrHAP)2Cu 0.0613 1.8039 7.35 8.18 
 
2.4 Physical properties of the prepared ligands and complexes:  
The physical properties of all the prepared ligands and complexes throughout this work 
including color, molecular weights, melting points and CHN elemental analysis were 
listed in appendix (A).  
 
 
 
 
CHAPTER THREE 
 
 
 
RESULTS AND DISCUSSION  
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3. Characterization of ligands and complexes 
 
3.1 IR spectra of ligands and complexes:  
 
3.1.1 IR spectra of the ligand: 1H-Indole-3-ethylenesalicylaldimine (TS) and its Zn, Ni, 
and Cu complexes:  
 
The IR spectra of the ligand and its associated complexes was summarized in table (3.1) 
and shown in Fig 3.1, 3.2., 3.3 and 3.4  
 
Table (3.1) IR data of TS and its Zn, Ni, and Cu complexes:  
Compound N-H O-H C-H 
aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar 
M-O M-N 
TS 3420 3049-
2857 
broad 
2936 1630 1281 746 - - 
(TS)2Zn 3411 - 3170-
2924 
1623 1302 738 596 489 
(TS)2Ni 3447 - 2926 1612 1332 740 597 421 
(TS)2Cu 3424 - 2901 1623 1326 743 579 427 
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It has been shown that by comparing the IR spectra of the ligand precursor, 
salicylaldehyde and the ligand itself, the absence of the characteristic aldehydic carbonyl 
group stretching band near 1700 cm-1, and the appearance of the azomethine –C=N band 
at 1630 cm-1 indicating the formation of the Schiff base. The broad band at 3049-2857 
cm-1 could be attributed to the intramolecular hydrogen-bonded O-H group [58]. The 
hydrogen bond arises between the azomethine nitrogen atom and the proton of the 
hydroxyl group [21]. The sharp band at 3420 cm-1 is due to the N-H stretching of the 
indole group. The C-O phenolic band appears at 1281 cm-1, and the strong band at 746 
cm-1 is attributed to the C-H out- of- plane aromatic bend.  
In the case of (TS)2Zn complex, it is clear that the hydroxyl band at 3049 cm
-1 of the 
ligand was disappeared indicating deprotonation of the ligand, and confirming co-
ordination of the phenolic oxygen atom to the metal [59]. This fact can also be supported 
further by the shifting of the C-O stretching band with respect to the same band in the 
free ligand. The azomethine stretching band in the free ligand shifts from 1630 cm-1 to 
1623 cm-1 in the complex. This supports the participation of the azomethine nitrogen 
atom in coordinate bond to the metal center.   
A new bands at 596 cm-1 and 489 cm-1 could be assigned to vibrations associated with 
Zn-O, and Zn-N bonds respectively [21,61]. 
For (TS)2Ni complex, the band at 1612 cm
-1 could be assigned to the shifted azomethine 
–C=N stretch upon complexation. C-O phenolic band shifts to 1332 cm-1 and Ni-O and 
Ni-N vibrations appear at 597 cm-1 and 421 cm-1 respectively. 
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Same explanations can be given to the copper complex (TS)2Cu indicating similar co-
ordination manner for the three metal ions. The -C=N band for the copper complex 
appears at 1623 cm-1 just like its zinc congener, C-O at 1326 cm-1 , Cu-O at 579 cm-1 and 
Cu-N at 427 cm-1. 
 
 
Fig 3.1: IR spectra of: 1H-Indole-3-ethylenesalicylaldimine (TS) 
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H
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Fig 3.2: IR spectra of: Bis(1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Zn(II) (TS)2Zn 
 
 
 
Fig 3.3: IR spectra of: Bis(1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Ni(II) (TS)2Ni 
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Fig 3.4: IR spectra of: Bis(1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Cu(II) (TS)2Cu 
 
 
 
3.1.2 IR spectra of the ligand: 1H-Indole-3-ethylene-5-chlorosalicylaldimine (TCS) and 
its Zn, Ni, and Cu complexes:  
 
The IR spectra of the ligand and its associated complexes were summarized in table (3.2) 
and shown in Fig 3.5, 3.6, 3.7 and 3.8  
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Table (3.2): IR spectra of TCS and its Zn, Ni, and Cu complexes: 
Compound N-H O-H C-H 
aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar 
M-O M-N 
TCS 3434 3054 2919 1630 1281 746 - - 
(TCS)2Zn 3409 - 2920 1630 1311 739 580 425 
(TCS)2Ni 3431 - 2918 1617 1326 739 463 420 
(TCS)2Cu 3431 - 2913 1622 1324 739 453 421 
   
 
It can be shown from the table that for the free ligand, the N-H indolic stretching 
frequency appears at 3434 cm-1 a little bit higher than TS ligand. The phenolic O-H band 
appears at 3054 cm-1 as a broad band. The azomethine –C=N band appears at the same 
frequency 1630 cm-1 as TS ligand indicating that the chlorine substituent in the fifth 
position of the phenolic ring does not affect the position of this band. Further more the  
C-O stretching vibration appears at 1281 cm-1, and the aromatic out-of-plane bending 
vibration at 746 cm-1. 
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In the spectra of (TCS)2Zn complex, the O-H band of the ligand at 3054 cm
-1 was also 
similarly disappeared indicating co-ordination through the phenolic oxygen to the zinc 
atom. This fact also reinforced by the shifting of the C-O band from 1281 cm-1 in the 
ligand to 1311 cm-1 in the complex . The bands observed at the region 580 cm-1 and 425 
cm-1 can be related to Zn-O and Zn-N stretching respectively.  
The spectra of (TCS)2Ni looks somewhat similar to the zinc complex except the 
azomethine –C=N band has shifted to lower frequency to be at 1617 cm-1, C-O band at 
1326 cm-1 and bands due to Ni-O and Ni-N at 463 cm-1 and 420 cm-1 respectively 
supporting the proposed structure.  
The same explanation could be described for the copper complex of the ligand. Both –
C=N and C-O stretching frequencies shifts to 1622 cm-1 and 1324 cm-1 in comparison to 
the free ligand because of complex formation. Cu-O and Cu-N bands observed at 453  
cm-1 and 421 cm-1 respectively. 
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Fig 3.5: IR spectra of: 1H-Indole-3-ethylene-5-chlorosalicylaldimine (TCS) 
 
 
 
 
Fig 3.6: IR spectra of: Bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ2N,O}zinc(II) (TCS)2Zn 
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Fig 3.7: IR spectra of: Bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ2N,O}nickel(II) (TCS)2Ni 
 
 
 
 
Fig 3.8: IR spectra of: Bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ2N,O}copper(II) (TCS)2Cu 
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3.1.3 IR spectra of the ligand:  1H-Indole-3-ethylene-5-nitrosalicylaldimine (TNS) and its 
Zn, Ni, and Cu complexes:  
 
The IR spectra of the ligand together with its complexes were shown in table (3.3) and 
figures 3.9, 3.10, 3.11 and 3.12. 
Table (3.3):  
IR spectra of the ligand TNS and its Zn, Ni, and Cu complexes:  
Compound N-H O-H C-H 
aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar 
M-O M-N 
TNS 3360 - 2929 1647 1301 741 - - 
(TNS)2Zn 3414 - 2925 1635 1316 739 518 425 
(TNS)2Ni 3414 - 2951 1603 1315 748 526 425 
(TNS)2Cu 3399 - 2913 1619 1301 739 553 446 
 
From the table above it can be concluded that for the free ligand N-H indolic stretching 
frequency appears at 3360 cm-1. The azomethine (–C=N) band in this case appears a little 
bit higher at 1647 cm-1 with respect to the previously described ligands. The band at 1301 
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cm-1 is assigned to the C-O stretching of the phenolic group and the band at 1545 cm-1 
could be ascribed to the vibrations of the nitro group [60]. 
With regard to the zinc complex of this ligand, the –C=N band was shifted to 1635 cm-1 
due to the withdrawal of electron density from the nitrogen atom owing to co-ordination 
to the Zn metal [62, 29]. Similar shift to higher frequency was observed for the C-O 
stretching band. Bands at 518 cm-1 and 425 cm-1 are due to Zn-O and Zn-N vibrations 
respectively.  
In (TNS)2Ni complex, the C=N band appears at a more lower wave number 1603 cm
-1 in 
comparison with the zinc complex of the same ligand. The band at 526 cm-1 was 
assignable to Ni-O bond, and Ni-N band is not clear in the spectra. Tentative assignments 
can be postulated for this bond either 425 cm-1 or 484 cm-1.  
The same description can be given to (TNS)2Cu complex. Similarities in the trends of IR 
bands were clearly observed suggesting similar structure to the zinc and nickel 
complexes. The bands between 588 – 420 cm-1 are assigned to vibrations that probably 
coupled Cu-N and Cu-O in accordance with the literature [21, 63, and 67]. 
 
 60  
 
 
Fig 3.9: IR spectra of: 1H-Indole-3-ethylene-5-nitrosalicylaldimine (TNS) 
 
 
 
 
Fig 3.10: IR spectra of: Bis {4-nitro-2-[2-(1H-indol-3-yl) ethyliminomethyl]phenolato-
κ2N,O}zinc(II) (TNS)2Zn 
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Fig 3.11: IR spectra of: Bis {4-nitro-2-[2-(1H-indol-3-yl) ethyliminomethyl]phenolato-
κ2N,O}nickel(II) (TNS)2Ni 
 
 
 
Fig 3.12: IR spectra of: Bis {4-nitro-2-[2-(1H-indol-3-yl) ethyliminomethyl] phenolato-
κ2N, O} copper (II) (TNS)2Cu 
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3.1.4 IR spectra of the ligand:  
1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldimine (TTET) and its Zn, Ni, and Cu 
complexes:  
Table (3.4):  
IR spectra of the ligand TTET and its Zn, Ni, and Cu complexes:  
Compound N-H O-H C-H 
aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar 
M-O M-N 
TTET 3400 overlap 2953 1631 1250 750 - - 
(TTET)2Zn 3410 - 2956 1615 1254 744 540 488 
(TTET)2Ni 3404 - 2952 1613 1255 742 542 485 
(TTET)2Cu 3428 - 2954 1618 1257 745 539 476 
 
IR spectra for the ligand and its complexes were shown in table (3.4) and figures 3.13, 
3.14, 3.15, and 3.16  
The stretching vibration of the indolic N-H group for the ligand was found at 3400 cm-1, 
while the broad band associated with the hydroxyl group overlaps the C-H aliphatic band 
range. The azomethine stretching frequency lies within the normal range at 1631 cm-1,  
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C-O at 1250 cm-1 and the aromatic out-of-plane bending mode at 750 cm-1. 
For (TTET)2Zn complex the broad overlapping O-H vibration was disappeared indicating 
that, the deprotonation of the ligand was occurred upon complexation, and this fact was 
supported by the downward displacement of the azomethine –C=N band to 1615 cm-1. 
The new band 540 cm-1 corresponds to Zn-O stretch and the band at 488 cm-1 
corresponds to Zn-N stretch. 
Similar correlations can be mentioned for Ni and Cu complexes, shifting to lower wave 
numbers was noted for the azomethine group due to co-ordination of the nitrogen atom to 
the metal center, thus for nickel complex this band shifts more further to 1613 cm-1, and 
be more or less the same for the copper complex at 1618 cm-1 as its zinc congener. For 
the three complexes the phenolic C-O band shifts to higher frequency [64, 57]. The shift 
may be interpreted in terms of π-conjugation between the benzene ring and the chelate 
ring of the complex [36]. 
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Fig 3.13: IR spectra of: 1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldimine (TTET) 
 
 
 
 
Fig 3.14: IR spectra of: Bis(1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Zn(II) (TTET)2Zn 
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Fig 3.15: Bis (1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-k2N,O)Ni(II) 
(TTET)2Ni 
 
 
 
Fig 3.16: IR spectra of: Bis (1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Cu(II) (TTET)2Cu 
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3.1.5 IR spectra of the ligand: 2-{1-[2-(1H-Indole-3-yl) ethylimino]-ethyl}phenol (THAP) 
and its Zn, Ni, and Cu complexes:  
The IR spectra of the ligand and its complexes have been summarized in table (3.5) and 
presented in figures 3.17, 3.18, 3.19 and 3.20  
Table (3.5): IR spectra of the ligand THAP and its Zn, Ni, and Cu complexes:  
Compound N-H O-H C-H 
Aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar. 
M-O M-N 
THAP 3433 3142-
2875Brd 
2926 1609 1265 731 - - 
(THAP)2Zn 3442 - 2872 1610 1261 750 581 - 
(THAP)2Ni 3409 - 2917 1611 1220 745 583 428 
(THAP)2Cu 3371 - 2940 1599 1237 738 525 429 
  
The indolic N-H stretching frequency is not clearly shown in the spectra and may be 
embedded in the broad hydroxyl band in the range 3433 cm-1 – 2875 cm-1, aliphatic C-H 
stretch appears at the wave number 2926 cm-1 and –C=N stretching frequency at 1609 
cm-1 as expected. C-O phenolic stretching vibration wave number was 1265 cm-1 and the 
aromatic out-of-plane bending mode at 731 cm-1[65]. 
In the zinc complex spectrum of the ligand, the indolic N-H vibration was clearly 
appeared at 3442 cm-1 owing to the disappearance of the broad O-H band upon 
complexation, indicating deprotonation of the ligand and the oxygen atom was 
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participated in bond formation with the metal center. The C-H aliphatic stretching 
frequency was shifted to 2872 cm-1, and the wave number of the C=N stretching 
frequency appears at 1610 cm-1. This band doesn’t shift considerably, and may indicate 
that the azomethine nitrogen atom does not contribute in bond formation through the lone 
pair donation. This phenomenon was confirmed by the X-ray crystal structure and the 
ligand acts only as a unidentate ligand through the hydroxyl oxygen atom [66]. Further 
evidence for this is derived from the shifting of the C-O band and the creation of the new 
band at 581 cm-1 assignable to Zn-O stretch as well as the disappearance of the Zn-N 
band as compared to the previous zinc complexes of similar ligands. 
For the nickel complex of the ligand, N-H stretching vibration appears at 3409 cm-1 upon 
disappearance of the broad O-H band, indicating co-ordination through O-H oxygen 
atom. Azomethine wave number appears at 1611 cm-1, and the C-O vibration shifts to 
lower frequency 1220 cm-1. New bands at 583 cm-1 and 428 cm-1 are assignable to M-O 
and M-N vibrations respectively [64]. 
In the case of copper complex of the ligand, as compared to the free ligand, the N-H 
indolic vibration was clearly shown at 3371 cm-1, and the O-H band was vanished. This 
illustrate that, deprotonation of the ligand occurred through complex formation. The –
C=N stretching vibration shifts to lower wave number and appears at 1599 cm-1 a feature 
indicates decreasing of the bond order upon complex formation due to the participation of 
the nitrogen lone pair on dative bond. The C-O phenolic band shifts to 1237 cm-1 as well. 
This also may confirm C-O     Cu donation. New bands appear in the spectrum at 525  
cm-1 and 429 cm-1 ascribed to Cu-O and Cu-N vibrations respectively. 
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Fig 3.17: IR spectra of: 2-{1-[2-(1H-Indole-3-yl) ethylimino]-ethyl} phenol (THAP) 
 
 
 
 
Fig 3.18: IR spectra of: Dichloridobis(2-{1-[2-(1H-indol-3-yl)- 
ethyliminio]ethyl}phenolate-kO)zinc(II) (THAP)2Zn 
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Fig 3.19 IR spectra of: bis(2-{1-[2-(1H-indol-3-yl)- ethyliminio]ethyl}phenolato-k2N, 
O)Ni(II) (THAP)2Ni 
 
Fig 3.20: IR spectra of: Preparation of: Bis(2-{1-[2-(1H-indol-3-yl)-
ethyliminio]ethyl}phenolato-k2N, O)Cu(II) (THAP)2Cu 
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 3.1.6 IR spectra of the ligand: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methyl 
phenol:  (TMeHAP) and its Cu complex:  
The summery for the spectral lines was given in table (3.6) and the spectra itself was 
shown in figures 3.21 and 3.22.  
Table (3.6): IR spectra of TMeHAP and its Cu complex: 
Compound N-H O-H C-H 
Aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar. 
M-O M-N 
TMeHAP Superimposed 3167-2915 2915 1605 1280 753 - - 
(TMeHAP)2Cu 3417 - 2918 1589 1315 740 509 424 
 
Like the previous ligand, the sharp N-H vibration band was superimposed on the broad 
O-H phenolic hydroxyl band at the range 3167 – 2915 cm-1. The strong band at 1605 cm-1 
belongs to the –C=N stretching frequency and the C-O phenolic band appears at 1280 
 cm-1. The strong sharp band at 753 cm-1 is due to aromatic out-of-plane bending mode. 
In the copper complex of the ligand, the broad O-H stretching band was disappeared and 
in turn the embedded N-H band was appeared as a sharp band at the wave number 3417 
cm-1. The azomethine band shifts to 1589 cm-1 upon complexation confirming the 
previously mentioned information of nitrogen lone pair donation towards the metal ion. 
The C-O band appears at 1315 cm-1 and the sharp strong band at 740 cm-1 could be 
attributed to the out-of-plane aromatic bending mode. Once again new bands in the 
region 509 cm-1 – 424 cm-1 were appeared due to Cu-O and Cu-N vibrations. 
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Fig 3.21: IR spectra of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methyl phenol 
(TMeHAP) 
 
 
 
Fig 3.22: IR spectra of: Bis {2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methyl 
phenolato-k2N, O}Cu(II) (TMeHAP)2Cu 
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3.1.7 IR spectra of the ligand: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy 
phenol (TOMeHAP) and its Ni, and Cu complexes:  
The main bands of the spectra were summarized in table (3.7) and complete spectra was 
shown in figures 3.23, and 3.24  
Table (3.7): IR spectra of the ligand TOMeHAP and its Ni, and Cu complexes  
Compound N-H O-H C-H 
Aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar. 
M-O M-N 
TOMeHAP - 3166 2913 1602 1222 757 - - 
(TOMeHAP)2Ni 3331 - 2929 1599 1214 745 536 426 
(TOMeHAP)2Cu 3413 - 2930 1598 1213 745 531 421 
 
It is shown from the table that, like the previously described ligand, the indolic N-H 
stretching frequency was overlapped by the broad O-H band at 3166 cm-1. The 
azomethine (–C=N) functional group frequency appears in the normal range at 1602 cm-1, 
and the band at 1222 cm-1 is due to the C-O phenolic stretching mode. The characteristic 
out-of-plane aromatic band displayed at 757 cm-1 in the spectra. 
In the case of Ni complex of the ligand, the N-H stretching band appears as a medium 
intensity band at 3331 cm-1and O-H phenolic band was not shown in the spectra. The 
C=N stretching band shifts a little bit to 1599 cm-1 as compared to the free ligand, and so 
the phenolic C-O band which shifts to 1214 cm-1. This phenomenon explained the fact 
that co-ordination through both nitrogen and oxygen atom has occurred. This fact can be 
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supported by the appearance of new band 536 cm-1 ascribed to Ni-O and 426 cm-1, may 
be due to Ni-N bond. 
The same explanation can be described to the copper complex. The O-H stretching 
frequency was diminished, and the azomethine C=N frequency shifts to lower wave 
number at 1598 cm-1 proving co-ordination through the nitrogen lone pair towards the 
copper ion. Similarly low frequency shift was observed for the phenolic C-O band from 
1222 cm-1 in the free ligand to 1213 cm-1 in the complex. A band at 531 cm-1 may be due 
to Cu-O bond and the Cu-N band appears as a weak band at 421 cm-1.  
 
 
 
Fig 3.23: IR spectra of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy phenol 
(TOMeHAP) 
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Fig 3.24: IR spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4  
methoxyphenolato-k2N,O}Ni(II): (TOMeHAP)2Ni 
 
 
Fig 3.25: IR spectra of: Bis {2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy 
phenolato-k2N,O}Cu(II) (TOMeHAP)2Cu 
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3.1.8 IR spectra of the ligand: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-chloro 
phenol: (TClHAP) and its Ni and Cu complexes:  
 
The main IR bands for the ligand and complexes are given in table (3.8) and figures 3.26, 
3.27 and 3.28  
 
Table (3.8): IR spectra of the ligand TClHAP and its Ni, and Cu complexes:  
Compound N-H O-H C-H 
Aliphatic 
C=N C-O C-H 
Out of 
plane 
Ar. 
M-O M-N 
TClHAP 3407 3055 2916 1614 1297 743 - - 
(TClHAP)2Ni 3350 - 2932 1602 1306 743 517 450 
(TClHAP)2Cu 3419 - 2920 1594 1315 737 593 490 
 
As it can be shown from the table, strong band at a wave number of 3407 cm-1 could be 
assigned to the N-H indolic stretching vibration; while the hydroxyl band can not be 
identified clearly in the spectra may be due to hydrogen bond. The band at 2916 cm-1 is 
due to C-H aliphatic stretching frequency. Schiff base formation can be proved by the 
appearance of the strong sharp band of azomethine –C=N group at 1614 cm-1 and the 
phenolic C-O band appears at 1297 cm-1 in the usual expected range. The strong sharp 
band at 743 cm-1 was attributable to aromatic out-of-plane C-H bending mode. 
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In comparing the spectra of the Ni complex to that of the free ligand, the most 
characteristic feature is the absence of the broad O-H band, probably due to 
deprotonation of the ligand upon complex formation. The azomethine -C=N stretching  
band shifts to lower wave number 1602 cm-1, while the phenolic C-O stretching band 
shifts remarkably to higher frequency 1306 cm-1 as compared to the ligand. This shift 
suggests that co-ordination through the oxygen atom has occurred. The sharp aromatic 
out-of-plane band remains intact, and the new bands at the low wave numbed end of the 
spectra 517 cm-1 and 450 cm-1 could be assigned to Ni-O and Ni-N frequencies 
respectively.  
The comparison of the IR spectra of the ligand and its copper complex illustrates, 
principally, coordination to the copper centre is in two ways. The band appearing at 1614 
cm-1 due to the azomethine linkage in the ligand is shifted to lower frequency by 20 cm-1 
in the complex. This proves azomethine nitrogen interaction with the metal ion. A broad 
band centered at 3055 cm-1 assigned to O-H in the Schiff base was no longer found in the 
spectra of the metal complex. Instead, appearance of strong band at 1315 cm-1 due to C-O 
stretching vibration was observed, indicating deprotonation and coordination of the 
hydroxyl oxygen to the copper ion. Further conclusive evidence of the coordination 
pattern was provided by the appearance of weak intensity bands at 593 cm-1 and 490 cm-1 
assignable to Cu-O and Cu-N vibrations respectively.   
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Fig 3.26: IR spectra of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-chloro phenol 
(TClHAP) 
 
 
 
Fig 3.27: IR spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
chlorophenolato-k2N,O}Ni(II): (TClHAP)2Ni 
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Fig 3.28: IR spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
chlorophenolato-k2N,O}Cu(II): (TClHAP)2Cu 
 
3.1.9 IR spectra of the ligand: 4-Bromo-2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-
phenol (TBrHAP) and its copper complex:  
The main IR bands of the ligand and complexes are given in table (3.9) and figures 3.29 
and 3.30 
Table (3.9): IR spectra of the ligand TBrHAP and its copper complex:  
Compound N-H O-H C-H 
Aliphatic 
C=N C-O C-H 
Out of plane 
Ar. 
M-O M-N 
TBrHAP 3406 3054 2915 1618 1230 746 - - 
(TBrHAP)2Cu 3414 - 2943 1592 1233 737 590 490 
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As for the previous chloro-substituted ligand, the indolic N-H stretching mode appears 
almost in the same frequency 3406 cm-1, and the broad band centered at 3054 cm-1 
belongs to the intra-molecular hydrogen bonded O-H group. The sharp band at 1618 cm-1 
could clearly be assigned to –C=N vibration. C-O stretching mode appears at low 
frequency 1230 cm-1 as compared to the chloro-substituted ligand described earlier, and 
the sharp band at 746 cm-1 is the aromatic out-of-plane bending vibration. 
In the spectra of the copper complex, there is a remarkable disappearance of the O-H 
band probably owing to deprotonation and co-ordination through the oxygen atom and 
the azomethine –C=N band shifts to lower wave number to be at 1592 cm-1. This imposes 
further evidence to the participation of the azomethine nitrogen atom in a dative bond 
through its lone pair of electrons and the ligand acts as a bidentate ligand. New bands at 
the wave numbers 590 cm-1 and 490 cm-1 could be ascribed to metal-ligand vibrations 
Cu-O and Cu-N respectively.  
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Fig 3.29: IR spectra of: 4-Bromo- 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}- phenol 
(TBrHAP) 
 
Fig 3.30: IR spectra of: Bis {2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-bromo 
phenolato-k2N,O}Cu(II) 
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3.2 Proton NMR spectra of the ligands and complexes:  
 
3.2.1 Proton NMR spectra of the ligand: 1H-Indole-3-ethylenesalicylaldimine (TS): 
 
The 1H NMR spectra of the ligand TS was recorded in d6-DMSO with chemical shifts 
expressed in ppm using tetramethylsilane (TMS) as internal standard was given in table 
(3.10) and shown in figure 3.31  
 
Table (3.10): 1H NMR spectra of TS and its Zn, Ni, and Cu complexes  
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Table 3.10: 1H NMR Chemical shifts in ppm:  
Compound Ha Hb Hc Hd He Haromatic 
TS 10.79(s) 3.03(t) 3.85(t) 8.43(s) - 6.81-7.32(m) 
(TS)2Zn 10.76(s) 2.88(t) 3.71(t) 8.39(s) - 6.56-7.30(m) 
(TS)2Ni No clear spectra    
(TS)2Cu No clear spectra 
 
It can be concluded that the data shown in the table agrees well with the proposed 
structure shown above. The indolic proton Ha appears as a singlet at 10.79 ppm, 
integration due to one proton. This position may be overlapping with the hydroxyl O-H 
proton when deuterated chloroform were used as a solvent [21] due to the effect of intra-
molecular hydrogen bonding with the azomethine nitrogen atom [63]. The aliphatic (-
CH2-) protons Hb resonate as a triplet at 3.03 ppm and the other (-CH2-) protons of the 
tryptamine moiety Hc also resonate as a triplet at higher frequency 3.85 ppm. The 
aldehydic proton Hd resonates as a singlet down field at 8.43 ppm, and the aromatic 
protons appears in the range 6.81 – 7.32 ppm as a multiplet integration indicates 9 
protons altogether. The peaks at 2.50 and ≈ 3.40 ppm are solvent peaks. 
If we consider the zinc complex of the ligand, the spectra is somewhat similar to the 
ligand indicating a symmetrical arrangement of the ligand around the metal ion (See Fig 
3.32). The O-H proton signal was disappeared as a result of proton substitution by a 
cation. Hb protons go to slightly lower chemical shift value 2.88 ppm and so Hc protons 
to 3.71 ppm. The aldehydic proton appears at 8.39 ppm as a singlet and the aromatic 
protons in the usual range 6.56 – 7.30 ppm as a multiplet.  
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No 1H NMR spectra was detected for Ni and Cu complexes of the ligand because they are 
paramagnetic in solution.  
 
3.2.2 Proton NMR spectra of the ligand: 1H-Indole-3-ethylene-5-chlorosalicylaldimine  
(TCS):  
 
The NMR spectrum of the ligand was summarized in table (3.11) with chemical shifts 
expressed in ppm downfield tetrametyl silane as internal reference. The full spectrum was 
shown in Fig 3.33. 
 
Table (3.11): 1H NMR spectra of TCS and its Zn complex:  
Compound Ha Hb Hc Hd He Haromatic 
TCS 10.80(s) 3.03(t) 3.85(t) 8.45(s) - 6.82-7.42(m) 
(TCS)2Zn 10.79(s) 2.90(t) 3.74(t) 8.40(s) - 6.74 –7.30(m) 
 
The indolic N-H proton appears as a singlet at 10.80 ppm. Two triplets at 3.03 ppm and 
3.85 ppm are due to the ethylene (-CH2-) groups of the tryptamine Hb and Hc 
respectively. The aldehydic proton Hd observed as a singlet at 8.45 ppm, and the aromatic 
protons in the range 6.82 – 7.42 ppm as a multiplet. Integration line indicates 8 protons 
altogether due to the presence of chlorine substituent compared to the previous 
unsubstituted ligand. 
For (TCS)2Zn complex, likewise the spectra appears to be closely similar to the ligand 
spectra (See Fig 3.34) and this phenomenon may be explained according to the 
 85  
symmetrical arrangement of the ligand atoms around the central zinc ion. The only 
remarkable difference is the absence of the hydroxyl proton signal He as a result of 
complex formation besides a slight shift of the position of the aromatic protons chemical 
shift values in relation to the ligand. 
No clear spectrum was recorded for the nickel and copper complexes of this ligand due to 
their paramagnetic nature in solution. 
 
3.2.3 Proton NMR spectra of the ligand: 1H-Indole-3-ethylene-5-nitrosalicylaldimine 
(TNS): 
The spectrum was shown in table (3.12) with chemical shifts in ppm downfield 
tetramethyl silane as refrence. Full spectrum was shown in Fig 3.35. 
Table (3.12): 1H NMR spectra of the ligand TNS and its complexes:  
Compound Ha Hb Hc Hd He Haromatic 
TNS 10.89(s) 3.10(t) 3.90(t) 8.59(s) - 6.52-7.98(m) 
(TNS)2Zn 10.77(s) 2.89(t) 3.82(t) 8.43(s) - 6.68-8.22(m) 
(TNS)2Ni No clear spectra 
(TNS)2Cu No clear spectra 
 
Ha proton in the structure proposed resonates as a singlet at 10.89 ppm and the aliphatic 
protons Hb and Hc resonate as triplets at 3.10 ppm and 3.90 ppm respectively. The 
aldehydic proton Hd appears as a singlet at 8.59 ppm and the aromatic protons in the 
range of 6.52 ppm to 7.98 ppm as multiplet. The integration line indicates that the signals 
are due to 8 protons as expected.  
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In the case of zinc complex of the ligand (See Fig 3.36), a slight displacement of 
chemical shift values has occurred. The indolic N-H proton labeled Ha appears at 10.77 
ppm compared to10.89 ppm in the free ligand. The aromatic protons range extends to 
8.22 ppm, reported data is recorded in table (3.12)  
No clear spectrum was recorded for nickel and copper complexes because they are 
paramagnetic in solution. 
3.2.4 Proton NMR spectra of the ligand:  
1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldimine (TTET) and its Zn, Ni, and Cu 
complexes:  
             
N
H
N C
H
HO
H H
H H
C(CH3)3
C(CH3)3
a
b
c
d
e
f
g
 
Table (3.13): 1H NMR spectra of the ligand TTET and its complexes: 
Compound Ha Hb Hc Hd He Hf Hg Haromatic 
TTET 10.72(s) 3.03(t) 3.81(t) 8.44(s) 9.90(s) 1.32(s) 1.24(s) 6.93-7.62(m) 
(TTET)2Zn 10.73(s) 3.02(t) 3.82(t) 8.44(s) - 1.35(s) 1.23(s) 6.68-7.36(m) 
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(TTET)2Ni No spectra (paramagnetic) 
(TTET)2Cu No spectra (paramagnetic) 
 
The data was summarized in table (3.13) and the spectra was shown in figure (3.37)  
It can be drawn from the table that, the indolic proton Ha resonates as a singlet at 10.72 
ppm, the triplets appears in 3.03 ppm and 3.81 ppm are due to the protons Hb and Hc 
respectively. This can be supported by the integration line which reveals that the signal is 
due to two protons each. Further more there are singlets at 1.32 ppm and 1.24 ppm due to 
9 protons each and this can be ascribed for the tertiary butyl protons Hf and Hg 
respectively. The aldehydic proton appears down field at 8.44 ppm and the aromatic 
protons appear as a multiplet in the range 6.93 – 7.62 ppm.  
With respect to zinc complex of the ligand (Fig 3.38), the hydroxyl He proton signal was 
disappeared indicating deprotonation and participation of the phenolic oxygen atom in 
co-ordination to zinc ion as proved by the X-ray structure. The indolic N-H proton Ha 
shifts a little bit to 10.73 ppm. The ethyleneic protons Hb and Hc appear in the usual range 
of aliphatic protons at 3.02 and 3.82 ppm respectively. Integration line indicates two 
protons each. Also the singlets at 1.35 ppm and 1.23 ppm were due to the tertiary butyl 
protons Hf and Hg successively. The spectra look somewhat similar to the ligand spectra 
indicating that the ligands arranged symmetrically around the metal ion which seems to 
be in the centre of symmetry.  
No spectra have been observed for Ni and Cu complexes due to paramagnetic effects in 
these compounds.  
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3.2.5 Proton NMR spectra of the ligand:   
2-{1-[2-(1H-Indole-3-yl)ethylimino]-ethyl } phenol (THAP) and its complexes:  
 
 
                
N
H
N C
HO
H H
H H
a
b
c
d
e
CH3
R
R = CH3 , OCH3 , Cl , Br  
Table (3.14): 1H NMR spectra of the ligand THAP and its zinc complex  
 
Compound Ha Hb Hc Hd He HR Haromatic 
THAP 10.82(s) 3.08(t) 3.84(t) 2.26(s) - - 6.66-7.57(m) 
(THAP)2Zn 10.83(s) 3.09(t) 3.86(t) 2.28(s) - - 6.67-7.59(m) 
 
1H NMR spectra of the ligand was summarized in table (3.14) with chemical shifts 
expressed in ppm down field tetra methylsilane as reference. The spectrum was shown in 
Fig. 3.39. 
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It can be shown from the table that the singlet appears at 10.82 ppm can be attributed to 
the indolic N-H proton Ha in the diagram of the structure proposed. As for the previous 
ligands, the ethyleneic protons Hb and Hc resonates at 3.08 ppm and 3.84 ppm as triplets 
respectively. The methyl protons Hd resonates at 2.26 ppm as a singlet. Integration line 
confirms 3 protons in contrast to only one proton for the previously described ligands.  
The signals between 6.66 ppm and 7.57 ppm are due to 9 aromatic protons as the 
integration implies. 
The proton signal He was absent in the zinc complex spectra (Fig.3.40). The absence of 
salicylaldehyde OH signal is evidently due to the coordination of this oxygen to the metal 
ion after deprotonation [29]. 
 
3.2.6 Proton NMR spectra of the ligand: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
methyl phenol (TMeHAP): 
 
Table (3.15): 1H NMR spectra of the ligand: TMeHAP and its complexes:  
 
Compound Ha Hb Hc Hd He HR Haromatic 
TMeHAP 10.82(s) 3.07(t) 3.83(t) 2.25(s) - 2.20(s) 6.63-7.57(m) 
(TMeHAP)2Cu No clear spectra 
  
The proton NMR spectra was displayed in figure (3.41) and summarized in table (3.15), 
chemical shifts are measured in ppm using d6-DMSO as solvent.  
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The spectrum is very similar to the previously described ligand except that the singlet at 
2.20 ppm is due to the methyl protons in the fifth position of the hydroxyaceophenone 
moiety. Further more, integration line indicates 8 protons in place of 9 protons in the case 
of THAP owing to the substitution of this proton by the methyl group. The copper 
complex spectrum was unclear.  
 
3.2.7 Proton NMR spectra of the ligand:  
2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy phenol (TOMeHAP):  
 
1H NMR spectra for the ligand was shown in figure (3.42) and summarized in table 
(3.16).  
 
Table (3.16): 1H NMR spectra of the ligand: TOMeHAP and its complexes:  
 
Compound Ha Hb Hc Hd He HR Haromatic 
TOMeHAP 10.82(s) 3.07(t) 3.84(t) 2.26(s) - 3.74(s) 6.69-7.58(m) 
(TOMeHAP)2Cu No clear spectra 
  
It can be shown from the table that, the indolic N-H proton Ha appears at 10.82 ppm and 
the ethyleneic two (-CH2-) groups of the tryptamine moiety Hb and Hc resonates at 3.07 
ppm and 3.84 ppm as a triplets respectively. These are quite similar to the same protons 
in the ligand TMeHAP described above. In relation to the methoxy (OCH3) protons, it is 
observed that these protons resonate further downfield at 3.74 ppm if compared to the 
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methyl protons of the previously described ligand. This is because of the effect exerted 
by the electronegative oxygen atom in the methoxy group. The aromatic protons are 
observed in the range 6.69 ppm to 7.58 ppm as a multiplet due to 8 protons.  
No spectrum was reported for the copper complex of this ligand because it is 
paramagnetic in solution. 
3.2.8 Proton NMR spectra of the ligand: 
2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-chloro phenol (TClHAP): 
 
Table (3.17): 1H NMR spectra of the ligand TClHAP: 
 
Compound Ha Hb Hc Hd He HR Haromatic 
TClHAP 10.83(s) 3.08(t) 3.87(t)  2.28(s) - - 6.72-7.57(m) 
  
Proton NMR spectra of this ligand was shown in figure (3.43) and summarized in table 
(3.17) 
It is clear that the signal at 10.83 ppm is due to the indolic N-H proton Ha in a similar 
manner as in the previously described ligands. Also the triplets due to ethylene groups in 
the tryptamine moiety which appears at 3.08 ppm and 3.87 ppm for the protons labeled 
(b) and (c) successively. The methyl protons (d) resonate as a singlet at 2.28 ppm, and the 
aromatic protons in the range of 6.72 – 7.57 ppm as a multiplet of 8 protons.  
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3.2.9 Proton NMR spectra of the ligand:  
2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-bromo phenol (TBrHAP):  
 
Table (3.18): 1H NMR spectra of the ligand TBrHAP: 
 
Compound Ha Hb Hc Hd He HR Haromatic 
TBrHAP 10.84(s) 3.08(t) 3.85(t) 2.28(s) - - 6.66-7.68(m) 
      
1H NMR spectra of the ligand with a summery of the main signals was reported in table 
(3.18), and shown in figure (3.44). It can be depicted that the general features of the 
spectra is closely similar to the chlorosubstituted ligand described above, and the same 
explanation can be drawn from the table as indicated.  
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3.3 
13
Carbon NMR spectra of the ligands and complexes:  
 
3.3.1 
13
C {
1
H} NMR spectra of the ligand: 1H-Indole-3-ethylenesalicylaldimine (TS) and 
its complexes:  
 
The 13C spectrum was recorded in d6-DMSO as solvent, chemical shifts expressed in ppm 
from tetra methylsilane. The spectra was summarized in table (3.19) and displayed in 
figure (3.45).  
 
Table (3.19): 13C NMR spectra of TS and its complexes:  
 
                 
N
H
N
H
C
HO
1
2
3
4
5
6
7
8
9
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12 13
14
1516
17
 
 
Chemical shift values in ppm: 
 
Compound Caromatic C9 C10 C11 C12 
TS 111.92-166.26 27.09 59.34 161.53 166.26 
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Table 3.19 continued 
Compound Caromatic C9 C10 C11 C12 
(TS)2Zn 111.01-172.35 26.67 60.88 170.48 172.35 
(TS)2Ni No clear spectra was obtained (paramagnetic) 
(TS)2Cu No clear spectra was obtained (paramagnetic) 
 
The peaks at low frequencies 27.09 and 59.34 ppm were characteristic of sp3 carbon 
atoms and can be assigned to the ethylenic carbons C9 and C10 labeled in the proposed 
structure above. Further support to the structure also comes from the appearance of two 
single peaks at high chemical shift values 161 ppm and 166 ppm which can be ascribed 
for the azomethine carbon C11 and the phenolic carbon C12 respectively. The aromatic 
carbons C1 to C8, and C13 to C17 appeared in the region 111.9 – 166.2 ppm within the 
normal range of aromatic carbons (100 –175 ppm) in general [67], and the total number 
of peaks agrees well with the expected peaks for the structure. 
13C spectrum of (TS)2Zn complex was shown in figure (3.46). The spectra showed that 
the azomethine carbon atom C11 shifts to higher frequency 170.48 ppm in comparison 
with 161.53 ppm in the free ligand. This result together with what have been reported in 
the IR spectra indicates that the ligand coordinated to the metal center through 
azomethine nitrogen atom. Further more, the phenolate carbon atom C12 found in the free 
ligand at 166.26 ppm was shifted to 172.35 ppm in the complex, indicating that the ligand 
coordinated to the metal center through deprotonated enolic form as shown in the 
complex sketch drawn above (See experimental part). All these facts have been supported 
by the X-ray structure analysis of the complex which will be discussed later.    
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3.3.2 
13
C {
1
H} NMR spectra of the ligand: 1H-Indole-3-ethylene-5-chlorosalicylaldimine  
(TCS) and its zinc complex:   
 
The 13C NMR spectra was summarized in table (3.20) and shown in figure (3.47), 
chemical shifts expressed in ppm and d6-DMSO was used as a solvent. 
Table (3.20): 13C NMR spectra of the ligand TCS and its Zn complex: 
 
Compound Caromatic C9 C10 C11 C12 
TCS 111.93-165.20 26.90 59.03 160.89 165.20 
(TCS)2Zn 110.91-171.44 26.68 60.97 169.13 171.44 
 
The proposed structure can also be verified from 13C spectral data. The greatest 
downfield peaks at 165.20 ppm attributed to a carbon atom directly attached to the 
electronegative oxygen atom. The second most down field peak at 160.89 ppm can be 
assigned to the azomethine carbon C11. The aliphatic carbons observed upfield at 26.90 
ppm for C9 and 59.03 ppm for C10. The rest of the peaks lie on the aromatic region of the 
spectra and hence can be attributed to 11 carbon atoms. 
13C spectrum for the zinc complex was shown in figure (3.48). In this spectra it is 
worthwhile to note here that the -C=N carbon was shifted further down field by 8.24 ppm 
proving the azomethine nitrogen engagement in bond formation with the zinc ion. 
Evidence of phenolic oxygen coordination can also be emphasized by the shift of the free 
ligand 13C signal (C12) from 165.20 ppm in the free ligand to 171.44 ppm in the complex.  
 
 111  
 
 112  
 
 113  
Other 13C signals look almost the same with minor change observed in the position of C10 
chemical shift.     
 
3.3.3 
13
C {
1
H} NMR spectra of the ligand: 1H-Indole-3-ethylene-5-nitrosalicylaldimine 
(TNS) and its zinc complex:   
 
Table (3.21): 13C NMR spectra of the ligand TNS and its Zn complex:  
 
Compound Caromatic C9 C10 C11 C12 
TNS 110.50-178.70 25.93 52.95 167.50 178.70 
(TNS)2Zn 111.41-176.58 27.51 61.49 171.17 176.58 
 
The spectrum of the ligand was shown in Fig. 3.49. 
The 13C NMR spectral data of the ligand in d6-DMSO exhibited 17 signals as expected. 
In comparison to the previous ligand the most downfield peak appears at 178.7 ppm and 
could be attributed to a carbon atom attached to electronegative atom C12 in the diagram. 
The azomethine carbon C11 was observed in the normal region 167.5 ppm in comparison 
to the previous ligand. The upfield signals 25.9 ppm and 52.9 ppm are likely to arise from 
the aliphatic C9 and C10 respectively. The rest of the signals in the range 110.5 to 178.7 
ppm are due to the aromatic carbons.  
The spectrum of zinc complex of the ligand was shown in figure (3.50) and summarized 
in table (3.21) above. Adequate support for the proposed structure was provided by 13C 
NMR spectrum where the azomethine –C=N carbon appears more downfield at 171.17 
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ppm suggesting coordination to the zinc ion via the attached nitrogen atom. Also the shift 
observed for C12 carbon signal implies participation of the phenolic oxygen atom in 
chelate formation with the metal center. Other bands such as C9 and C10 shifts slightly to 
higher chemical shift values as it can be seen in the table above.     
 
3.3.4 
13
C {
1
H} NMR spectra of the ligand:    
1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldimine (TTET): 
 
The spectra was summarized in table (3.22) and displayed in figure (3.51). 
 
Table (3.22): 13C NMR spectra of the ligand TTET and its Zn complex:  
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Table 3.22: Chemical shift values imp pm: 
Compound C 
(Aromatic) 
C9 C10 C11 C12 C18 C19,20,21 C22,23,24 C25 
T-TET 111.8-167.4 34.34 59.46 158.45 167.43 27.22 31.83 29.77 35.09 
(TTET)2Zn 111.11-
173.14 
34.08 61.11 168.01 173.14 26.97 31.88 29.85 35.70 
 
It is worthwhile to mention here that, there are more peaks in this spectra compared to the 
previous ones due to the presence of two tertiary butyl groups in position 3 and 5 of the 
salicylaldehyde moiety. Carbons C19, C20, and C21 are equivalent and gives rise to only 
one peak at 31.83 ppm, while C22, C23 and C24 are equivalent and gives rise to a single 
peak at 29.77 ppm. The quaternary carbon atoms C18 and C25 resonate at 27.22 and 35.09 
ppm respectively. The ethylenic carbons appear in the usual range 34.34 ppm and 59.46 
ppm for C9 and C10 respectively. The down field signals at 158.45 ppm and 167.43 ppm 
could be assigned to C11 and C12 successively. Those positions are due to the effects 
exerted by the azomethine nitrogen and phenolic oxygen atoms directly attached. The rest 
of the signals at the range 111.8 ppm – 167.4 ppm are due to aromatic carbons. 
The 13C spectrum of zinc complex of this ligand was shown in figure (3.52). From the 
spectra it was clearly shown that the significant shift observed on the azomethine –C=N 
carbon to lower field 168.01 ppm compared to the ligand implies strong participation of 
the azomethine nitrogen atom in chelate formation to the metal center through its lone 
pair. Moreover, the phenolic carbon C12 chemical shift value shifts to 173.14 ppm than 
167.43 ppm in the ligand. This also can be considered as adequate evidence for the 
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involvement of the phenolic oxygen tom in bond formation to the zinc ion after 
deprotonation. These facts have been supported by the X-ray diffraction structure for the 
complex, and it will be discussed later in this thesis. Other signals display almost the 
same chemical shift values with little variations and can be assigned accordingly.    
 
3.3.5 
13
C {
1
H} NMR spectra of the ligand:   
2-{1-[2-(1H-Indole-3-yl)ethylimino]-ethyl } phenol (THAP):  
 
The spectra was summarized in table (3.23) and shown in figure (3.53)  
 
Table (3.23): 13C NMR spectra of the ligand: THAP  
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Table 3.23: Chemical shifts in ppm  
Compound C (Aromatic) C9 C10 C11 C12 C18 C(Me,OMe) 
THAP 111.40-136.26 25.92 49.00 164.43 172.42 14.27 - 
(THAP)2Zn 111.92-136.77 26.42 49.48 165.00 172.99 14.81 - 
 
It can be shown that, 13C spectra of this ligand provides further support to the proposed 
structure shown. There are 18 peaks representing all the existing carbon atoms as 
expected. The most down field peak at 172.42 ppm could be assigned to the phenolic 
carbon C-OH labeled C12. This position is because of the deshielding effect of the electro 
negatively oxygen atom directly attached, while the peak at 164.43 ppm can be assigned 
to the azomethine carbon atom C11. 13 peaks in the region 111.40 – 136.26 arose as a 
result of the aromatic carbon atoms and the up field peaks at 25.92 ppm and the 49.00 
ppm were attributed to the carbons labeled C9 and C10 respectively.  
The spectrum of the zinc complex is shown in Fig. 3.54.  
It is clear from the spectra that the azomethine carbon atom C11 does not shift 
considerably like the affected carbon atoms of similar zinc complexes described 
previously in this thesis (at least 3.37 ppm in (TNS)2Zn). This implies that this carbon 
atom does not participate in bond formation with the zinc ion, a phenomenon that was 
confirmed by X-ray structure analysis. Also, slight shift was noted for the phenolic 
carbon C12 chemical shift value (ca 0.57 ppm) in comparison to the ligand, though X-ray 
study reveals that the oxygen atom is coordinated to the zinc ion. 
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3.3.6 
13
C {
1
H} NMR spectra of the ligand:  
2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methyl phenol (TMeHAP):  
 
The 13C spectra of this ligand is shown in table (3.24) and figure (3.55)  
 
Table (3.24): 13C NMR spectra of the ligand TMeHAP:  
Compound C Aromatic C9 C10 C11 C12 C18 C(Me,OMe) 
TMeHAP 111.44-172.11 26.06 49.28 161.57 172.11 14.31 20.27 
    
Compared to the previously discussed ligand, the spectra of this ligand reveals one more 
additional peak in the up field region associated to the methyl group carbon on position 5 
of the hydroxyacetophenone moiety. Aromatic carbons exist in the region between 
111.44 ppm to 172.11 ppm. The down field peaks at 161.57 ppm and 172.11 were 
ascribed to the carbons C11 and C12 respectively. The peak at 14.31 ppm is due to the 
methyl carbon C18 and the ethylenic carbons appear in their expected positions 26.06 ppm 
for C9 and 49.28 ppm for C10 as compared to the previous ligand.  
No clear spectrum was shown for the Cu complex of this ligand due to paramagnetic 
effects.  
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3.3.7 
13
C {
1
H} spectra of the ligand: 
2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy phenol (TOMeHAP): 
 
The spectra was also summarized in table (3.25) and shown in figure (3.56)  
 
Table (3.25): 13C NMR spectra of the ligand TOMeHAP:  
 
Compound C (Aromatic) C9 C10 C11 C12 C18 C(Me,OMe) 
TOMeHAP 111.41-171.7 26.09 49.61 157.32 171.73 14.53 55.70 
 
The remarkable difference between the spectra of this ligand and the previously 
mentioned methyl substituted one lies in the position of the chemical shift of the methoxy 
carbon atom which lie at 55.70 ppm compared to 20.27 ppm for the previous ligand. This 
is because of the effect exerted by the electronegative oxygen atom. The rest of the 
spectra look somewhat similar to the previous one with some variations in the positions 
of chemical shift values.  
 
3.3.8 
13
C {
1
H} NMR spectra of the the ligand:  
4-choloro- 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}- phenol (TClHAP): 
 
The spectrum was shown in table (3.26) with the most important chemical shift values for 
different carbon atoms, and figure (3.57).  
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Table (3.26): 13C NMR spectra of the ligand TClHAP: 
 
Compound C (Aromatic) C9 C10 C11 C12 C18 C(Me,OMe) 
TClHAP 111.46-172.28 25.67 48.68 164.55 172.28 14.40 - 
 
18 peaks were shown in the spectra as expected in which 15 of them are in the range of 
aromatic carbons, while the rest lies up field at 14.40 ppm, 25.67 ppm, and 48.68 ppm 
assignable to C18, C9 and C10 labeled in the proposed structure above. The most down 
field peaks at 172.28 ppm and 164.55 ppm could be attributed to the phenolic C12 and 
azomethine carbon atom C11 respectively. 
 
3.3.9 
13
C {
1
H} NMR spectra of the the ligand:  
4-bromo- 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}- phenol (TBrHAP): 
 
The spectrum was summarized in table (3.27) with the most important chemical shift 
values for different carbon atoms, and shown in figure (3.58).  
Table (3.27): 13C NMR spectra of the ligand TBrHAP: 
 
Compound C (Aromatic) C9 C10 C11 C12 C18 C(Me,OMe) 
TBrHAP 106.8-172.77 26.13 49.08 165.55 172.77 14.88 - 
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Also 18 peaks were shown in the spectra as expected in which 15 of them are in the range 
of aromatic carbons, while the rest lies up field at 14.88 ppm, 26.13 ppm, and 49.08 ppm 
assignable to C18, C9, and C10 labeled in the proposed structure above. The most down 
field peaks at 172.77 ppm and 165.55 ppm could be attributed to the phenolic C12 and 
azomethine carbon atom C11 respectively. 
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3.4 UV-Visible Spectra of the ligands and complexes: 
  
3.4.1 UV-Vis spectra of the ligand: 1H-Indole-3-ethylenesalicylaldimine (TS) and its Zn, 
Ni, and Cu complexes:  
 
The electronic spectra of the ligand TS and its zinc, nickel and copper complexes with 
their tentative assignments are given in table (3.28) and figures (3.59, 3.60, 3.61 and 
3.62)  
 
Table (3.28): UV-Vis spectra of TS and its Zn, Ni, and Cu complexes:  
 
Compound  Conc (mol/L) ε ( mol-1Lcm-1)  λ max (nm)  Assignment 
TS 2.84×10-4 5.32×103 314 n - π* 
  8.75×103 291 π – π* chelate 
ring 
  9.13×103 283 π – π* chelate 
ring 
  9.41×103 267 π – π* indole 
group 
(TS)2Zn 1.26×10
-4 8.67×103 364.5 CT 
  1.77×104 275 π – π* ligand 
  2.50×103 244 π – π* ligand 
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Table 3.28 continued 
Compound  Conc (mol/L) ε ( mol-1Lcm-1)  λ max (nm)  Assignment 
(TS)2Ni 2.56×10
-4 222.4 605 d-d transition 
 1.28×10-4 5.74×103 377 n - π* 
  7.36×103 323 CT 
  2.68×103 278 π – π* ligand 
  3.00×103 216 π – π* ligand 
(TS)2Cu  1.22×10
4 364.5 CT , n - π* 
  2.44×104 283 π – π* 
  2.61×104 275 π – π* 
 
 
The spectra were measured in dimethyl sulphoxide (DMSO) as a solvent. For the ligand 
the intense double band in the region 283 nm to 291 nm is characteristic for π – π* 
transitions of hydrogen-bonded conjugated chelate rings [22]. This phenomenon seems to 
arise from the two tautomeric forms (keto-enol) possible for each hydrogen-bonded ring 
of the ligand [24]. The band at 267 nm is associated with π – π* transition of the indole 
group, where as the weak band at 404 nm is assignable to transition of the chelate ring.  
In the case of metal complexes, the absorption band assigned to n - π* looks quite 
different from those of the ligand. Instead of the simple double or triple bands, the metal 
chelates have complicated systems of bands of different intensities. This provides further 
evidence for complex formation. (TS)2Zn complex exhibits two absorption maxima. The 
band at 364 nm is due to charge transfer probably from metal to ligand. The intensity and 
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position of this band seems to indicate the presence of a tetrahedral environment around 
the zinc ion [68]. The bands at 275 nm and 244 nm could be attributed to the ligand.  
With respect to the nickel complex (TS)2Ni, three absorption maxima was observed as 
well as a weak band at 605 nm when more concentrated solution was used. The band at 
377 nm may be due to n - π* transition, where as the more intense band at 323 nm was 
attributed to charge transfer from ligand to metal or vise versa. The band at 605 nm is 
typical of ligand field transition (d-d transition) [21]. The position of this band could 
never be obtained with any accuracy because of the more intense higher energy ligand 
bands, and even the existence of the lower energy band can only be postulated on the 
basis of comparison with other compounds of similar structure [58]. This is why this 
band disappears from the spectra of dilute solution of the complex. This band could be 
attributed to 1A1g – 
1B1g transition [26] suggesting a trans-planar arrangement for the 
NiN2O2 chromophore. 
Regarding the copper complex, 3 bands can be identified. The band at 364 nm is in part 
due to an internal n – π* transition of the ligand and also to a charge transference probably 
from the metal to the ligand [21]. The fine-structured bands at 283 nm and 275 nm could 
be a composite of different types of individual transitions [58].  
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Fig 3.59: UV spectra of: 1H-Indole-3-ethylenesalicylaldimine (TS) 
 
Fig 3.60: UV spectra of:  bis (1H-Indole-3-ethylenesalicylaldiminato-k2N, O)Zn(II): 
(TS)2Zn 
 
n - π* 
CT 
π – π* 
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Fig 3.61: UV spectra of: bis (1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Ni(II): 
(TS)2Ni 
 
 
 
 
Fig 3.62: UV spectra of: bis (1H-Indole-3-ethylenesalicylaldiminato-k2N,O)Cu(II): 
(TS)2Cu 
 
n - π* CT 
π – π* 
CT 
π – π* 
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3.4.2 UV-Vis spectra of the ligand: 1H-Indole-3-ethylene-5-chlorosalicylaldimine (TCS) 
and its Zn, Ni and Cu complexes:  
 
The UV-Vis spectra of the ligand together with its zinc, nickel, and copper complexes 
were shown in table (3. 29) and figure (3.63, 3.64, 3.65 and 3.66).  
 
Table (3.29): UV-Vis. spectra of TCS and its Zn, Ni and Cu complexes:  
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
TCS 4.01×10-4 684.7 419.5 n - π* 
  4.11×103 326 π – π* indole 
group 
  8.0×103 284 π – π* chelate 
ring 
  7.72×103 265 π – π* chelate 
ring 
(TCS)2Zn 1.26×10
-4 1.34×104 375.5 CT ,  n - π* 
  2.07×104 272 π – π* ligand 
(TCS)2Ni 4.20×10
-5 1.06×104 384.5 CT 
  2.83×104 273.5 π – π* ligand 
  - 226.5 π – π* ligand 
(TCS)2Cu 4.17×10
-5 9.73×103 373 CT , n - π* 
  1.76×104 291 π – π* ligand 
  2.23×104 260 π – π* ligand 
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The UV-Vis spectra of the ligand look closely similar to the spectra of TS with some 
shifts in the position of the bands. The peak at 419 nm could be related to n - π* (ε = 
684.7 mol-1Lcm-1). The double band in the region 250 nm – 300 nm is characteristic of a 
hydrogen-bonded π – π* transitions indicating an equilibrium between keto and enol 
forms. The band at 326 nm could be attributed to π – π* transition of indole group. This 
band shifts to longer wave length may be due to the effect of the chlorine substituent in 
the salicylaldehyde moiety with respect to the unsubstituted ligand.  
The complexes spectra generally show the characteristic bands of the free ligand with 
some changes both in wave lengths and intensity. Spectra of the zinc complex of the 
ligand exhibit two distinctive bands. The band at 375 nm with molar absorptivity of 
1.3×104 mol-1Lcm-1 could be ascribed to a combination of charge transfer and n - π* 
transitions. The position of this band is consistent with a tetrahedral geometry around the 
zinc ion [55]. The other band at 272 nm was associated with the ligand.  
For Ni complex, the charge transfer band at 384.5 nm is more intense with respect to the 
same band in (TS)2Ni  complex, with a bathochromic shift of 61.5 nm may be due to the 
effect of the chlorine substituent. The rest of the bands at 273 nm and 226 nm were 
associated with the π – π* transitions of the ligand.  
In the copper complex of the ligand, the band at 373 nm is associated with a combination 
of charge transfer and n - π* transition, whereas bands between 260-291 nm were ligand  
π – π* transitions. 
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Fig 3.63: UV spectra of: 1H-Indole-3-ethylene-5-chlorosalicylaldimine (TCS) 
 
Fig 3.64: UV spectra of: bis {4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ
2N, O} zinc(II): (TCS)2Zn 
 
 
 
n - π* 
π – π* 
π – π* 
CT 
π – π* 
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Fig 3.65: UV spectra of: bis {4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ
2N, O} nickel(II): (TCS)2Ni 
 
Fig 3.66: UV spectra of: bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ
2N, O} copper(II): (TCS)2Cu 
CT 
π – π* 
CT 
π – π* 
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3.4.3 UV-Vis spectra of the ligand: 1H-Indole-3-ethylene-5-nitrosalicylaldimine (TNS) 
and its Zn, Ni, and Cu complexes:  
 
The UV-Vis spectra of the ligand and complexes was carried out in DMSO as a solvent 
and represented in table (3.30) and figures (3.67, 3.68, 3.69, and 3.70) together with their 
tentative assignments.  
 
Table (3.30): UV-Vis spectra of TNS and its Zn, Ni, and Cu complexes:  
 
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
TNS 9.70×10-5 1.40×104 420 n - π* 
  1.18×104 368 π – π* chelate 
ring 
  1.20×104 260 π – π* chelate 
ring 
(TNS)2Zn 5.50×10
-5 3.01×104 377.5 CT ,  n - π* 
  2.22×104 260 π – π* indole 
group 
(TNS)2Ni 3.70×10
-5 5.87×104 410 CT 
  2.84×104 283 π – π* ligand 
  2.68×104 259 π – π* ligand 
(TNS)2Cu 3.67×10
-5 4.25×104 383 CT , n - π* 
  4.03×104 261 π – π* ligand 
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The spectra of the ligand show 3 absorption maxima. The intense band at 420 nm could 
be attributed to n - π*. The intensity of this band have been increased because of the 
additive effect of the two isolated chromophores (–CH=N-) and the nitro group in the 
fifth position of the benzene ring [69]. The band at 368 nm is due to π – π* transition of 
the chelate ring. A bathochromic shift of this band in relation to the 314 nm band of TS 
ligand is due to the increased ketonic character of the phenolic C-O bond caused by the 
effect of electron withdrawal of the nitro group. The band at 260 nm could be assigned to 
π – π* transition associated with the indole group.  
In case of zinc complex of this ligand, likewise two bands arose. The intense band at 377 
nm may be assigned to both n - π* transition and charge transfer from metal to the ligand. 
The band at 260 nm exhibit shoulder and may be associated with transitions π – π* of the 
indole group of the ligand.  
Similarly the nickel complex spectra exhibit three main absorption bands. The band at 
410 nm was assignable to charge transfer as indicated for the zinc complex mentioned 
above. The other bands could be assigned to the ligand π – π* transitions. The ligand field 
transition was not shown in the spectra, may be due to the use of very dilute solution, in 
addition to the relatively low molar extinction coefficient (ε) for this type of transition. 
The copper complex electronic spectra in DMSO shows bands at 383 nm (ε = 4.25×104 
mol-1Lcm-1), 261 nm (ε = 4.0 ×104 mol-1Lcm-1) and a weak band at 249 nm (ε = 1.1×104 
mol-1Lcm-1). The band at 383 nm is ascribed to the charge transfer between the metal and 
the ligand, while the band at 261 nm can be attributed to π – π* transition of the ligand. 
Also the ligand field d-d transition is not seen in the spectra, perhaps due to 
comparatively low molar absorptivity coefficient associated with this transition.  
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Fig 3.67: UV spectra of: 1H-Indole-3-ethylene-5-nitrosalicylaldimine (TNS) 
 
Fig 3.68: UV spectra of: bis {4-nitro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ
2N, O} zinc(II): (TNS)2Zn  
n - π* π – π* 
CT π – π* 
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Fig 3.69: UV spectra of: bis {4-nitro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ
2N, O} nickel(II): (TNS)2Ni 
 
Fig 3.70: UV spectra of: bis{4-nitro-2-[2-(1H-indol-3-yl)ethyliminomethyl]phenolato-
κ
2N, O} copper(II): (TNS)2Cu 
CT 
π – π* 
CT 
π – π* 
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3.4.4 UV-Vis spectra of the ligand:  
1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldimine (TTET) and its Zn, Ni, and Cu 
complexes: 
 
The UV-Vis spectra of the ligand in DMSO together with its zinc, nickel, and copper 
complexes were shown in table (3.31) and figures (3.71, 3.72, 3.73 and 3.74).  
Table (3.31): UV-Vis spectra of the ligand TTET and its Zn, Ni, and Cu complexes. 
 
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
TTET 3.45×10-4 376.5 417 n - π* 
  3.53×103 327 π – π* chelate 
ring 
  9.77×103 267 π – π* indole 
group 
(TTET)2Zn 1.60×10
-4 9.32×104 381.5 CT ,  n - π* 
  1.93×104 283 π – π* ligand 
(TTET)2Ni 1.50×10
-4 7.65×103 385 CT 
  2.67×104 281 π – π* ligand 
  1.50×104 248 π – π* ligand 
(TTET)2Cu 1.60×10
-4 1.09×104 377 CT , n - π* 
  1.07×104 325 π – π* ligand 
  2.48×104 282 π – π* ligand 
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The spectra of the ligand composed of 3 main absorption maxima. n - π* transition 
appears as a low intensity band at 417 nm (ε = 376.5 mol-1cm-1). This band considerably 
shifts to longer wave length as compared to the previous ligand may be due to the effect 
of two tertiary butyl substituents in position 3 and 5 in the salicylaldehyde moiety. The 
band at 327 nm with intermediate intensity could be assigned to π – π* transition of 
hydrogen-bonded chelate ring, where as the band at 267 nm is attributed to π – π* 
transitions of indole group.  
As for the previous ligands, the zinc complex of this ligand also reveals two absorption 
maxima. The intense charge transfer band at 381 nm which is characteristic of a 
tetrahedrally co-ordinated zinc ion, and a band at 283 nm which can be assigned for 
ligand transitions.  
For Ni complex of the ligand, the band at 385 nm is assigned to the phenolate to nickel 
charge transfer while the band at 281 nm, 248 nm were associated with π – π* transitions 
of the ligand.  
With respect to the copper complex spectra of this ligand, if compared with the free 
ligand, the band at 377 nm is more intense than the corresponding band 417 nm of the 
ligand and this band can be assigned to a mixed charge transfer and n - π* transition. This 
band was also revealed a hyperchromic (blue) shift upon complexation. The other bands 
at 325 nm and 282 nm are associated with the ligand.  
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Fig 3.71: UV spectra of: 1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldimine 
(TTET)  
 
 
 
 
 
Fig 3.72: UV spectra of: bis(1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Zn(II): (TTET)2Zn 
 
n - π* 
π – π* 
π – π* 
CT 
π – π* 
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Fig 3.73: UV spectra of: bis (1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Ni(II): (TTET)2Ni  
 
 
 
 
 
 
Fig 3.74: UV spectra of: bis (1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-
k2N,O)Cu(II): (TTET)2Cu 
CT 
π – π* 
CT 
π – π* 
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3.4.5 UV-Vis spectra of the ligand:  
2-{1-[2-(1H-Indole-3-yl)ethylimino]-ethyl } phenol (THAP) and its complexes:  
The UV-Vis spectra of the ligand was carried out in DMSO as solvent, and shown in 
table (3.32) and figures (3.75, 3.76, 3.77 and 3.78). 
 
Table (3.32): UV-Vis spectra of THAP and its zinc, nickel and copper complexes:  
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
THAP 9.88×10-5 1.56×103 395 n - π* 
  3.67×103 317 π – π* chelate 
ring 
  6.94×103 291 - 
  7.74×103 282 - 
  7.78×103 276 π – π* indole 
group 
  9.42×103 260 π – π* indole 
group 
(THAP)2Zn 1.08×10
-4 3.63×103 394 n - π* 
  9.93×103 316 π – π* chelate 
ring 
  2.20×104 275 π – π* indole 
group 
  2.36×104 262 π – π* indole 
group 
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Table 3.32 continued 
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
(THAP)2Ni 7.33×10
-5 - 572 d-d transition 
  5.06×103 388 CT, n - π* 
  2.34×104 263 π – π* indole 
group 
(THAP)2Cu 6.47×10
-5 7.86×103 358 CT ,  n - π* 
  2.13×104 273 π – π* ligand 
 
 The spectra exhibit bands at 395 nm, 317 nm, 291 nm and 276 nm which are well 
consistent with what have been reported by Perdo Martin et al with same ligand in 
chloroform [25]. The band at 395 nm could be assigned to n - π* transition of chelate ring 
in the same way as in the ligand TS. Further more the band at 317 nm was assigned to π – 
π* transition of chelate ring. This band has been shifted slightly to longer wave length in 
comparison to TS described earlier. The bands at 276 nm and 260 nm were associated 
with π – π* transitions of the indole group. 
If we compare the spectra of the zinc complex with that of the free ligand, it was 
observable that there is no remarkable difference between the two. Since the azomethine 
group does not participate in coordination with the zinc atom, the n - π* transition remains 
the same and has not been affected. No charge transfer bands were observed due to the 
stable d10 configuration in the zinc ion. 
For nickel complex, the n - π* transition has shifted to lower wave length indicating 
coordination of the azomethine nitrogen atom to the metal centre. The band at 263 nm is 
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due to π – π* transition of the ligand. A low intensity band at 572 nm is due to d-d 
transition. 
For copper complex of the ligand, two bands can be distinguished in the spectra. The 
band at 358 nm is in part due to n - π* transition, and also to charge transference probably 
from ligand to the metal. It has been reported that, the diffuse reflectance spectra of 
copper complexes of this type of ligands exhibit bands at 700-800 nm consistent with a 
distorted pseudotetrahedral disposition around the copper ion [25, 73]. The band at 273 
nm is due to π – π* transition of the ligand. 
 
 
Fig 3.75: UV spectra of: 2-{1-[2-(1H-Indole-3-yl)ethylimino]-ethyl}phenol (THAP) 
 
                                                                                                                                                            
 
 
 
 
 
 
 
n - π* 
π – π* 
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Fig 3.76: UV spectra of: dichloridobis(2-{1-[2-(1H-indol-3-yl) 
ethyliminio]ethyl}phenolate-kO)zinc(II) (THAP)2Zn  
 
 
 
Fig 3.77: UV spectra of: bis(2-{1-[2-(1H-indol-3-yl)- ethyliminio]ethyl}phenolato-k2N, 
O)Ni(II): (THAP)2Ni 
n - π* 
π – π* 
CT 
π – π* 
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Fig 3.78: UV spectra of: bis (2-{1-[2-(1H-indol-3-yl)-ethyliminio]ethyl}phenolato-k2N, 
O)Cu(II): (THAP)2Cu 
 
3.4.6 UV-Vis spectra of the ligand: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methyl 
phenol (TMeHAP) and its copper complex:  
 
The UV-Vis spectra of the ligand and its complex together with the corresponding 
tentative assignments are given in table (3.33) and figure (3.79 and 3.80). 
 
CT 
π – π* 
 154  
Table (3.33): UV-Vis spectra of TMeHAP and its copper complex:  
 
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
TMeHAP 1.54×10-4 3.77×103 338 π – π* chelate 
ring 
  8.08×103 282 π – π* indole 
group 
  8.02×103 275 π – π* indole 
group 
  1.03×104 260 π – π* indole 
group 
(TMeHAP)2Cu 6.57×10
-5 9.71×103 358 CT ,  n - π* 
  2.40×104 272 π – π* ligand 
  
It is clearly observed that the spectrum of this ligand is closely similar to the spectra of 
THAP mentioned above with the bands red shifted. The band at 338 nm compared to 317 
nm in THAP ligand is related to π – π* transition of chelate ring, while the double bands 
at 282 nm, 275 nm and 260 nm were associated with π – π* transitions of indole group.  
With regard to the copper complex of the ligand, two bands have been identified. The 
band at 358 nm could be assigned to a mixed n - π* transition of the ligand and charge 
transfer from ligand to the metal. As it has been reported by Perdo Martin et al [25], the 
copper ion have been slightly distorted from trans planar N2O2 arrangement to 
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pseudotetrahedral geometry probably due to the substitution of the hydrogen atom on the 
iminic carbon by methyl group. The band at 272 nm is assigned to π – π* of the ligand. 
 
Fig 3.79: UV spectra of: 2-{1-[2-(1H-Indole-3-yl )-ethylimino]-ethyl}-4-methyl phenol 
(TMeHAP) 
 
 
 
 
 
 
 
π – π* 
π – π* 
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Fig 3.80: UV spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
methylphenolato-k2N,O}Cu(II): (TMeHAP)2Cu 
 
 
3.4.7 UV-Vis spectra of the ligand: 
2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy phenol (TOMeHAP) and its 
nickel and copper complexes:  
 
The spectra of the ligand have been summarized with relevant assignments in table (3.34) 
and shown in figures (3.81, 3.82 and 3.83)  
 
 
 
 
 
CT 
π – π* 
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Table (3.34): UV-Vis spectra of the ligand TOMeHAP and its nickel and copper 
complexes:  
 
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
TOMeHAP 1.13×10-4 3.98×103 346 π – π* chelate 
ring 
  7.94×103 281 π – π* indole 
group 
  9.40×103 261 π – π* indole 
group 
(TOMeHAP)2Ni 1.48×10
-4 364.86 572 d-d transition 
  4.03×103 412 CT, n-π* 
transition 
  7.97×103 344 π – π* chelate 
ring 
  2.48×104 273 π – π* indole 
group 
(TOMeHAP)2Cu 1.91×10
-4 6.45×103 386 CT ,  n - π* 
  1.80×104 268 π – π* ligand 
 
Three main bands can be distinguished in this case. The band at 346 nm is due to π – π* 
transition of the chelate ring. This band is red shifted in comparison to the same band in 
THAP ca 317 nm. This shift indicates that the ketonic character of the C-O bond have 
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been increased as a result of the deactivation effect exerted in the ortho and para position 
of the phenyl ring by the methoxy group [24]. The bands at 281 nm and 261 nm were 
well consistent with those found by P.Gili et al in similar ligands and can be assigned to  
π – π* transitions of the indole group [24].  
With regard to the nickel complex, the band at 572 nm could be assigned to 1A1g-
1B1g 
transition which is consistent with a square planar geometry around the nickel ion [71]. 
The band at 412 nm is probably a mixed n - π* and charge transfer. There is a slight 
hypsochromic shift of the π – π* band upon coordination [60, 72]. The strong absorption 
at 273 nm is assigned to π – π* of benzene ring.  
For copper complex of the ligand, the spectra reveal two main bands. The band at 386 nm 
is bathochromically shifted in comparison to the same band at 358 nm of the previous 
copper complex of the ligand TMeHAP and can be assigned to a mixed n - π* transition 
and charge transference. The band at 268 nm is associated with π – π* transition of the 
ligand. 
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Fig 3.81: UV spectra of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-methoxy phenol 
(TOMeHAP) 
 
 
Fig 3.82: UV spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
methoxyphenolato-k2N,O}Ni(II): (TOMeHAP)2Ni 
 
 
π – π* 
π – π* 
d-d 
CT 
π – π* 
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Fig 3.83: UV spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
methoxyphenolato-k2N,O}Cu(II): (TOMeHAP)2Cu 
 
 
3.4.8 UV-Vis Spectra of the ligand:  
4-choloro- 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}- phenol (TClHAP) and its nickel 
and copper complexes:  
 
Table (3.35) summarizes the main spectral bands of the compounds with their tentative 
assignments. Full spectra were provided in figures (3.84, 3.85 and 3.86)  
 
  
CT 
π – π* 
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Table 3.35:  
 UV-Vis Spectra of the ligand:  4-choloro- 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}- 
phenol (TClHAP) and its nickel and copper complexes:  
 
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
TClHAP 1.51×10-4 1.87×103 405 n- π* 
  3.20×103 329 π – π* ligand 
  7.45×103 275 π – π* ligand 
  8.21×103 260 - 
(TClHAP)2Ni  179.45 557 d-d transition 
  7.01×103 392 CT 
  6.14×103 333 π – π* 
  2.47×104 270 π – π* benzene 
ring 
(TClHAP)2Cu 3.0×10
-3 229.14 615 d-d transition 
  1.22×104 368 CT 
  2.60×104 283 π – π* ligand 
  2.75×104 260 π – π* ligand 
 
The ligand spectrum reveals four main bands. The band at 405 nm is related to n- π* 
transition, whereas the band at 329 nm is assigned to π – π* which involves molecular 
orbitals essentially localized on the C=N group and the benzene ring. The strong 
absorptions at 275 nm and 260 nm were assigned to π – π* transitions of the benzene ring 
[60]. 
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Differences are observed in the UV-Vis. Spectra of the nickel complex when compared 
with that of the corresponding free ligand. The n- π* transition of the ligand was obscured 
by the strong charge transfer band at 392 nm. The π – π* type of transition due to –C=N 
chromophore shifts to 333 nm on coordination. There is a weak intensity band at 557 nm 
which is related to d-d transitions.  
The copper complex spectra show four main bands. The band at 615 nm is related to a d-
d transition expected for pseudotetrahedral geometry [70]. The strong band at 368 nm 
could be assigned to LMCT, whereas the bands at 283 nm and 260 nm were assigned to  
π – π* transitions of the ligand.  
 
Fig 3.84: UV spectra of: 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-chloro phenol 
(TClHAP) 
 
 
 
n - π* 
π – π* 
π – π* 
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Fig 3.85: UV-Vis spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
chlorophenolato-k2N,O}Ni(II): (TClHAP)2Ni 
 
 
 
 
 
 
Fig 3.86: UV-Vis spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
chlorophenolato-k2N,O}Cu(II): (TClHAP)2Cu 
 
d-d band 
CT 
π – π* 
CT 
π – π* 
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3.4.9 UV-Vis Spectra of the ligand:  
 
4-bromo- 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}- phenol (TBrHAP) and its copper 
complex:  
 
The main spectral bands were summarized in table (3.36), and the complete spectra were 
shown in figures (3.87 and 3.88).  
 
Table 3.36:  
UV-Vis Spectra of: 4-bromo- 2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}- phenol 
(TBrHAP) and its copper complex:  
 
Compound  Conc ( mol/L ) ε ( mol-1Lcm-1)  λ max ( nm )  Assignment 
TBrHAP 3.35×10-4 823.8 405 n – π* 
  1.16×103 330 π – π* imino 
group 
  2.81×103 275 π – π* ligand 
  3.33×103 259 π – π* ligand 
(TBrHAP)2Cu 1.5410
-4 7.86×103 364 CT 
  2.54×104 270 π – π* 
 
In the spectra of the ligand, the bands between 259-275 nm were attributed to benzene  
π – π* transitions [56, 76]. The band at 405 nm is assigned to n – π* transition, associated 
with the azomethine chromophore, whereas the band at 330 nm could be related to the 
imino π – π* transition. 
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In the copper complex, the n – π* band of the ligand, was obscured or disappeared, 
probably because of the ligand imino-nitrogen coordination to the copper ion. The intense 
band at 364 nm was associated with a charge transfer between the metal and the ligand. 
The imino π – π* transitions in the complex were also shifted to some extent confirming 
the ligand bonding to the copper ion through the imino nitrogen atom. The d-d bands 
were not observed due to the low concentration of the complex solution.  
 
Fig 3.87: UV spectra of: 4-Bromo-2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-phenol 
(TBrHAP) 
n - π* 
π – π* 
π – π* 
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Fig 3.88: UV spectra of: bis{2-{1-[2-(1H-Indole-3-yl)-ethylimino]-ethyl}-4-
bromophenolato-k2N,O}Cu(II): (TBrHAP)2Cu 
 
 
3.5. X-ray structures of the ligands and complexes:  
 
Only the successful attempts to re-crystallize the compounds were described here. 
 
3.5.1 Crystal structure of the ligand:  1H-Indole-3-ethylene-5-nitrosalicylaldimine (TNS): 
  
Crystal data and structure refinement for the ligand were summarized in table (3.37), and 
bond lengths and bond angles are given in tables (3.38, 3.39) 
CT 
π – π* 
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Table 3.37: 
Crystal data and structure refinement for TNS: 
Identification code TNS  
Empirical formula C17H15N3O3 
Formula weight 309.32 
Temperature 139 (2) K 
Wavelength 0.71073 A 
Crystal system, space group Monoclinic, C2/c 
a = 14.5990 (7) A   alpha = 90 deg. 
b = 9.5027 (5) A    beta = 95.712 (2) deg. 
Unit cell dimensions 
c = 21.5373 (10) A   gamma = 90 deg. 
Volume 2973.0 (3) A^3 
Z, Calculated density 8, 1.382 Mg/m^3 
Absorption coefficient 0.10 mm-1 
F(000) 1296 
Crystal size 0.51 × 0.30 × 0.19 mm 
Theta range for data collection 5.1–59.5 deg. 
Limiting indices h = −14→18, k = −12→9, l = −27→26 
Reflections collected / unique 6383 / 3312 [R(int) = 0.023] 
Completeness to theta = 25.00 100.0 % 
Absorption correction none 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 3312 / 2 / 216 
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Goodness-of-fit on F^2 1.06 
Final R indices [I>2sigma(I)] R1 = 0.049, wR2 = 0.161 
Largest diff. peak and hole 1.18 and -0.27 e.A^-3 
 
Table 3.38:  
Bond lengths (Å) for TNS:  
 
O1—C1 1.264 (2) C7—H7 0.9500 
O2—N1 1.231 (2) C8—C9 1.527 (3) 
O3—N1 1.237 (2) C8—H8A 0.9900 
N1—C4 1.433 (2) C8—H8B 0.9900 
N2—C7 1.292 (2) C9—C10 1.498 (2) 
N2—C8 1.454 (2) C9—H9A 0.9900 
N2—H2N 0.883 (10) C9—H9B 0.9900 
N3—C12 1.363 (3) C10—C11 1.359 (3) 
N3—C11 1.371 (2) C10—C17 1.430 (2) 
N3—H3N 0.879 (10) C11—H11 0.9500 
C1—C2 1.439 (2) C12—C13 1.396 (3) 
C1—C6 1.446 (3) C12—C17 1.407 (2) 
C2—C3 1.355 (3) C13—C14 1.375 (3) 
C2—H2 0.9500 C13—H13 0.9500 
C3—C4 1.402 (3) C14—C15 1.389 (4) 
C3—H3 0.9500 C14—H14 0.9500 
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C4—C5 1.375 (2) C15—C16 1.375 (3) 
C5—C6 1.393 (3) C15—H15 0.9500 
C5—H5 0.9500 C16—C17 1.394 (3) 
C6—C7 1.421 (2) C16—H16 0.9500 
 
 
Table (3.39): Bond angles (Deg) for TNS:  
 
O2—N1—O3 121.71 (18) N2—C8—H8B 109.5 
O2—N1—C4 118.51 (17) C9—C8—H8B 109.5 
O3—N1—C4 119.78 (16) H8A—C8—H8B 108.1 
C7—N2—C8 125.09 (16) C10—C9—C8 111.78 (14) 
C7—N2—H2N 114.5 (16) C10—C9—H9A 109.3 
C8—N2—H2N 120.4 (16) C8—C9—H9A 109.3 
C12—N3—C11 108.79 (15) C10—C9—H9B 109.3 
C12—N3—H3N 127.4 (16) C8—C9—H9B 109.3 
C11—N3—H3N 123.3 (16) H9A—C9—H9B 107.9 
O1—C1—C2 121.60 (16) C11—C10—C17 106.10 (15) 
O1—C1—C6 122.27 (16) C11—C10—C9 127.56 (17) 
C2—C1—C6 116.12 (16) C17—C10—C9 126.29 (17) 
C3—C2—C1 122.05 (17) C10—C11—N3 110.38 (16) 
C3—C2—H2 119.0 C10—C11—H11 124.8 
C1—C2—H2 119.0 N3—C11—H11 124.8 
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C2—C3—C4 119.64 (16) N3—C12—C13 130.60 (18) 
C2—C3—H3 120.2 N3—C12—C17 107.60 (15) 
C4—C3—H3 120.2 C13—C12—C17 121.76 (19) 
C5—C4—C3 121.81 (17) C14—C13—C12 117.22 (19) 
C5—C4—N1 119.53 (17) C14—C13—H13 121.4 
C3—C4—N1 118.65 (16) C12—C13—H13 121.4 
C4—C5—C6 119.41 (17) C13—C14—C15 121.91 (19) 
C4—C5—H5 120.3 C13—C14—H14 119.0 
C6—C5—H5 120.3 C15—C14—H14 119.0 
C5—C6—C7 119.05 (16) C16—C15—C14 120.9 (2) 
C5—C6—C1 120.95 (16) C16—C15—H15 119.6 
C7—C6—C1 119.97 (16) C14—C15—H15 119.6 
N2—C7—C6 123.14 (17) C15—C16—C17 119.08 (19) 
N2—C7—H7 118.4 C15—C16—H16 120.5 
C6—C7—H7 118.4 C17—C16—H16 120.5 
N2—C8—C9 110.52 (14) C16—C17—C12 119.15 (17) 
N2—C8—H8A 109.5 C16—C17—C10 133.65 (16) 
C9—C8—H8A 109.5 C12—C17—C10 107.12 (16) 
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Hydrogen bond geometry:  
D—H……A D—H H……..A D……A D—H…..A 
N2—H2n….O1 0.88 (1) 1.87 (2) 2.602 (2) 139 (2) 
N3—H3n…O2i 0.88 (1) 2.36 (2) 3.027 (2) 133 (2) 
N3—H3n…O3i 0.88 (1) 2.23 (1) 3.100 (2) 171 (2) 
Symmetry code: (i) x - 1; y; z. 
 
The carbon-bound H atoms were placed at calculated positions (C–H 0.95 Å), and were 
included in the refinement in the riding model approximation with U(H) set to 
1.2Ueq(C). The amino hydrogen atom was located in a difference fourier map, and was 
refined with a distance restraint of N–H 0.88±0.01 Å [74]. 
The final difference fourier map had a large peak at 1.5 Å from O1 and H2n. This peak is 
not near the nitro group even though this group has larger thermal parameters than the 
rest of the molecule. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. 
planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into 
account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; 
correlations between e.s.d.'s in cell parameters are only used when they are defined by 
crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for 
estimating e.s.d.'s involving l.s. planes. 
As it can be seen from the X-ray perspective attached (Figure (3.89)) the ligand exists in 
the zwitterionic form with the phenol H atom transferred to the imine group. Adjacent 
zwitterions are linked into a linear chain running along the axis by an indole–hydroxy 
N—H····O hydrogen bond [3.100 (2) A°]. The C10-C11 bond length in the indolic group 
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is 1.36 Å slightly shorter than a normal aromatic C-C bond (1.39 Å) as it has been 
reported for the ligand TS described earlier [75], and the phenomena also has been 
described in a radiation protector tryptamine hydrochloride [76]. 
                
Fig 3.89: X-ray perspective of: 1H-Indole-3-ethylene-5-nitrosalicylaldimine (TNS)  
 
3.5.2 Crystal structure of the complex: Bis(1H-Indole-3-ethylenesalicylaldiminato-
k
2
N,O)Ni(II) (TS)2Ni: 
 
The crystal data and structure refinement for the complex were shown in table (3.40), and 
bond lengths and bond angles were summarized in tables (3.41 and 3.42). Thermal 
ellipsoid plot for the complex was given in figure (3.90). 
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Table 3.40:  
Crystal data and structure refinement for (TS)2Ni:  
Identification code (TS)2Ni  
Empirical formula [Ni(C17H15N2O)2]_2C3H7NO 
Formula weight 731.52 
Temperature 103 (2) K 
Wavelength 0.71073A 
Crystal system, space group Monoclinic, C2/c 
a = 38.927 (2)A   alpha = 90 deg. 
b = 5.6999 (3)A    beta = 98.489 (2)deg. 
Unit cell dimensions 
c = 15.7560 (8)A   gamma = 90 deg. 
Volume 3457.6 (3)A^3 
Z, Calculated density 4, 1.405 Mg/m^3 
Absorption coefficient 0.61 mm-1 
F(000) 1544 
Crystal size 0.70 × 0.32 × 0.07mm 
Theta range for data collection 2.6–28.5 deg. 
Limiting indices h = −48→50, k = −7→5, l = −19→20 
Reflections collected / unique 3875 / 2900 [R(int) = 0.030] 
Completeness to theta = 25.00 100.0 % 
Absorption correction multi-scan (SADABS; Sheldrick, 1996) 
Max. and min. transmission 0.958 and 0.673 
Refinement method Full-matrix least-squares on F^2 
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Data / restraints / parameters 3875 / 0 / 234 
Goodness-of-fit on F^2 1.03 
Final R indices [I>2sigma(I)] R1 = 0.048, wR2 = 0.133 
Largest diff. peak and hole 0.82and −0.48 e.A^-3 
 
Table 3.41:  
Bond lengths (Å) for (TS)2Ni:  
Ni1—O1 1.829 (2) C8—H8A 0.9900 
Ni1—N1 1.922 (2) C8—H8B 0.9900 
O1—C1 1.310 (3) C9—C11 1.490 (4) 
O2—C18 1.184 (5) C9—H9A 0.9900 
N1—C7 1.297 (3) C9—H9B 0.9900 
N1—C8 1.479 (3) C10—C11 1.368 (4) 
N3—C17 1.363 (4) C10—H10 0.9500 
N3—C10 1.373 (4) C11—C12 1.433 (4) 
N3—H3N 0.8800 C12—C13 1.397 (4) 
N4—C18 1.320 (4) C12—C17 1.423 (4) 
N4—C19 1.431 (4) C13—C14 1.375 (4) 
N4—C20 1.445 (4) C13—H13 0.9500 
C1—C2 1.408 (4) C14—C15 1.412 (5) 
C1—C6 1.410 (4) C14—H14 0.9500 
C2—C3 1.383 (4) C15—C16 1.373 (5) 
C2—H2 0.9500 C15—H15 0.9500 
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C3—C4 1.394 (4) C16—C17 1.393 (4) 
C3—H3 0.9500 C16—H16 0.9500 
C4—C5 1.372 (4) C18—H18 0.9500 
C4—H4 0.9500 C19—H19A 0.9800 
C5—C6 1.405 (4) C19—H19B 0.9800 
C5—H5 0.9500 C19—H19C 0.9800 
C6—C7 1.432 (4) C20—H20A 0.9800 
C7—H7 0.9500 C20—H20B 0.9800 
C8—C9 1.524 (4) C20—H20C 0.9800 
 
Table 3.42:  
Bond angles for (TS)2Ni: 
O1i—Ni1—O1 180.00 (10) H9A—C9—H9B 108.1 
O1i—Ni1—N1i 92.81 (9) C11—C10—N3 110.8 (3) 
O1—Ni1—N1i 87.19 (9) C11—C10—H10 124.6 
O1i—Ni1—N1 87.19 (9) N3—C10—H10 124.6 
O1—Ni1—N1 92.81 (9) C10—C11—C12 105.9 (2) 
N1i—Ni1—N1 180.000 (1) C10—C11—C9 127.1 (3) 
C1—O1—Ni1 127.41 (19) C12—C11—C9 127.0 (2) 
C7—N1—C8 114.6 (2) C13—C12—C17 118.4 (3) 
C7—N1—Ni1 124.0 (2) C13—C12—C11 134.6 (3) 
C8—N1—Ni1 121.26 (17) C17—C12—C11 107.0 (2) 
C17—N3—C10 108.6 (2) C14—C13—C12 119.3 (3) 
 176  
C17—N3—H3N 125.7 C14—C13—H13 120.3 
C10—N3—H3N 125.7 C12—C13—H13 120.3 
C18—N4—C19 120.9 (3) C13—C14—C15 121.3 (3) 
C18—N4—C20 121.4 (3) C13—C14—H14 119.3 
C19—N4—C20 117.6 (3) C15—C14—H14 119.3 
O1—C1—C2 118.5 (3) C16—C15—C14 120.9 (3) 
O1—C1—C6 123.2 (2) C16—C15—H15 119.6 
C2—C1—C6 118.3 (3) C14—C15—H15 119.6 
C3—C2—C1 120.4 (3) C15—C16—C17 117.9 (3) 
C3—C2—H2 119.8 C15—C16—H16 121.1 
C1—C2—H2 119.8 C17—C16—H16 121.1 
C2—C3—C4 120.9 (3) N3—C17—C16 130.1 (3) 
C2—C3—H3 119.5 N3—C17—C12 107.7 (3) 
C4—C3—H3 119.5 C16—C17—C12 122.2 (3) 
C5—C4—C3 119.5 (3) O2—C18—N4 127.9 (4) 
C5—C4—H4 120.2 O2—C18—H18 116.1 
C3—C4—H4 120.2 N4—C18—H18 116.1 
C4—C5—C6 120.7 (3) N4—C19—H19A 109.5 
C4—C5—H5 119.6 N4—C19—H19B 109.5 
C6—C5—H5 119.6 H19A—C19—H19B 109.5 
C5—C6—C1 120.0 (3) N4—C19—H19C 109.5 
C5—C6—C7 119.2 (3) H19A—C19—H19C 109.5 
C1—C6—C7 120.8 (2) H19B—C19—H19C 109.5 
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N1—C7—C6 126.2 (3) N4—C20—H20A 109.5 
N1—C7—H7 116.9 N4—C20—H20B 109.5 
C6—C7—H7 116.9 H20A—C20—H20B 109.5 
N1—C8—C9 113.5 (2) N4—C20—H20C 109.5 
N1—C8—H8A 108.9 H20A—C20—H20C 109.5 
C9—C8—H8A 108.9 H20B—C20—H20C 109.5 
N1—C8—H8B 108.9 H9A—C9—H9B 108.1 
C9—C8—H8B 108.9 C11—C10—N3 110.8 (3) 
H8A—C8—H8B 107.7 C11—C10—H10 124.6 
C11—C9—C8 110.4 (2) N3—C10—H10 124.6 
C11—C9—H9A 109.6 C10—C11—C12 105.9 (2) 
C8—C9—H9A 109.6 C10—C11—C9 127.1 (3) 
C11—C9—H9B 109.6 C12—C11—C9 127.0 (2) 
C8—C9—H9B 109.6 C13—C12—C17 118.4 (3) 
Symmetry codes: (i) −x+1/2, −y+3/2, −z+1. 
 
The carbon-bound H atoms were placed at calculated positions (C—H = 0.95–0.98 Å) 
and were included in the refinement in the riding-model approximation, with U(H) set to 
1.2–1.5Ueq(C). The amino H atom also similarly generated [N—H = 0.88Å and U(H) = 
1.2Ueq(N)].  
The nickel atom lies on a centre of inversion. It is N,O-chelated by the deprotonated 
Schiff base 2-[2-(1H-indol-3-yl)ethyliminomethyl] phenolate ligand in a square-planar 
coordination environment. The molecule is linked to a solvent molecule by an indole–
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dimethylformamide N—H·····O hydrogen bond. Deviations in the planarity of the trans 
NiN2O2 group has occurred. The Ni – O distance is 1.83 Å and the Ni – N distance is 
1.92 Å, hence the planar coordination around the nickel atom is rhombically distorted 
with the longer axis along N – Ni – N and shorter along O –Ni – O, with N1-Ni-O1 angle 
of 92.81 degrees analogous to other planar complexes found in the literature [66, 80, 81].  
Upon complexation, the C1-O1 bond distance goes from 1.34 Å in the ligand to 1.31 Å in 
the complex as a consequence of deprotonation at O1 and formation of the complex. Also 
as expected the angles in the salicylaldehyde moiety undergo modifications on 
coordination, for example, the angle O1-C1-C6 in the ligand which was found to be 
120.7 o in the ligand goes to 123.2o as a result of complex formation [58, 82]. 
 
Fig 3.90: Thermal ellipsoid plot of Ni(C17H14N2O)2.2DMF; displacement ellipsoids are 
drawn at the 70% probability level, and H atoms are shown as spheres of arbitrary radii. 
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3.5.3 X-ray crystal structure for the complex: Bis{4-chloro-2-[2-(1H-indol-3-
yl)ethyliminomethyl] phenolato-κ2N,O}zinc(II): (TCS)2Zn: 
 
Crystal data and structure refinement for the complex were shown in table (3.43), and 
bond lengths and bond angles were summarized in tables (3.44 and 3.45). Thermal 
ellipsoid plot for the complex was given in figure (3.91). 
Table 3.43:  
Crystal data and structure refinement for (TCS)2Zn : 
Identification code (TCS)2Zn 
Empirical formula Zn(C17H14ClN2O)2 
Formula weight 660.87 
Temperature 128 (2) K 
Wavelength 0.71073 A 
Crystal system, space group Monoclinic,  C2/c 
a = 25.8989(3) A   alpha = 90 deg. 
b = 5.4960(1)A    beta = 91.801 (1) deg. 
Unit cell dimensions 
c = 20.6138(3)A   gamma = 90 deg. 
Volume 2932.73 (8)A^3 
Z, Calculated density 4 ,  1.497Mg/m^3 
Absorption coefficient 1.06 mm^-1 
F(000) 1360  
Crystal size 0.50 x 0.30 x 0.17 mm 
Theta range for data collection 2.5 —31.2° deg. 
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Limiting indices -33<=h<=33 , -6<=k<=7 , -26<=l<=26 
Reflections collected / unique 17664 / 3352 [R(int) = 0.025] 
Completeness to theta = 25.00 100.0 % 
Absorption correction Multi-scan  
Max. and min. transmission 0.840 and 0.714 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 3352 / 14 / 251 
Goodness-of-fit on F^2 1.21 
Final R indices [I>2sigma(I)] R1 = 0.025 , wR2 = 0.100 
Largest diff. peak and hole 0.55 and - 0.56 e.A^-3 
  
Table 3.44:  
Bond lengths (Å) for: (TCS)2Zn 
Zn1-O2 1.907(1) C7-H7 0.994(9) 
Zn1-O1 1.907(1) C8-C9 1.523(2) 
Zn1-N1 2.016(1) C8-H81 0.989(9) 
Zn1-N3 2.016(1) C8-H82 0.994(10) 
Cl1-C4 1.745(2) C9-C10 1.502(2) 
O1-C1 1.312(2) C9-H91 0.998(10) 
N1-C7 1.282(2) C9-H92 1.004(10) 
N1-C8 1.469(2) C10-C11 1.366(3) 
C1-C2 1.419(2) C10-C12 1.439(3) 
C1-C6 1.427(2) C11-H11 0.990(10) 
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N2-C17 1.374(2) C12-C13 1.402(3) 
N2-C10 1.383(2) C19-C18 1.415(2) 
N2-H2N 0.870(10) C13-C14 1.379(3) 
C2-C3 1.374(2) C13-H13 0.998(10) 
C2-H2 0.994(10) C15-C16 1.405(3) 
C3-C4 1.391(3) C15-H15 0.990(10) 
C3-H3 1.001(10) C16-C17 1.382(3) 
C4-C5 1.370(2) C16-H16 0.992(10) 
C5-C6 1.410(2) C17-C12 1.398(2) 
C5-H5 0.999(10) C17-H17 0.996(10) 
C6-C7 1.453(2)   
 
Table 3.45:  
Bond angles for (TCS)2Zn 
O1-Zn1-O2 116.62(8) N1-C8-H81 108.7(12) 
O1-Zn1-N1 95.57(5) C9-C8-H81 109.5(12) 
O1-Zn1-N3 125.55(6) N1-C8-H82 109.4(14) 
O2-Zn1-N1 125.55(6) C9-C8-H82 110.3(13) 
O2-Zn1-N3 95.57(5) H81-C8-H82 107.8(18) 
N1-Zn1-N3 99.56(8) C10-C9-C8 110.87(15) 
C1-O1-Zn1 124.38(11) C10-C9-H91 109.5(17) 
C7-N1-C8 118.25(14) C8-C9-H91 109.0(16) 
C7-N1-Zn1 120.68(11) C10-C9-H92 110.3(16) 
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C8-N1-Zn1 119.96(10) C8-C9-H92 110.3(15) 
O1-C1-C2 118.25(15) H91-C9-H92 107(2) 
O1-C1-C6 124.63(15) C11-C10-C12 106.68(16) 
C2-C1-C6 117.12(14) C11-C10-C9 127.04(19) 
C17-N2-C10 109.06(15) C12-C10-C9 126.20(17) 
C17-N2-H2N 125.3(18) C11-C10-N2 109.81(16) 
C10-N2-H2N 125.7(18) C13-C12-C17 118.94(17) 
C3-C2-C1 122.28(16) C13-C12-C11 134.06(17) 
C3-C2-H2 118.2(14) C17-C12-C11 106.99(15) 
C1-C2-H2 119.6(14) C14-C13-C12 118.76(19) 
C2-C3-C4 119.47(15) C14-C13-H13 120.0(14) 
C2-C3-H3 119.0(14) C12-C13-H13 121.2(14) 
C4-C3-H3 121.5(14) C14-C15-C16 121.4(19) 
C5-C4-C3 120.68(16) C14-C15-H15 118.7(15) 
C5-C4-C11 119.65(14) C16-C15-H15 119.8(15) 
C3-C4-C11 119.66(13) C17-C16-C15 121.4(2) 
C4-C5-C6 120.98(16) C17-C16-H16 120.4(16) 
C4-C5-H5 118.2(14) C15-C16-H16 118.2(16) 
C6-C5-H5 120.8(14) C16-C17-C18 117.02(18) 
C5-C6-C1 119.38(14) C16-C17-H17 121.9(15) 
C5-C6-C7 115.93(14) C16-C17-H17 121.1(15) 
C1-C6-C7 124.69(14) N2-C17-C16 130.10(17) 
N1-C7-C6 126.44(15) N2-C17-C12 107.45(15) 
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N1-C7-H7 118.8(12)   
C6-C7-H7 114.6(12)   
N1-C8-C9 111.15(14)   
Symmetry codes: (i) –x+1, y ,-z+3/2. 
 
All hydrogen atoms were located in a difference fourier map and were refined with 
distance restraints of C-H 1.00 Å and N-H 0.88 Å; their temperature factors were freely 
refined. The Zn atom in the title compound, [Zn(C17H14ClN2O)2], is N,O-chelated by 
two deprotonated Schiff base monoanionic ligands in a tetrahedral coordination 
geometry. The Zn atom lies on a special position of site symmetry 2. The chlorine 
substituent does not lead to significant changes to the bond dimensions of the central 
metal.O1-Zn1-N1 bond angle was 95.57o considerably different from the normal 
tetrahedral angle 109o , while the angle O1-Zn1-N3 125.55o more wider than the normal 
tetrahedral angle. This implies a distorted tetrahedral environment around the zinc atom. 
Moreover, the Zn1-O bond distance is 1.90 Å while Zn1-N distance is 2.01 Å [80].  
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Fig 3.91: Thermal ellipsoid plot of Zn(C17H14ClN2O), displacement ellipsoids are 
drawn at 50% probability level, and hydrogen atoms are shown as spheres of arbitrary 
radii.  
 
3.5.4 X-ray crystal structure for the complex:   
Bis(1H-Indole-3-ethylene-3-5-di-tertiarybutylsalicylaldiminato-k
2
N,O)Zn(II) (TTET)2Zn: 
 
Crystal data and structure refinement for the complex were shown in table (3.46), and 
bond lengths and bond angles were summarized in tables (3.47 and 3.38). Thermal 
ellipsoid plot for the complex was given in figure (3.92). 
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Table: 3.46:  
Crystal data and structure refinement for: (TTET)2Zn complex:  
 
Identification code (TTET)2Zn 
Empirical formula C27 H37 N2 O2 S Zn0.50 
Formula weight 486.33 
Temperature 100(2) K 
Wavelength 0.71073 A 
Crystal system, space group Orthorhombic,  Pbcn 
a = 19.9694(4) A   alpha = 90 deg. 
b = 8.1019(2) A    beta = 90 deg. 
Unit cell dimensions 
c = 32.7530(6) A   gamma = 90 deg. 
Volume 5299.11(19) A^3 
Z, Calculated density 8,  1.219 Mg/m^3 
Absorption coefficient 0.589 mm^-1 
F(000) 2080 
Crystal size 0.40 x 0.07 x 0.03 mm 
Theta range for data collection 2.04 to 30.51 deg. 
Limiting indices -26<=h<=27, -11<=k<=11, -46<=l<=46 
Reflections collected / unique 55274 / 7854 [R(int) = 0.0793] 
Completeness to theta = 25.00 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9826 and 0.7986 
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Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 7854 / 78 / 336 
Goodness-of-fit on F^2 1.019 
Final R indices [I>2sigma(I)] R1 = 0.0560, wR2 = 0.1271 
R indices (all data) R1 = 0.0996, wR2 = 0.1485 
Largest diff. peak and hole 0.803 and -0.606 e.A^-3 
 
Table 3.47:  
Bond lengths (Å) for (TTET)2Zn complex:  
Zn-O(1) 1.9121(15) C(13)-H(13) 0.9500 
Zn-N(1) 1.993(2) C(14)-C(15) 1.399(5) 
N(1)-C(7) 1.281(3) C(14)-H(14) 0.9500 
N(1)-C(8) 1.468(3) C(15)-C(16) 1.369(5) 
O(1)-C(1) 1.315(3) C(15)-H(15) 0.9500 
C(1)-C(6) 1.427(3) C(16)-C(17) 1.395(4) 
C(1)-C(2) 1.433(3) C(16)-H(16) 0.9500 
C(2)-C(3) 1.385(3) C(20)-C(22) 1.526(4) 
C(2)-C(20) 1.540(3) C(20)-C(23) 1.528(4) 
C(3)-C(4) 1.409(3) C(20)-C(21) 1.538(4) 
C(3)-H(3) 0.9500 C(21)-H(21A) 0.9800 
C(4)-C(5) 1.371(3) C(21)-H(21B) 0.9800 
C(4)-C(40) 1.528(3) C(21)-H(21C) 0.9800 
C(5)-C(6) 1.412(3) C(22)-H(22A) 0.9800 
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C(5)-H(5) 0.9500 C(22)-H(22B) 0.9800 
C(6)-C(7) 1.443(3) C(22)-H(22C) 0.9800 
C(7)-H(7) 0.9500 C(23)-H(23A) 0.9800 
C(8)-C(9) 1.493(4) C(23)-H(23B) 0.9800 
C(8)-H(8A) 0.9900 C(23)-H(23C) 0.9800 
C(8)-H(8B) 0.9900 C(40)-C(41) 1.492(7) 
C(9)-C(11) 1.501(3) C(40)-C(43) 1.515(7) 
C(9)-H(9A) 0.9900 C(40)-C(42) 1.610(8) 
C(9)-H(9B) 0.9900 C(41)-H(41A) 0.9800 
N(2)-C(17) 1.370(3) C(41)-H(41B) 0.9800 
N(2)-C(10) 1.371(3) C(41)-H(41C) 0.9800 
N(2)-H(2) 0.8800 C(42)-H(42A) 0.9800 
C(10)-C(11) 1.367(4) C(42)-H(42B) 0.9800 
C(10)-H(10) 0.9500 C(42)-H(42C) 0.9800 
C(11)-C(12) 1.435(4) C(43)-H(43A) 0.9800 
C(12)-C(13) 1.402(4) C(43)-H(43B) 0.9800 
C(12)-C(17) 1.410(3) C(43)-H(43C) 0.9800 
C(13)-C(14) 1.381(4) C(13)-H(13) 0.9500 
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Table 3.48:  
Bond angles (Deg.) for (TTET)2Zn complex:  
O(1)-Zn-O(1/) 116.04(10) C(13)-C(12)-C(11) 133.9(2) 
O(1)-Zn-N(1) 95.89(7) C(17)-C(12)-C(11) 107.0(2) 
O(1)#1-Zn-N(1) 122.39(8) C(14)-C(13)-C(12) 118.1(3) 
N(1)-Zn-N(1)#1 105.87(12) C(14)-C(13)-H(13) 121.0 
C(7)-N(1)-C(8) 117.5(2) C(12)-C(13)-H(13) 121.0 
C(7)-N(1)-Zn 120.34(16) C(13)-C(14)-C(15) 121.7(3) 
C(8)-N(1)-Zn 122.07(16) C(13)-C(14)-H(14) 119.2 
C(1)-O(1)-Zn 125.73(14) C(15)-C(14)-H(14) 119.2 
O(1)-C(1)-C(6) 122.7(2) C(16)-C(15)-C(14) 121.6(3) 
O(1)-C(1)-C(2) 119.7(2) C(16)-C(15)-H(15) 119.2 
C(6)-C(1)-C(2) 117.6(2) C(14)-C(15)-H(15) 119.2 
C(3)-C(2)-C(1) 118.5(2) C(15)-C(16)-C(17) 117.0(3) 
C(3)-C(2)-C(20) 120.8(2) C(15)-C(16)-H(16) 121.5 
C(1)-C(2)-C(20) 120.7(2) C(17)-C(16)-H(16) 121.5 
C(2)-C(3)-C(4) 124.7(2) N(2)-C(17)-C(16) 129.9(2) 
C(2)-C(3)-H(3) 117.7 N(2)-C(17)-C(12) 107.6(2) 
C(4)-C(3)-H(3) 117.7 C(16)-C(17)-C(12) 122.5(3) 
C(5)-C(4)-C(3) 116.2(2) C(22)-C(20)-C(23) 107.7(2) 
C(5)-C(4)-C(40) 122.7(2) C(22)-C(20)-C(21) 107.1(2) 
C(3)-C(4)-C(40) 121.2(2) C(23)-C(20)-C(21) 110.1(2) 
C(4)-C(5)-C(6) 122.7(2) C(22)-C(20)-C(2) 112.0(2) 
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C(4)-C(5)-H(5) 118.6 C(23)-C(20)-C(2) 109.9(2) 
C(6)-C(5)-H(5) 118.6 C(21)-C(20)-C(2) 110.0(2) 
C(5)-C(6)-C(1) 120.3(2) C(20)-C(21)-H(21A) 109.5 
C(5)-C(6)-C(7) 114.7(2) C(20)-C(21)-H(21B) 109.5 
C(1)-C(6)-C(7) 125.0(2) H(21A)-C(21)-H(21B) 109.5 
N(1)-C(7)-C(6) 127.9(2) C(20)-C(21)-H(21C) 109.5 
N(1)-C(7)-H(7) 116.0 H(21A)-C(21)-H(21C) 109.5 
C(6)-C(7)-H(7) 116.0 H(21B)-C(21)-H(21C) 109.5 
N(1)-C(8)-C(9) 110.3(2) C(20)-C(22)-H(22A) 109.5 
N(1)-C(8)-H(8A) 109.6 C(20)-C(22)-H(22B) 109.5 
C(9)-C(8)-H(8A) 109.6 H(22A)-C(22)-H(22B) 109.5 
N(1)-C(8)-H(8B) 109.6 C(20)-C(22)-H(22C) 109.5 
C(9)-C(8)-H(8B) 109.6 H(22A)-C(22)-H(22C) 109.5 
H(8A)-C(8)-H(8B) 108.1 H(22B)-C(22)-H(22C) 109.5 
C(8)-C(9)-C(11) 114.2(2) C(20)-C(23)-H(23A) 109.5 
C(8)-C(9)-H(9A) 108.7 C(20)-C(23)-H(23B) 109.5 
C(11)-C(9)-H(9A) 108.7 H(23A)-C(23)-H(23B) 109.5 
C(8)-C(9)-H(9B) 108.7 C(20)-C(23)-H(23C) 109.5 
C(11)-C(9)-H(9B) 108.7 H(23A)-C(23)-H(23C) 109.5 
H(9A)-C(9)-H(9B) 107.6 H(23B)-C(23)-H(23C) 109.5 
C(17)-N(2)-C(10) 109.0(2) C(41)-C(40)-C(43) 108.1(4) 
C(17)-N(2)-H(2) 125.5 C(41)-C(40)-C(4) 113.0(3) 
C(10)-N(2)-H(2) 125.5 C(43)-C(40)-C(4) 114.9(3) 
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C(11)-C(10)-N(2) 110.1(2) C(41)-C(40)-C(42) 108.5(4) 
C(11)-C(10)-H(10) 125.0 C(43)-C(40)-C(42) 104.8(4) 
N(2)-C(10)-H(10) 125.0 C(4)-C(40)-C(42) 107.0(3) 
C(10)-C(11)-C(12) 106.3(2) C(40)-C(41)-H(41A) 109.5 
C(10)-C(11)-C(9) 128.3(2) C(40)-C(41)-H(41B) 109.5 
C(12)-C(11)-C(9) 125.4(2) C(40)-C(41)-H(41C) 109.5 
C(13)-C(12)-C(17) 119.1(2) C(40)-C(42)-H(42A) 109.5 
  C(40)-C(42)-H(42B) 109.5 
 
 Because the zinc atom lies on a crystallographic 2-fold rotational axis of symmetry, it 
must be coordinated to two Schiff base ligand molecules. Bonding is through the 
deprotonated phenolate oxygen atom O1 and the azomethine nitrogen atom N1. Zinc 
coordination is only approximately tetrahedral, since the angles O1-Zn-O1/ (116.04(10)), 
O1-Zn-N1 (95.89(7)) and N1-Zn-N1/ (105.87(12)) differ significantly from the normal 
tetrahedral angle. The tertiary butyl group, connected to C4 of the salicylaldehyde 
moiety, is rotationally disordered around C4-C40 bond. Both this molecule and one 
solvate DMSO molecule are disordered in the crystal structure. The DMSO disorder is 
complex, but both are adequately modeled.  In a similar compound [80], the angle N1-
Zn-N1/ which is 105.87(12) Å here, is larger than the corresponding angle (99.56(8)) in 
bis{4-chloro-2-[2-(1H-indol-3-yl)ethyliminomethyl] phenolato-κ2N, O} zinc(II). This 
may be due to the steric effects exerted by the bulky tertiary butyl groups in the 
salicylaldehyde moiety. 
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Fig 3.92: Thermal ellipsoid plot of (TTET)2Zn drawn at the 50% probability level. 
Hydrogen atoms are shown as spheres of arbitrary radii. 
 
3.5.5 X-ray crystal structure of the complex:  
Dichloridobis(2-{1-[2-(1H-indol-3-yl)-ethyliminio]ethyl}phenolate-kO)zinc(II) 
(THAP)2Zn: 
 
Crystal data and structure refinement for the complex were shown in table (3.49), and 
bond lengths and bond angles were summarized in tables (3.50 and 3.51). X-ray 
molecular structure diagram was shown in figure (3.93). 
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Table 3.49:  
Crystal data and structure refinement for: (THAP)2Zn  
 
Identification code (THAP)2Zn 
Empirical formula [ZnCl2(C18H18N2O)2]_2C18H18N2O 
Formula weight 1249.65 
Temperature 295 (2) K 
Wavelength 0.71073A 
Crystal system, space group Monoclinic, C2 
a = 25.8073 (4)A   alpha = 90 deg. 
b = 9.1754 (1)A    beta = 112.566 (1) deg. 
Unit cell dimensions 
c = 14.3265 (2) A   gamma = 90 deg.  
Volume 3132.67 (7)A^3 
Z, Calculated density 2 Mg/m^3 
Absorption coefficient 0.54 mm-1  
F(000) 1312 
Crystal size 0.10 × 0.06 × 0.05mm 
Theta range for data collection 2.4–23.8 deg. 
Limiting indices h = −33→32, k = −11→11, l = −18→18 
Reflections collected / unique 36333 / 7190 [R(int) = 0.039] 
Completeness to theta = 25.00 100.0 % 
Absorption correction multi-scan 
Max. and min. transmission 0.974 and 0.866 
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Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 7190 / 10 / 413 
Goodness-of-fit on F^2 1.00 
Final R indices [I>2sigma(I)] R1 = 0.037, wR2 = 0.091 
Largest diff. peak and hole 0.36 and −0.30e.A^-3 
  
Table 3.50:  
Bond lengths (Å) for: (THAP)2Zn:  
Zn1—O1i 1.987 (2) C14—H14 0.9300 
Zn1—O1 1.987 (2) C15—C16 1.383 (5) 
Zn1—Cl1i 2.2260 (6) C15—H15 0.9300 
Zn1—Cl1 2.2260 (6) C16—C17 1.377 (5) 
O1—C1 1.323 (3) C16—H16 0.9300 
O2—C19 1.298 (4) C17—C18 1.391 (3) 
N1—C7 1.290 (3) C17—H17 0.9300 
N1—C9 1.464 (3) C19—C24 1.414 (4) 
N1—H1N 0.86 (1) C19—C20 1.416 (4) 
N2—C12 1.363 (4) C20—C21 1.365 (6) 
N2—C18 1.367 (3) C20—H20 0.9300 
N2—H2N 0.86 (1) C21—C22 1.358 (6) 
N3—C25 1.273 (4) C21—H21 0.9300 
N3—C27 1.500 (7) C22—C23 1.367 (5) 
N3—C27' 1.502 (7) C22—H22 0.9300 
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N3—H3N 0.87 (1) C23—C24 1.413 (4) 
N4—C30 1.364 (4) C23—H23 0.9300 
N4—C36 1.373 (4) C24—C25 1.438 (4) 
N4—H4N 0.86 (1) C25—C26 1.489 (5) 
C1—C2 1.401 (3) C26—H26A 0.9600 
C1—C6 1.421 (3) C26—H26B 0.9600 
C2—C3 1.374 (4) C26—H26C 0.9600 
C2—H2 0.9300 C27—C28 1.491 (9) 
C3—C4 1.386 (4) C27—H27A 0.9700 
C3—H3 0.9300 C27—H27B 0.9700 
C4—C5 1.372 (3) C28—C29 1.506 (8) 
C4—H4 0.9300 C28—H28A 0.9700 
C5—C6 1.406 (3) C28—H28B 0.9700 
C5—H5 0.9300 C27'—C28' 1.485 (9) 
C6—C7 1.449 (3) C27'—H27C 0.9700 
C7—C8 1.492 (3) C27'—H27D 0.9700 
C8—H8A 0.9600 C28'—C29 1.502 (8) 
C8—H8B 0.9600 C28'—H28C 0.9700 
C8—H8C 0.9600 C28'—H28D 0.9700 
C9—C10 1.520 (4) C29—C30 1.355 (4) 
C9—H9A 0.9700 C29—C31 1.428 (4) 
C9—H9B 0.9700 C30—H30 0.9300 
C10—C11 1.500 (4) C31—C32 1.392 (4) 
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C10—H10A 0.9700 C31—C36 1.406 (3) 
C10—H10B 0.9700 C32—C33 1.375 (4) 
C11—C12 1.358 (3) C32—H32 0.9300 
C11—C13 1.420 (4) C33—C34 1.386 (4) 
C12—H12 0.9300 C33—H33 0.9300 
C13—C14 1.398 (3) C34—C35 1.365 (5) 
C13—C18 1.418 (4) C34—H34 0.9300 
C14—C15 1.374 (4) C35—C36 1.386 (4) 
  C35—H35 0.9300 
 
Table 3.51:  
Bond angles for (THAP)2Zn:  
O1—Zn1—O1i 99.84 (9) N2—C18—C17 130.8 (3) 
O1—Zn1—Cl1 110.51 (5) N2—C18—C13 107.3 (2) 
O1i—Zn1—Cl1i 110.51 (5) C17—C18—C13 122.0 (3) 
O1—Zn1—Cl1i 110.14 (5) O2—C19—C24 121.6 (3) 
O1i—Zn1—Cl1 110.14 (5) O2—C19—C20 121.2 (3) 
Cl1—Zn1—Cl1i 114.72 (3) C24—C19—C20 117.2 (3) 
C1—O1—Zn1 120.01 (14) C21—C20—C19 121.5 (4) 
C7—N1—C9 127.5 (2) C21—C20—H20 119.3 
C7—N1—H1N 114 (2) C19—C20—H20 119.3 
C9—N1—H1N 118 (2) C20—C21—C22 121.4 (3) 
C12—N2—C18 108.7 (2) C20—C21—H21 119.3 
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C12—N2—H2N 125 (2) C22—C21—H21 119.3 
C18—N2—H2N 126 (2) C21—C22—C23 119.5 (4) 
C25—N3—C27 130.9 (9) C21—C22—H22 120.3 
C25—N3—C27' 119.5 (9) C23—C22—H22 120.3 
C27—N3—C27' 25.6 (9) C22—C23—C24 121.6 (3) 
C25—N3—H3N 120 (3) C22—C23—H23 119.2 
C27—N3—H3N 102 (3) C24—C23—H23 119.2 
C27'—N3—H3N 121 (3) C19—C24—C23 118.8 (3) 
C30—N4—C36 109.6 (3) C19—C24—C25 121.3 (3) 
C30—N4—H4N 130 (2) C23—C24—C25 119.9 (3) 
C36—N4—H4N 120 (2) N3—C25—C24 117.8 (3) 
O1—C1—C2 120.9 (2) N3—C25—C26 120.5 (3) 
O1—C1—C6 121.4 (2) C24—C25—C26 121.7 (3) 
C2—C1—C6 117.8 (2) C25—C26—H26A 109.5 
C3—C2—C1 121.8 (2) C25—C26—H26B 109.5 
C3—C2—H2 119.1 H26A—C26—H26B 109.5 
C1—C2—H2 119.1 C25—C26—H26C 109.5 
C2—C3—C4 120.5 (2) H26A—C26—H26C 109.5 
C2—C3—H3 119.8 H26B—C26—H26C 109.5 
C4—C3—H3 119.8 C28—C27—N3 107.4 (8) 
C5—C4—C3 119.2 (3) C28—C27—H27A 110.2 
C5—C4—H4 120.4 N3—C27—H27A 110.2 
C3—C4—H4 120.4 C28—C27—H27B 110.2 
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C4—C5—C6 121.9 (3) N3—C27—H27B 110.2 
C4—C5—H5 119.1 H27A—C27—H27B 108.5 
C6—C5—H5 119.1 C27—C28—C29 110.8 (10) 
C5—C6—C1 118.8 (2) C27—C28—H28A 109.5 
C5—C6—C7 119.9 (2) C29—C28—H28A 109.5 
C1—C6—C7 121.3 (2) C27—C28—H28B 109.5 
N1—C7—C6 119.6 (2) C29—C28—H28B 109.5 
N1—C7—C8 119.2 (2) H28A—C28—H28B 108.1 
C6—C7—C8 121.2 (2) C28'—C27'—N3 107.8 (10) 
C7—C8—H8A 109.5 C28'—C27'—H27C 110.2 
C7—C8—H8B 109.5 N3—C27'—H27C 110.2 
H8A—C8—H8B 109.5 C28'—C27'—H27D 110.2 
C7—C8—H8C 109.5 N3—C27'—H27D 110.2 
H8A—C8—H8C 109.5 H27C—C27'—H27D 108.5 
H8B—C8—H8C 109.5 C27'—C28'—C29 111.4 (11) 
N1—C9—C10 109.8 (2) C27'—C28'—H28C 109.3 
N1—C9—H9A 109.7 C29—C28'—H28C 109.3 
C10—C9—H9A 109.7 C27'—C28'—H28D 109.3 
N1—C9—H9B 109.7 C29—C28'—H28D 109.3 
C10—C9—H9B 109.7 H28C—C28'—H28D 108.0 
H9A—C9—H9B 108.2 C30—C29—C31 106.5 (3) 
C11—C10—C9 112.9 (2) C30—C29—C28 132.3 (8) 
C11—C10—H10A 109.0 C31—C29—C28 121.1 (8) 
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C9—C10—H10A 109.0 C30—C29—C28' 119.6 (8) 
C11—C10—H10B 109.0 C31—C29—C28' 133.9 (8) 
C9—C10—H10B 109.0 C28—C29—C28' 12.8 (15) 
H10A—C10—H10B 107.8 C29—C30—N4 109.8 (3) 
C12—C11—C13 106.5 (2) C29—C30—H30 125.1 
C12—C11—C10 127.6 (3) N4—C30—H30 125.1 
C13—C11—C10 125.8 (2) C32—C31—C36 118.1 (3) 
C11—C12—N2 110.6 (2) C32—C31—C29 134.4 (2) 
C11—C12—H12 124.7 C36—C31—C29 107.5 (3) 
N2—C12—H12 124.7 C33—C32—C31 119.4 (3) 
C14—C13—C18 118.0 (2) C33—C32—H32 120.3 
C14—C13—C11 135.1 (2) C31—C32—H32 120.3 
C18—C13—C11 106.9 (2) C32—C33—C34 121.1 (3) 
C15—C14—C13 119.9 (3) C32—C33—H33 119.5 
C15—C14—H14 120.0 C34—C33—H33 119.5 
C13—C14—H14 120.0 C35—C34—C33 121.3 (3) 
C14—C15—C16 120.8 (3) C35—C34—H34 119.3 
C14—C15—H15 119.6 C33—C34—H34 119.3 
C16—C15—H15 119.6 C34—C35—C36 117.6 (3) 
C17—C16—C15 121.6 (3) C34—C35—H35 121.2 
C17—C16—H16 119.2 C36—C35—H35 121.2 
C15—C16—H16 119.2 N4—C36—C35 131.0 (3) 
C16—C17—C18 117.7 (3) N4—C36—C31 106.5 (2) 
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C16—C17—H17 121.2 C35—C36—C31 122.5 (3) 
C18—C17—H17 121.2   
Symmetry codes: (i) −x+1, y, −z. 
 
The ethylene linkage in the free Schiff base is disordered over two positions; these were 
arbitrarily assigned 0.5 site occupancies; the temperature factors of the primed atoms 
were set to those of the unprimed atoms. The N3–C27 and N3–C27' were restrained to 
within 0.01 Å of each other; the four C–C bonds were restrained to 1.50±0.01 Å. 
Carbon-bound H-atoms were placed in calculated positions (C—H 0.93 to 0.98 Å) and 
were included in the refinement in the riding model approximation, with U(H) set to 1.2 
to 1.5U(C). The amino H-atoms were located in a difference Fourier map, and were 
refined with an N–H distance restraint of 0.86±0.01 Å; their temperature factors were 
freely refined.  
The compound crystallizes as a cocrystal coordinated and free zwitterions with an 
intramolecular N···O hydrogen bond. 
In the mononuclear complex molecule the Zn atom, which lies on a twofold rotation axis, 
is coordinated by phenolate O atoms in tetrahedral coordination geometry. The 
coordinated Schiff base uses its indole NH donor site to form a hydrogen bond to the 
negatively charged phenolate O atom of the uncoordinated zwitterionic Schiff base. 
There is an intramolecular N—H···O hydrogen bond in the coordinated and 
uncoordinated Schiff bases. The indole NH site of the uncoordinated Schiff base does not 
engage in a hydrogen bond interaction. The CH2—CH2 group in the uncoordinated 
Schiff base is disordered equally over two positions. The Zn1—O1 bond distance is 1.98 
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Å while the Zn1—Cl1 bond length is 2.22 Å, O1—Zn1—Cl1 angle 110.51o (5) deviates 
some what from the normal tetrahedral angle, and so do the Cl1—Zn1—Cl1i bond angle 
[81].    
 
 
 
 
Fig 3.93: Thermal ellipsoid plot of ZnCl2(C18H18N2O)2.2C18H18N2O at the 70% 
probability level; hydrogen atoms are drawn as spheres of arbitrary radii. The symmetry-
related zwitterionic Schiff base is not shown. Dashed lines denote hydrogen bonds. The 
mononuclear molecule lies on a twofold rotation axis. 
 
 
 
 
CHAPTER FOUR 
 
 
 
BIOLOGICAL ACTIVITIES  
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4. Biological activities 
 
4.1 The anti-ulcerogenic activity of the Schiff bases and complexes (general aspects):  
The anti-ulcer activity of a number of the Schiff base ligands and their metal complexes 
were evaluated against ethanol-induced gastric ulcer in rats. Experimental groups were 
orally pre-treated with low (30 mg/kg body weight) and high (60 mg/kg body weight) 
doses of the test compounds in 10% Tween-20 suspension. The ulcer control groups were 
pre-treated with vehicle 10% Tween-20. The reference group was orally pre-treated with 
50 mg/kg Cimetidine.  
Gastric ulcer was induced by intragstric application of absolute ethanol (5 ml/kg) 
according to the method described by Robert et al [82] with slight modification in adult 
male rats.  
Peptic ulcers are caused when the natural balances between the aggressive factors of acid 
and pepsin and defensive mechanisms of mucus, bicarbonate, mucosal turnover and 
blood supply (mucosal barrier) are disturbed [83]. Baron et al, [84] have suggested that 
acid and pepsin are relatively less important as causative agents and that a defect in the 
defensive mechanism of gastric mucosa is the first step toward ulcer formation. Although 
in most cases the etiology of ulcer is unknown, it is generally accepted that it is the result 
of an imbalance between aggressive factors and maintenance of the mucosal integrity 
through the endogenous defense mechanism [83].  
Ethanol is commonly used for inducing ulcer in experimental rats and lead to intense 
gastric mucosal damage. Ethanol shows its harmful effects either through direct 
generation of reactive metabolites, including free radical species that react with most of 
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the cell components, changing their structures and functions, or promote enhanced 
oxidative damage [85, 86]. Ethanol damage to the gastrointestinal mucosa starts with 
microvascular injury, namely disruption of the vascular endothelium resulting in 
increased vascular permeability, edema formation and epithelial lifting [87]. Ethanol 
produces necrotic lesions in the gastric mucosa by its direct toxic effect, reducing the 
secretion of bicarbonates and production of mucus [88]. Exposure to ethanol increases 
the extension of cellular damage in a dose-dependent way [89]. Ethanol is metabolized in 
the body and release superoxide anion and hydroperoxyl free radicals which are involved 
in the mechanism of acute and chronic ulceration in the gastric mucosa. Furthermore, 
disturbances in gastric secretion, damage to the gastric mucosa, alterations in 
permeability, gastric mucus depletion and free—radical production are observed after the 
administration of ethanol [90]. 
4.2 Animal Experiments:  
4.2.1 Anti-ulcer experiment:  
Adult male Sprague-Dawley rats were fasted for 48 hours before the experiment [91], but 
were allowed free access to drinking water till two hours before the experiment. During 
the fasting period, the rats were placed in four cages, with wide-mesh wire bottoms to 
prevent coprophagia, each cage contains six randomly selected rats. 
Gastric ulcer was induced according to the method described by Robert et al. [82] with 
some modification in adult male Sprague-Dawley rats. Group 1 rats were negative 
controls that received 10 ml/kg of 10% Tween-20 orally by orogastric intubations; 
whereas Group 2 rats received oral doses of 50 mg/kg Cimetidine (10 ml/kg) as positive 
controls. Group 3 and 4 rats received oral high dose (60 mg/kg) and low dose (30 mg/kg) 
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of different synthesized Schiff bases and complexes, respectively. One hour after this pre-
treatment, rats were gavaged with absolute ethanol (5 ml/kg) in order to induce gastric 
ulcers. The rats were euthanized 60 minutes later [92] by overdoses of diethyl ether and 
their stomachs were immediately excised. Each stomach was opened along the greater 
curvature, washed with distilled water and fixed in 10% buffered formalin for 15 
minutes. 
The stomachs were removed and the gastric juice was obtained from each stomach. The 
surface area (mm2) covered by each lesion was measured [93], and the sum of erosion 
areas per rat stomach was estimated by using a microscope at magnification ×1.8. 
Percentage ulcerated surface (US), was calculated as: US(mm2)=(total area covered by 
ulcers ÷total corpus mucosal surface) ×100.The ulcer index (UI) for each animal was then 
calculated as the mean ulcer score. Percentage inhibition (%I) was determined as [(UI in 
control – UI in test group) ÷ UI in control group] ×100 [94]. 
After the stomach contents were collected, they were centrifuged and gastric juice was 
separated from the mucus. The mucus content was weighed and expressed in terms of 
grams [95] and the pH of the stomach juice was recorded. 
4.2.2 Acute toxicity test LD50: 
Adult male and female ICR mice (8 weeks old) were obtained from the Animal House, 
Faculty of Medicine, University of Malaya. The mice weighed between 30 -40 g. The 
animals were given standard rat pellets and tap water ad libitum. The acute toxicity study 
was used to determine a safe dose for the compounds. Thirty six ICR mice (18 males and 
18 females) were assigned equally into 3 groups labeled as vehicle 10% Tween-20 (5 
ml/kg); 2 g/kg and 5 g/kg for each of the compounds in 10% Tween-20 preparation. 
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These animals were subjected to overnight fasting (food but not water) prior to dosing. 
Food was withheld for a further 3 to 4 hours after dosing. The animals were observed for 
30 min and 1, 2, 3 and 24 h after the administration for the onset of clinical or 
toxicological symptoms. Mortality, if any was observed over a period of 2 weeks. The 
acute toxicity LD50 was calculated as the geometric mean of the dose that resulted in 
100% lethality and that which caused no lethality at all. The animals were sacrificed on 
the 15th day. Histology, hematological and serum biochemical parameters were 
determined following standard methods [96, 97]. The study was approved by the ethics 
committee for animal experimentation, Faculty of Medicine, University of Malaya. All 
animals received human care according to the criteria outlined in the “Guide for the Care 
and Use of laboratory Animals” prepared by the National Academy of Sciences and 
published by the national Institute of health. 
Results were shown in table (4.4). 
4.3 Statistical analysis: 
All values were reported as mean + S.E.M. The statistical significance of 
differences between groups was assessed using one-way ANOVA. A value of p<0.05 
was considered significant. (See appendix B) 
 
4.4 The anti-ulcerogenic activity of: 1H-Indole-3-ethylenesalicylaldimine (TS) and 
its zinc, nickel and copper complexes:  
The anti-ulcer results of TS and its Zn(II), Ni(II) and Cu(II) complexes were shown in 
table (4.1 ), and presented diagrammatically in figures (4.1, 4.2 and 4.3)  
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Figure 4.1: Ulcer area (mm2) of TS and its Zn, Ni and Cu complexes: 
 
 
 
 
 
 
 
 
 
Figure 4.2: Comparison of ulcer areas (mm2) among TS and its complexes. 
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Percent inhibition for TS and its complexes
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Figure 4.3: Percent inhibition for TS and its Zn, Ni and Cu complexes 
Fig (4.1) shows the ulcer area (mm2) in rat stomachs for the ligand and its complexes 
together with the positive and negative controls. It is clearly evident that TS and its 
complexes significantly reduced the ulcer area compared to Cimetidine when applied as 
high or low dose. Complexation of zinc metal to the ligand doesn’t manifest any 
difference in lesions inhibition compared to the uncomplexed ligand, but still can be 
considered as potent anti-ulcer drug. Reduction of ulcer areas in the case of complexes 
probably have been achieved by stimulating the production of more mucus as it was 
shown in table (4.1). 
It could be also concluded from figures (4.2) and (4.3) that, among the series, TS and its 
zinc complex reveals the greatest inhibition percentage, and the oral administration of the 
ligand or its zinc complex before ethanol administration significantly prevent ulceration 
up to 100%. Copper complex, when applied as a high dose, appears to have stronger 
effect in reducing the ulcer area than the nickel complex. Since copper complexes seem 
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to have superoxide dismutating activity, it is reasonable to suggest that the inactivation of 
superoxide anions protects the stomach wall. The radical scavenging property of the 
copper complex together with an increase of PGs may help to explain the 
gastroprotective effect of the compound [98]. 
Flattening of the folds was also observed (See Appendix C, a-c), which suggests that 
gastroprotective effect of the compounds might be due to a decrease in gastric motility. It 
is reported that the changes in the gastric motility may play a role in the development and 
prevention of experimental gastric lesions [99, 100]. Relaxation of circular muscles may 
protect the gastric mucosa through flattening of the folds. This will increase the mucosal 
area exposed to necrotizing agents and reduce the volume of the gastric irritants on rugal 
crest [101]. Ethanol produces a marked contraction of the circular muscles of rat fundic 
strip, and such a contraction can lead to mucosal compression at the site of the greatest 
mechanical stress, at the crests of mucosal folds leading to necrosis and ulceration [102]. 
 
4.5 The anti-ulcerogenic activity of: 1H-Indole-3-ethylene-5-chlorosalicylaldimine 
(TCS) and its zinc, nickel and copper complexes:  
 
The anti-ulcer activity of TCS and its Zn(II), Ni(II) and Cu(II) complexes were 
summarized in table (4.2), and presented in figures (4.4, 4.5 and 4.6) 
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Figure 4.4: Ulcer area (mm2) of TCS and its Zn, Ni and Cu complexes 
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Figure 4.5: Comparison of ulcer areas (mm2) among TCS and its complexes. 
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Figure 4.6: Percent inhibition for TCS and its Zn, Ni and Cu complexes. 
TCS complexes are more effective as ulcer inhibitors than the free ligand, and reveal 
enhanced prevention when applied as high dose compared to Cimetidine, a standard drug 
used for curing gastric ulcer. Likewise, (TCS)2Cu complex was also considered as a more 
effective compound in reducing ulcer area among this series. This can be explained on 
the basis of stimulating the stomach to produce more mucus (2.8g compared to about 
1.5g in the case of Ni and Zn complexes). Copper complexes have been shown to be 
concerned with the synthesis of procollagen, proelastin, or mucoplysaccharide, which are 
necessary for healing following tissue damage [48].  
In the case of nickel complex, both the high and low doses brought about significant 
reduction of ulcer area compared to Cimetidine, and no significant difference were noted 
between the two doses. It is also noted here that, (TCS)2Zn, in general, causes lesion 
damage resistance by approximately double the efficiency of (TCS)2Ni counterpart (Fig 
4.5).  
 213 
The unusual high ulcer damage observed upon application of high dose of the free ligand 
prior to ethanol administration can be understood on the basis of overdosing which brings 
about adverse effects and causes alterations in permeability and tissue functional 
disturbances.   
 
4.6 The anti-ulcerogenic activity of: 1H-Indole-3-ethylene-5-nitrosalicylaldimine 
(TNS) and its Zn(II), Ni(II) and Cu(II) complexes:  
 
The anti-ulcer activity of TNS and its Zn(II), Ni(II) and Cu(II) complexes were 
summarized in table (4.3), and presented in figures (4.7, 4.8 and 4.9) 
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Figure 4.7: Ulcer area (mm2) of TNS and its Zn, Ni and Cu complexes 
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Comparison between ulcer area of TNS and its complexes
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Figure 4.8: Comparison of ulcer areas (mm2) among TNS and its complexes. 
Percent inhibition of TNS and its complexes
0
20
40
60
80
100
120
Cim
eti
din
e
Tw
ee
n-2
0
TN
S
(TN
S)
Zn
(TN
S)
2N
i
(TN
S)
2C
u
Compound
pe
rc
en
t i
nh
ib
iti
on
 (%
)
60 mg/kg
30 mg/kg
 
Figure 4.9: Percent inhibition for TNS and its Zn, Ni and Cu complexes. 
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In contrast to TCS and its complexes, TNS ligand is more effective as anti-ulcer drug 
than its zinc, nickel and copper complexes, yet, the ligands and complexes can be 
considered as potential anti-ulcer drugs compared to Cimetidine as shown in figure (4.8). 
This can be explained in the bases of reducing the acidity of the stomach juice as it can be 
implied from the pH values. These results also confirm the antisecretory ability of these 
compounds as reflected from the significant reduction of gastric juice volume and acid 
output, beside the enhancement of mucus secretion. However, (TNS)2Cu complex ranks 
on top of its counterparts, (TNS)2Ni complex comes at the second close, whereas zinc 
complex is the least effective. It has been reported that the gastric cytoprotection might 
be mediated by at least two different mechanisms: one of them through prostaglandine 
synthesis, and the second one by increasing the mucosal glycoproteins production [103, 
104]. Copper complexes were shown to enhance the formation of prostaglandine E2 and 
are likely to participate in gastroprotective activity [105,106].  The unusual feature in 
figure (4.8) is that, with respect to (TNS)2Cu complex, the low dose appear to have more 
better effect in reducing ulcer areas than the high dose and can be considered as the 
optimum dose, more higher doses will affect the physiological properties and lead to 
more bleeding and damage.  
4.7 Histological evaluation of gastric lesions:  
Histological observation of ethanol induced gastric lesions in ulcer control group pre-
treated with 10% Tween 20, showed comparatively extensive damage to the gastric 
mucosa, and oedema and leucocytes infiltration of the submucosal layer (Appendix D, d-
f). Rats that received pre-treatment with synthesized Schiff bases and complexes had 
comparatively better protection of the gastric mucosa as seen by reduction in ulcer area, 
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reduced or absence of submucosal edema and leucocytes infiltration (Appendix D 1e and 
f). The synthesized Schiff bases and complexes have been shown to exert the 
cytoprotective effects in a dose-dependent manner. 
4.8 Anti-oxidant activity:  
4.8.1 DPPH assay:  
The total free radical scavenging capacity of the Schiff bases and complexes studied was 
estimated and compared to Vit C and BHT as standards. 
Freshly prepared DPPH solution (100 µM) in DMSO was used in the determination. 5 µL 
of the samples (with a concentration range between 50-250 µM) and standards were 
added to 195 µL of DPPH reagent to start the reaction. The final concentration was 97.5 
µM for DPPH and varies between 50-250 µM for the test compounds. This has been done 
to determine the optimum concentration that achieves maximum inhibition of DPPH. The 
plate was read at 515 nm for 3 hours with 20 minutes intervals to reach a steady state 
against DMSO as a blank. The percentage DPPH quenched was calculated according to 
the equation:  
DPPH quenched (%) = (Abs. blank – Abs. sample)/ Abs. blank × 100. 
All tests were conducted in triplicate, and the curves were shown in appendix (E).  
 
4.8.2 Scavenging capacities for the series of tryptamine-salicylaldehydes and their 
complexes:  
 
The total DPPH scavenging capacities of each of the compounds at 200 µM 
concentration were measured and compared to vitamin C and BHT (butylated 
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hydroxytoluene). Moderate DPPH radical scavenging capacity was detected in the 
complexes, but weak in the case of the ligands at the selected concentration, although the 
tested compounds differ in their activity to react and quench DPPH radicals (Fig 4.10). 
DPPH percent inhibition of TS series
69.9
82
11.509
15.509
63.93
20.912
30.035
17.193
39.205
6.459
15.509
11.018
0.982
16.211 17.544
36.491
63.018
10.175
0
10
20
30
40
50
60
70
80
90
BH
T
Vit
 C TS
(TS
)2Z
n
(TS
)2N
i
(TS
)2C
u
TC
S
(TC
S)
2Z
n
(TC
S)
2N
i
(TC
S)
2C
u
TN
S
(T
NS
)2Z
n
(TN
S)
2N
i
(TN
S)
2C
u
TT
ET
(TT
ET
)2Z
n
(TT
ET
)2N
i
(TT
ET
)2C
u
Compound
Pe
rc
en
t i
nh
ib
iti
on
   
Figure 4.10: DPPH inhibition percentages amongst TS series compounds 
  
In general, the complexes show comparable scavenging activity against DPPH radical 
than do the ligands. However, none of the compounds were found to be better than 
vitamin C or BHT. (TS)2Cu and (TTET)2Cu reveals the strongest radical scavenging 
activity among the series, whereas (TNS)2Cu complex represents the least. The different 
relative scavenging capacity of individual compounds against different radicals may be 
explained by the different mechanisms involved in the radical-antioxidant reactions. 
Chemical compounds that inhibit the peroxidase activity may reduce the DPPH. Other 
factors, such as stereoselectivity of the radicals or the solubility of these compounds in 
different testing systems, may also affect the capacity of individual compounds to react 
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and quench different radicals. This observation was supported by the study of Wang and 
Jiao [107] who evaluated the radical scavenging capacity of berry corps using superoxide 
radicals, hydroxyl radicals, and other reactive oxygen species. The berry corp that had a 
greater scavenging activity against superoxide radicals did not necessarily have a higher 
activity to quench hydroxyl radicals. 
4.8.3 Scavenging capacities for the series of tryptamine-hydroxyacetophenones and their 
complexes:    
Through the series of tryptamine-hydroxyacetophenones either ligands or complexes, 
none of them show a potent anti-oxidant property to suppress DPPH radicals as do 
vitamin C. Among the series, copper complexes were the most effective anti-oxidants, 
and their activity varies with concentration as shown in appendix E. The compounds in 
this series does not act as an efficient radical scavengers in any way comparable to other 
compounds of TS series, and even (TMeHAP)2Cu complex functions more as a 
prooxidant in high concentrations.  
4.8.4 FRAP Assay:  
Total anti-oxidant activity is measured by ferric reducing anti-oxidant power (FRAP) 
assay of Benzie and Strain [108]. Frap assay uses anti-oxidants as reductants in a redox-
linked colorimetric method, employing an easily reduced oxidant system present in 
stoichiometric excess.  
At low pH, reduction of ferric tripyridyl triazine (Fe III TPTZ) complex to ferrous form 
(which has an intense blue color) can be monitored by measuring the change in 
absorption at 593 nm. The reaction is non specific, in that any half reaction that has lower 
redox potential, under reaction conditions, than that of ferric-ferrous half reaction, will 
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derive the ferrous (Fe III to Fe II) ion formation. The change in absorbance is therefore, 
directly proportional to the combined or total reducing power of the electron donating 
anti-oxidants present in the reaction mixture.  
The FRAP reagent was prepared by mixing 50 ml of 300 mmol/L sodium acetate buffer 
(pH 3.6), with 5 ml of 10 mmol/L TPTZ in 40 mmol/L HCl and 5 ml of 20 mmol/L 
FeCl3.6H2O. Samples (10 µL) and standards (Vit. C and BHT) were mixed with 300 µL 
of the working FRAP reagent, and the absorbance at 593 nm was measured at 0 minute 
after mixing and 4 minutes. Each test was carried out in triplicates. 
The FRAP value was calculated as ferrous equivalents which obtained by comparing the 
absorbance change in the test reaction mixture with those containing known 
concentrations of ferrous ions (Standard). Calibration curve was shown in appendix (E).  
 
4.8.5 FRAP results for TS series:  
The Frap values of TS and its substituted derivatives expressed in µM ferrous equivalents 
in comparison with Vitamin C and BHT were given in figures (4.11 and 4.12).  
In general, it is clearly evident that the complexes show more prominent efficacy as ferric 
reducing compounds than do the free ligands. None of the compounds are more powerful 
than vitamin C; nevertheless, they show comparable results with BHT. The highest 
reducing ability being in TTET and its zinc and copper complexes, with a Frap value of 
more than 2000 µM ferrous equivalents, whilst TS and its zinc and copper complexes 
represent the bottom of the series with a Frap value of less than 500 µM ferrous 
equivalents. (TTET)2Zn and (TTET)2Cu complexes reveal better reducing abilities than 
BHT with a Frap values of 2627 and 2883 µM ferrous equivalents respectively in 
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comparison to only 2463 µM ferrous equivalent for BHT. The nitro-substituted 
complexes, with the exception of nickel complex, appear to be more powerful anti-
oxidants than the chloro-substituted counterparts with a Frap values lying between 1500-
857 µM ferrous equivalents. However, the Frap values of chloro-substituted nickel 
complex is slightly under 1000 µM ferrous equivalent contrary to its group members 
which show just approximately half of its activity. 
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Figure 4.11: Frap assay for TS series in comparison with vitamin C and BHT 
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Frap assay of TS series comparing with BHT
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Figure 4.12: Frap assay of TS series in comparison with BHT only. 
 
4.8.6 FRAP results for THAP series:  
The column graph in figure (4.13) compares the proportions of ferric reducing abilities of 
THAP series with vitamin C and BHT as standards. In this series of compounds, the 
highest reducing ability have been found in TOMeHAP which accounts for 6570 µM 
ferrous equivalents four times as effective as BHT. This had decreased gradually from 
nickel to copper complexes of this ligand but still better than BHT. Likewise the trend 
has been observed for the methyl-substituted ligand and its copper complex. In this 
category the ligand shows a potency of approximately ten-fold of the corresponding 
copper complex, and approaches three times the activity of BHT. 
For TBrHAP and its copper complex, the pattern is reversed. There are about 1955 µM 
ferrous equivalents Frap value for copper complex compared to only 876 µM for the free 
ligand. TBrHAP appears to be slightly effective anti-oxidant than BHT. Chloro-
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substituted category and the un-substituted group have weak ferric reducing abilities of 
Frap values 1000 µM or less.  
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Figure 4.13: Frap values for THAP series in comparison with vitamin C and BHT 
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Figure 4.14: Frap values of THAP series in comparison with BHT only. 
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4.9 Acute toxicity study:  
Table (4.4): 
Physical observation for abnormalities or mortalities after test compounds administration. 
Compounds ½ hour 1 hour 2 hours 3 hours 24 hours 
      
TS + + + + + 
TCS + + + D1/2 + 
TNS + + + + + 
TTET - - - - D1/2 
      
THAP - D1/2 - - - 
TMeHAP + + + + + 
TOMeHAP + + + + + 
TClHAP + + + + + 
TBrHAP - + + + + 
      
+ Mice were active and did not show sign(s) of abnormalities. 
- Mice were less active. 
-  D1/2 half of the mice died. 
 
 
For TS, TNS, TMeHAP, TOMeHAP and TClHAP the acute toxicity profile of the 
compounds for both genders could be considered favorable judging from the absence of 
adverse clinical manifestations in experimental animal after two week of observation. All 
the animals remain alive and did not manifest any significant visible signs of toxicity at 
these doses. There were no abnormal signs, behavioral changes, body weight changes, or 
macroscopic finding at any time of observation. There was no mortality in the above-
mentioned doses at the end of 14 days of observation. Histology of liver and kidney, 
hematology and serum biochemistry revealed no significant differences between groups.  
It is concluded that acute toxicity study with a dose of 5g/kg did not manifest any 
toxicological signs in mice and that the oral lethal dose for male and female mice is in 
excess of 5g/kg. Based on these acute toxicity tests, the compounds were found safe. 
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For TCS no sign of physical abnormalities or mortality during the first two hours was 
observed, but after 3 hours, half of the mice died in the high dose group, and third of the 
total in the low dose group. This may imply that the LD50 value of this compound is 
around 5g/kg, and this must be taken into account if we are to consider the compound for 
bio activity.  
TTET is by no means un-toxic. In spite of no death was recorded for the first half an hour 
after administration, physical abnormalities were observed and the mice tend to behave 
less active and their movement became very slow and they preferred to stay in their place 
for longer time during the subsequent 3 hours. After 24 hours, half of the mice were died 
in both high and low dose groups.  
THAP can also be regarded as toxic only if it was administered in high dose. No 
toxicological symptoms were observed when it applied in low dose.    
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
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Conclusion 
 
The condensation reaction of tryptamine with salicylaldehyde and its chloro, nitro and 3,5 
di-tertiarybutyl derivatives; 2-hydroxyacetophenone, and its methyl, methoxy, chloro, 
and bromo derivatives afforded the corresponding Schiff base ligands with a good yield.  
Spectroscopic data proved the formation of the Schiff base ligands as ascertained by the 
appearance of the azomethine linkage between tryptamine and the carbonyl compound 
moieties.  
Metal complexes of these ligands with Zn(II), Ni(II) and Cu(II) have been obtained with 
good stoichiometric yields. Spectroscopic studies revealed that zinc complexes adopt 
slightly distorted tetrahedral geometries through coordination of the zinc ion to phenolate 
oxygen and azomethine nitrogen atoms of two molecules of the Schiff base. Comparable 
results have been offered by X-ray crystal structure analysis of (TCS)2Zn and (TTET)2Zn 
complexes. The bond angle O1-Zn-O1\ in (TCS)2Zn (116.62) is closely similar to the 
same angle in (TTET)2Zn complex (116.04). Further more, the angle O1-Zn-N1 for 
(TCS)2Zn which is 95.57 was also comparable to the same angle in (TTET)2Zn (95.89). 
Similar observations were also detected for O1-Zn-N1 bond angles. The only remarkable 
difference was in the N1-Zn-N1\ bond angles which proved to be more wider in 
(TTET)2Zn complex (105.87) in comparison to (99.56) in (TCS)2Zn due to the steric 
effects exerted by the bulky tertiary butyl groups in position 3 and 5 in the 
salicylaldehyde moiety of (TTET)2Zn complex.  
Nickel complexes adopt trans square planar geometries, rhombically distorted in the case 
of (TS)2Ni complex with longer axis along N-Ni-N and shorter along O-N-O direction.  
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All attempts to obtain suitable crystal for X-ray study of copper complexes were 
unsuccessful. It is believed that Cu(II) complexes adopt pseudotetrahedral geometry with 
the same mode of coordination of the Zn(II) and Ni(II) counterparts.  
A considerable efforts have been put to obtain Zn(II) complexes of the ligands 
TOMeHAP, TClHAP; and Zn(II) and Ni(II) complexes for the ligands TMeHAP and 
TBrHAP, including modifications in the reaction conditions, the use of different 
deprotonating agents, etc but all were unsuccessful. This point here still deserves further 
consideration in the future of research to probe the reasons behind.  
The anti-ulcerogenic activity of the ligands and complexes shows a potent effect for the 
compounds, in general, towards preventing gastric ulcer formation. Amongst TS, the 
nitro derivative TNS and their complexes, both the ligand and the complexes proved to 
be more effective in preventing gastric injuries than the positive control Cimetidine. TCS 
and its complexes were slightly less effective though (TCS)2Cu complex show high 
activity. The mechanism of ulcer prevention is complex, and need to be addressed for 
further investigations, although it is evident that, in principle, the compounds stimulate 
the production of more mucus and reduce the destructive gastric acidity.  
Due to the interest in anti-oxidants, particularly in those intended to prevent the presumed 
deleterious effects of the free radicals in the human body, and to prevent the deterioration 
of fats and other constituents of foodstuffs, the anti-oxidant properties of the synthesized 
ligands and complexes have been tested through the popular methods based on the use of 
the stable free radical diphenylpicryl hydrazyl (DPPH) and ferric reducing anti-oxidant 
power (FRAP) assays.  
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Through the series of TS and its chloro, nitro, and tertiarybutyl derivatives, the 
complexes reveal a comparable scavenging activity in the DPPH assay as compared to 
Vitamin C and BHT standards. However, none of the compounds were found to be more 
effective than Vitamin C, but with the exception (TNS)2Cu, copper complexes proved to 
have the strongest radical scavenging activity. The series of hydroxyacetophenones were 
far poorer in their scavenging capabilities for DPPH free radicals than TS counterparts. 
More efforts should be done to study the detailed structural conformations of these 
compounds towards their anti-oxidant activities.  
In the FRAP assay, the complexes generally show more prominent efficacy as ferric 
reducing compounds than do the free ligands. TTET and its complexes represent the crest 
as compared to the standard anti-oxidant BHT. Likewise, TOMeHAP and its complexes 
reveal better anti-oxidant power in the FRAP assay than BHT.  
The acute toxicity profile of the compounds could be considered favorable judging from 
the high oral lethal dose (LD50) value obtained and the absence of adverse clinical 
manifestations in animal experiments after two week of observation. It is concluded that 
acute toxicity study with a dose of 2g/kg did not manifest any toxicological signs in mice 
and that the oral lethal dose for male and female mice is in excess of 2g/kg. Based on 
these acute toxicity tests, the compounds were found safe. This implies a high therapeutic 
index, which is ideal for any drug. 
For future work, it is of interest to study the effects of modification in the ligand 
structures especially in the indole residue on the biological activities since it is obvious 
from the X-ray structures that this part of the whole molecule is not involved in 
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coordination. Also it is of value from biological point of view to enhance the aqueous 
solubility of these compounds for more relevant bioactivity.   
 
 
  
 
 
 
 
 
 
APPENDICES  
 
 
 
 
Appendix (A) 
 
Physical properties of the compounds derived from TS and its derivatives:  
 
No. Name of the compound Molecular formula Molecular 
weight  
Color Melting point (ºC) 
1 TS C17H16N2O 264.32 Yellow 100 
2 (TS)2Zn C34H30N4O2Zn 592.02 White 275 (decomposition) 
3 (TS)2Ni C34H30N4O2Ni 585.33 Green 222 (decomposition) 
4 (TS)2Cu C34H30N4O2Cu 590.18 Brown 214 (decomposition) 
5 TCS C17H15N2OCl 298.77 Yellow 110 
6 (TCS)2Zn C34H28N4O2Cl2Zn 660.91 White 290 
7 (TCS)2Ni C34H28N4O2Cl2Ni 654.22 Green 247 
8 (TCS)2Cu C34H28N4O2Cl2Cu 687.13 Pale green 190 (decomposition) 
9 TNS C17H15N3O3 309.32 Yellow 170 
10 (TNS)2Zn  C34H28N6O6Zn 682.01 Bright yellow 310 (decomposition) 
11 (TNS)2Ni C34H28N6O6Ni 675.32 Green 238 (decomposition) 
12 (TNS)2Cu C34H28N6O6Cu 680.18 Green 264 
13 TTET C25H32N2O 376.54 Pale yellow 100 
14 (TTET)2Zn C50H62N4O2Zn 816.45 Pale yellow 205 (decomposition) 
15 (TTET)2Ni C50H62N4O2Ni 809.76 Yellowish brown 232 (decomposition) 
16 (TTET)2Cu C50H62N4O2Cu 814.61 Brown 182 (decomposition) 
 
 
 
 
Physical properties of the compounds derived from THAP and its derivatives: 
 
 
No. Name of the compound Molecular formula Molecular 
weight  
Color Melting point (ºC) 
1 THAP C18H18N2O 278.35 Yellow 112 
2 (THAP)2Zn C36H34N4O2Cl2Zn 690.98 Yellow 121 
3 (THAP)2Ni C36H34N4O2Ni 613.38 Yellowish green 249 (decomposition) 
4 (THAP)2Cu C36H34N4O2Cu 618.24 Brown 212 (decomposition)  
5 TMeHAP C19H20N2O 292.38 Yellow 175 
6 (TMeHAP)2Cu C38H38N4O2Cu 646.29 Brown 282 (decomposition) 
7 TOMeHAP C19H20N2O2 308.38 Bright yellow 179 
8 (TOMeHAP)2Ni C38H38N4O4Ni 673.43 Brownish yellow 238 (decomposition) 
9 (TOMeHAP)2Cu C38H38N4O4Cu 678.29 Brown 206 
10 TClHAP C18H17N2OCl 296.80 Yellow 160 
11 (TClHAP)2Ni C36H32N4O2Cl2Ni 682.27 Yellowish green 280 (decomposition) 
12 (TClHAP)2Cu C36H32N4O2Cl2Cu 687.13 Brown 232 
13 TBrHAP C18H17N2OBr 357.25 Yellow 182 
14 (TBrHAP)2Cu C36H32N4O2Br2Cu 776.03 Brown 238 
 
 
 
 
Elemental Analysis (CHN) for the compounds derived from TS and its derivatives:  
 
No. Name of the 
compound 
Molecular formula Molecular 
weight  
C% 
Calculated(Found) 
H% 
Calculated(Found) 
N% 
Calculated(Found) 
1 TS C17H16N2O 264.32 77.17(76.99) 6.05(6.04) 10.59(10.23) 
2 (TS)2Zn C34H30N4O2Zn 592.02 68.89(68.97) 5.06(4.96) 9.45(9.62) 
3 (TS)2Ni C34H30N4O2Ni 585.33 69.70(70.09) 5.12(5.51) 9.56(9.33) 
4 (TS)2Cu C34H30N4O2Cu 590.18 69.13(69.50) 5.08(5.46) 9.48(9.34) 
5 TCS C17H15N2OCl 298.77 68.34(68.26) 5.06(4.96) 9.38(9.16) 
6 (TCS)2Zn C34H28N4O2Cl2Zn 660.91 61.72(61.48) 4.23(4.08) 8.47(8.20) 
7 (TCS)2Ni C34H28N4O2Cl2Ni 654.22 62.36(62.55) 4.28(4.37) 8.56(8.24) 
8 (TCS)2Cu C34H28N4O2Cl2Cu 687.13 61.90(61.78) 4.25(4.32) 8.49(8.52) 
9 TNS C17H15N3O3 309.32 66.01(65.97) 4.89(4.79) 13.58(13.63) 
10 (TNS)2Zn  C34H28N6O6Zn 682.01 59.82(59.67) 4.10(4.32) 12.31(12.65) 
11 (TNS)2Ni C34H28N6O6Ni 675.32 60.41(60.32) 4.14(4.24) 12.43(12.21) 
12 (TNS)2Cu C34H28N6O6Cu 680.18 59.98(59.62) 4.11(4.32) 12.35(12.17) 
13 TTET C25H32N2O 376.54 79.75(79.58) 8.57(8.72) 7.44(7.22) 
14 (TTET)2Zn C50H62N4O2Zn 816.45 73.48(73.24) 7.59(7.35) 6.85(6.80) 
15 (TTET)2Ni C50H62N4O2Ni 809.76 74.09(74.15) 7.65(7.56) 6.91(6.78) 
16 (TTET)2Cu C50H62N4O2Cu 814.61 73.65(73.38) 7.61(7.88) 6.87(6.90) 
 
 
 
 
Elemental Analysis (CHN) for the compounds derived from THAP and its derivatives: 
 
No. Name of the 
compound 
Molecular 
formula 
Molecular 
weight  
C% 
Calculated(Found) 
H% 
Calculated(Found) 
N% 
Calculated(Found) 
1 THAP C18H18N2O 278.35 77.67(77.52) 6.52(6.25) 10.06(10.05 
2 (THAP)2Zn C36H34N4O2Cl2Zn 690.98 62.52(62.81) 4.92(4.68) 6.94(7.01) 
3 (THAP)2Ni C36H34N4O2Ni 613.38 70.43(70.56) 5.54(5.20) 9.13(8.97) 
4 (THAP)2Cu C36H34N4O2Cu 618.24 69.87(70.11) 5.49(5.77) 9.05(8.92) 
5 TMeHAP C19H20N2O 292.38 77.90(77.62) 6.84(6.62) 9.57(9.83) 
6 (TMeHAP)2Cu C38H38N4O2Cu 646.29 70.55(70.75) 5.87(5.57) 8.66(8.59) 
7 TOMeHAP C19H20N2O2 308.38 74.00(74.20) 6.54(6.19) 9.08(9.13) 
8 (TOMeHAP)2Ni C38H38N4O4Ni 673.43 67.71(67.54) 5.64(5.48) 8.31(8.07) 
9 (TOMeHAP)2Cu C38H38N4O4Cu 678.29 67.22(67.49) 5.60(5.90) 8.25(8.23) 
10 TClHAP C18H17N2OCl 296.80 69.12(69.24) 5.48(5.75) 8.96(8.54) 
11 (TClHAP)2Ni C36H32N4O2Cl2Ni 682.27 63.31(63.09) 4.65(4.52) 8.15(7.92) 
12 (TClHAP)2Cu C36H32N4O2Cl2Cu 687.13 62.87(63.00) 4.65(4.38) 8.15(8.05) 
13 TBrHAP C18H17N2OBr 357.25 60.52(60.11) 4.80(4.50) 7.84(7.73) 
14 (TBrHAP)2Cu C36H32N4O2Br2Cu 776.03 55.66(55.53) 4.12(4.16) 7.21(7.08) 
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Appendix (B)  
Statistical analysis (One way AVONA) 
1. TS series 
 
Descriptive 
 
Treatment         
 95% Confidence Interval for 
Mean 
 N Mean Std. Deviation Std. Error Lower Bound Upper Bound Minimum Maximum 
negative control 6 1438.0000 143.44895 58.56279 1287.4596 1588.5404 1238.00 1638.00 
positive control 6 168.0000 12.06648 4.92612 155.3370 180.6630 150.00 184.00 
TS(H) 6 .0000 .00000 .00000 .0000 .0000 .00 .00 
TS(L) 6 .0000 .00000 .00000 .0000 .0000 .00 .00 
(TS)2Zn(H) 6 .0000 .00000 .00000 .0000 .0000 .00 .00 
(TS)2Zn(L) 6 .0000 .00000 .00000 .0000 .0000 .00 .00 
(TS)2Ni(H) 6 9.6000 .46043 .18797 9.1168 10.0832 9.00 10.20 
(TS)2Ni(L) 6 20.2333 .33862 .13824 19.8780 20.5887 19.90 20.70 
(TS)2Cu(H) 6 2.4000 .30332 .12383 2.0817 2.7183 1.90 2.70 
(TS)2Cu(L) 6 52.8000 .52154 .21292 52.2527 53.3473 52.00 53.40 
Total 60 169.1033 431.47445 55.70311 57.6417 280.5650 .00 1638.00 
 
 
 
 
 
ANOVA 
 
Treatment      
 Sum of Squares df Mean Square F Sig. 
Between Groups 1.088E7 9 1208935.850 583.354 .000 
Within Groups 103619.453 50 2072.389   
Total 1.098E7 59    
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Multiple Comparisons 
Treatment 
Bonferroni 
      
95% Confidence Interval 
(I) group (J) group 
Mean Difference 
(I-J) Std. Error Sig. Lower Bound Upper Bound 
positive control 1270.00000* 26.28301 .000 1179.0379 1360.9621 
TS(H) 1438.00000* 26.28301 .000 1347.0379 1528.9621 
TS(L) 1438.00000* 26.28301 .000 1347.0379 1528.9621 
(TS)2Zn(H) 1438.00000* 26.28301 .000 1347.0379 1528.9621 
(TS)2Zn(L) 1438.00000* 26.28301 .000 1347.0379 1528.9621 
(TS)2Ni(H) 1428.40000* 26.28301 .000 1337.4379 1519.3621 
(TS)2Ni(L) 1417.76667* 26.28301 .000 1326.8046 1508.7287 
(TS)2Cu(H) 1435.60000* 26.28301 .000 1344.6379 1526.5621 
negative control 
(TS)2Cu(L) 1385.20000* 26.28301 .000 1294.2379 1476.1621 
negative control -1270.00000* 26.28301 .000 -1360.9621 -1179.0379 
TS(H) 168.00000* 26.28301 .000 77.0379 258.9621 
TS(L) 168.00000* 26.28301 .000 77.0379 258.9621 
(TS)2Zn(H) 168.00000* 26.28301 .000 77.0379 258.9621 
(TS)2Zn(L) 168.00000* 26.28301 .000 77.0379 258.9621 
(TS)2Ni(H) 158.40000* 26.28301 .000 67.4379 249.3621 
(TS)2Ni(L) 147.76667* 26.28301 .000 56.8046 238.7287 
(TS)2Cu(H) 165.60000* 26.28301 .000 74.6379 256.5621 
positive control 
(TS)2Cu(L) 115.20000* 26.28301 .003 24.2379 206.1621 
negative control -1438.00000* 26.28301 .000 -1528.9621 -1347.0379 
positive control -168.00000* 26.28301 .000 -258.9621 -77.0379 
TS(L) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Zn(H) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Zn(L) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Ni(H) -9.60000 26.28301 1.000 -100.5621 81.3621 
(TS)2Ni(L) -20.23333 26.28301 1.000 -111.1954 70.7287 
(TS)2Cu(H) -2.40000 26.28301 1.000 -93.3621 88.5621 
TS(H) 
(TS)2Cu(L) -52.80000 26.28301 1.000 -143.7621 38.1621 
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95% Confidence Interval 
(I) group (J) group 
Mean Difference 
(I-J) Std. Error Sig. Lower Bound Upper Bound 
negative control -1438.00000* 26.28301 .000 -1528.9621 -1347.0379 
positive control -168.00000* 26.28301 .000 -258.9621 -77.0379 
TS(H) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Zn(H) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Zn(L) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Ni(H) -9.60000 26.28301 1.000 -100.5621 81.3621 
(TS)2Ni(L) -20.23333 26.28301 1.000 -111.1954 70.7287 
(TS)2Cu(H) -2.40000 26.28301 1.000 -93.3621 88.5621 
TS(L) 
(TS)2Cu(L) -52.80000 26.28301 1.000 -143.7621 38.1621 
negative control -1438.00000* 26.28301 .000 -1528.9621 -1347.0379 
positive control -168.00000* 26.28301 .000 -258.9621 -77.0379 
TS(H) .00000 26.28301 1.000 -90.9621 90.9621 
TS(L) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Zn(L) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Ni(H) -9.60000 26.28301 1.000 -100.5621 81.3621 
(TS)2Ni(L) -20.23333 26.28301 1.000 -111.1954 70.7287 
(TS)2Cu(H) -2.40000 26.28301 1.000 -93.3621 88.5621 
(TS)2Zn(H) 
(TS)2Cu(L) -52.80000 26.28301 1.000 -143.7621 38.1621 
negative control -1438.00000* 26.28301 .000 -1528.9621 -1347.0379 
positive control -168.00000* 26.28301 .000 -258.9621 -77.0379 
TS(H) .00000 26.28301 1.000 -90.9621 90.9621 
TS(L) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Zn(H) .00000 26.28301 1.000 -90.9621 90.9621 
(TS)2Ni(H) -9.60000 26.28301 1.000 -100.5621 81.3621 
(TS)2Ni(L) -20.23333 26.28301 1.000 -111.1954 70.7287 
(TS)2Cu(H) -2.40000 26.28301 1.000 -93.3621 88.5621 
(TS)2Zn(L) 
(TS)2Cu(L) -52.80000 26.28301 1.000 -143.7621 38.1621 
negative control -1428.40000* 26.28301 .000 -1519.3621 -1337.4379 
positive control -158.40000* 26.28301 .000 -249.3621 -67.4379 
TS(H) 9.60000 26.28301 1.000 -81.3621 100.5621 
TS(L) 9.60000 26.28301 1.000 -81.3621 100.5621 
(TS)2Ni(H) 
(TS)2Zn(H) 9.60000 26.28301 1.000 -81.3621 100.5621 
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(TS)2Zn(L) 9.60000 26.28301 1.000 -81.3621 100.5621 
(TS)2Ni(L) -10.63333 26.28301 1.000 -101.5954 80.3287 
(TS)2Cu(H) 7.20000 26.28301 1.000 -83.7621 98.1621 
(TS)2Cu(L) -43.20000 26.28301 1.000 -134.1621 47.7621 
negative control -1417.76667* 26.28301 .000 -1508.7287 -1326.8046 
positive control -147.76667* 26.28301 .000 -238.7287 -56.8046 
TS(H) 20.23333 26.28301 1.000 -70.7287 111.1954 
TS(L) 20.23333 26.28301 1.000 -70.7287 111.1954 
(TS)2Zn(H) 20.23333 26.28301 1.000 -70.7287 111.1954 
(TS)2Zn(L) 20.23333 26.28301 1.000 -70.7287 111.1954 
(TS)2Ni(H) 10.63333 26.28301 1.000 -80.3287 101.5954 
(TS)2Cu(H) 17.83333 26.28301 1.000 -73.1287 108.7954 
(TS)2Ni(L) 
(TS)2Cu(L) -32.56667 26.28301 1.000 -123.5287 58.3954 
negative control -1435.60000* 26.28301 .000 -1526.5621 -1344.6379 
positive control -165.60000* 26.28301 .000 -256.5621 -74.6379 
TS(H) 2.40000 26.28301 1.000 -88.5621 93.3621 
TS(L) 2.40000 26.28301 1.000 -88.5621 93.3621 
(TS)2Zn(H) 2.40000 26.28301 1.000 -88.5621 93.3621 
(TS)2Zn(L) 2.40000 26.28301 1.000 -88.5621 93.3621 
(TS)2Ni(H) -7.20000 26.28301 1.000 -98.1621 83.7621 
(TS)2Ni(L) -17.83333 26.28301 1.000 -108.7954 73.1287 
(TS)2Cu(H) 
(TS)2Cu(L) -50.40000 26.28301 1.000 -141.3621 40.5621 
negative control -1385.20000* 26.28301 .000 -1476.1621 -1294.2379 
positive control -115.20000* 26.28301 .003 -206.1621 -24.2379 
TS(H) 52.80000 26.28301 1.000 -38.1621 143.7621 
TS(L) 52.80000 26.28301 1.000 -38.1621 143.7621 
(TS)2Zn(H) 52.80000 26.28301 1.000 -38.1621 143.7621 
(TS)2Zn(L) 52.80000 26.28301 1.000 -38.1621 143.7621 
(TS)2Ni(H) 43.20000 26.28301 1.000 -47.7621 134.1621 
(TS)2Ni(L) 32.56667 26.28301 1.000 -58.3954 123.5287 
(TS)2Cu(L) 
(TS)2Cu(H) 50.40000 26.28301 1.000 -40.5621 141.3621 
*. The mean difference is significant at the 0.05 level.    
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2. TCS series 
 
Descriptive 
 
Treatment         
 95% Confidence Interval for 
Mean 
 N Mean Std. Deviation Std. Error Lower Bound Upper Bound Minimum Maximum 
negative control 6 1438.0000 143.44895 58.56279 1287.4596 1588.5404 1238.00 1638.00 
positive control 6 168.0000 12.06648 4.92612 155.3370 180.6630 150.00 184.00 
TCS(H) 6 262.8000 2.03568 .83106 260.6637 264.9363 260.20 265.60 
TCS(L) 6 .0000 .00000 .00000 .0000 .0000 .00 .00 
(TCS)2Zn(H) 6 12.0000 .26077 .10646 11.7263 12.2737 11.70 12.40 
(TCS)2Zn(L) 6 69.6000 .96540 .39412 68.5869 70.6131 68.00 70.70 
(TCS)2Ni(H) 6 38.4000 .44272 .18074 37.9354 38.8646 37.90 39.00 
(TCS)2Ni(L) 6 117.6000 2.56982 1.04913 114.9031 120.2969 114.20 121.00 
(TCS)2Cu(H) 6 2.4000 .83905 .34254 1.5195 3.2805 1.00 3.40 
(TCS)2Cu(L) 6 4.8000 .99398 .40579 3.7569 5.8431 3.60 6.00 
Total 60 211.3600 422.58326 54.55526 102.1952 320.5248 .00 1638.00 
 
 
 
 
ANOVA 
Treatment      
 Sum of Squares df Mean Square F Sig. 
Between Groups 1.043E7 9 1159148.416 558.980 .000 
Within Groups 103684.180 50 2073.684   
Total 1.054E7 59    
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Multiple Comparisons 
Treatment 
Bonferroni 
      
95% Confidence Interval 
(I) group (J) group 
Mean Difference 
(I-J) Std. Error Sig. Lower Bound Upper Bound 
positive control 1270.00000* 26.29121 .000 1179.0095 1360.9905 
TCS(H) 1175.20000* 26.29121 .000 1084.2095 1266.1905 
TCS(L) 1438.00000* 26.29121 .000 1347.0095 1528.9905 
(TCS)2Zn(H) 1426.00000* 26.29121 .000 1335.0095 1516.9905 
(TCS)2Zn(L) 1368.40000* 26.29121 .000 1277.4095 1459.3905 
(TCS)2Ni(H) 1399.60000* 26.29121 .000 1308.6095 1490.5905 
(TCS)2Ni(L) 1320.40000* 26.29121 .000 1229.4095 1411.3905 
(TCS)2Cu(H) 1435.60000* 26.29121 .000 1344.6095 1526.5905 
negative control 
(TCS)2Cu(L) 1433.20000* 26.29121 .000 1342.2095 1524.1905 
negative control -1270.00000* 26.29121 .000 -1360.9905 -1179.0095 
TCS(H) -94.80000* 26.29121 .032 -185.7905 -3.8095 
TCS(L) 168.00000* 26.29121 .000 77.0095 258.9905 
(TCS)2Zn(H) 156.00000* 26.29121 .000 65.0095 246.9905 
(TCS)2Zn(L) 98.40000* 26.29121 .021 7.4095 189.3905 
(TCS)2Ni(H) 129.60000* 26.29121 .000 38.6095 220.5905 
(TCS)2Ni(L) 50.40000 26.29121 1.000 -40.5905 141.3905 
(TCS)2Cu(H) 165.60000* 26.29121 .000 74.6095 256.5905 
positive control 
(TCS)2Cu(L) 163.20000* 26.29121 .000 72.2095 254.1905 
negative control -1175.20000* 26.29121 .000 -1266.1905 -1084.2095 
positive control 94.80000* 26.29121 .032 3.8095 185.7905 
TCS(L) 262.80000* 26.29121 .000 171.8095 353.7905 
(TCS)2Zn(H) 250.80000* 26.29121 .000 159.8095 341.7905 
(TCS)2Zn(L) 193.20000* 26.29121 .000 102.2095 284.1905 
(TCS)2Ni(H) 224.40000* 26.29121 .000 133.4095 315.3905 
(TCS)2Ni(L) 145.20000* 26.29121 .000 54.2095 236.1905 
(TCS)2Cu(H) 260.40000* 26.29121 .000 169.4095 351.3905 
TCS(H) 
(TCS)2Cu(L) 258.00000* 26.29121 .000 167.0095 348.9905 
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95% Confidence Interval 
(I) group (J) group 
Mean Difference 
(I-J) Std. Error Sig. Lower Bound Upper Bound 
negative control -1438.00000* 26.29121 .000 -1528.9905 -1347.0095 
positive control -168.00000* 26.29121 .000 -258.9905 -77.0095 
TCS(H) -262.80000* 26.29121 .000 -353.7905 -171.8095 
(TCS)2Zn(H) -12.00000 26.29121 1.000 -102.9905 78.9905 
(TCS)2Zn(L) -69.60000 26.29121 .487 -160.5905 21.3905 
(TCS)2Ni(H) -38.40000 26.29121 1.000 -129.3905 52.5905 
(TCS)2Ni(L) -117.60000* 26.29121 .002 -208.5905 -26.6095 
(TCS)2Cu(H) -2.40000 26.29121 1.000 -93.3905 88.5905 
TCS(L) 
(TCS)2Cu(L) -4.80000 26.29121 1.000 -95.7905 86.1905 
negative control -1426.00000* 26.29121 .000 -1516.9905 -1335.0095 
positive control -156.00000* 26.29121 .000 -246.9905 -65.0095 
TCS(H) -250.80000* 26.29121 .000 -341.7905 -159.8095 
TCS(L) 12.00000 26.29121 1.000 -78.9905 102.9905 
(TCS)2Zn(L) -57.60000 26.29121 1.000 -148.5905 33.3905 
(TCS)2Ni(H) -26.40000 26.29121 1.000 -117.3905 64.5905 
(TCS)2Ni(L) -105.60000* 26.29121 .009 -196.5905 -14.6095 
(TCS)2Cu(H) 9.60000 26.29121 1.000 -81.3905 100.5905 
(TCS)2Zn(H) 
(TCS)2Cu(L) 7.20000 26.29121 1.000 -83.7905 98.1905 
negative control -1368.40000* 26.29121 .000 -1459.3905 -1277.4095 
positive control -98.40000* 26.29121 .021 -189.3905 -7.4095 
TCS(H) -193.20000* 26.29121 .000 -284.1905 -102.2095 
TCS(L) 69.60000 26.29121 .487 -21.3905 160.5905 
(TCS)2Zn(H) 57.60000 26.29121 1.000 -33.3905 148.5905 
(TCS)2Ni(H) 31.20000 26.29121 1.000 -59.7905 122.1905 
(TCS)2Ni(L) -48.00000 26.29121 1.000 -138.9905 42.9905 
(TCS)2Cu(H) 67.20000 26.29121 .615 -23.7905 158.1905 
(TCS)2Zn(L) 
(TCS)2Cu(L) 64.80000 26.29121 .774 -26.1905 155.7905 
negative control -1399.60000* 26.29121 .000 -1490.5905 -1308.6095 
positive control -129.60000* 26.29121 .000 -220.5905 -38.6095 
TCS(H) -224.40000* 26.29121 .000 -315.3905 -133.4095 
TCS(L) 38.40000 26.29121 1.000 -52.5905 129.3905 
(TCS)2Ni(H) 
(TCS)2Zn(H) 26.40000 26.29121 1.000 -64.5905 117.3905 
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(TCS)2Zn(L) -31.20000 26.29121 1.000 -122.1905 59.7905 
(TCS)2Ni(L) -79.20000 26.29121 .183 -170.1905 11.7905 
(TCS)2Cu(H) 36.00000 26.29121 1.000 -54.9905 126.9905 
(TCS)2Cu(L) 33.60000 26.29121 1.000 -57.3905 124.5905 
negative control -1320.40000* 26.29121 .000 -1411.3905 -1229.4095 
positive control -50.40000 26.29121 1.000 -141.3905 40.5905 
TCS(H) -145.20000* 26.29121 .000 -236.1905 -54.2095 
TCS(L) 117.60000* 26.29121 .002 26.6095 208.5905 
(TCS)2Zn(H) 105.60000* 26.29121 .009 14.6095 196.5905 
(TCS)2Zn(L) 48.00000 26.29121 1.000 -42.9905 138.9905 
(TCS)2Ni(H) 79.20000 26.29121 .183 -11.7905 170.1905 
(TCS)2Cu(H) 115.20000* 26.29121 .003 24.2095 206.1905 
(TCS)2Ni(L) 
(TCS)2Cu(L) 112.80000* 26.29121 .004 21.8095 203.7905 
negative control -1435.60000* 26.29121 .000 -1526.5905 -1344.6095 
positive control -165.60000* 26.29121 .000 -256.5905 -74.6095 
TCS(H) -260.40000* 26.29121 .000 -351.3905 -169.4095 
TCS(L) 2.40000 26.29121 1.000 -88.5905 93.3905 
(TCS)2Zn(H) -9.60000 26.29121 1.000 -100.5905 81.3905 
(TCS)2Zn(L) -67.20000 26.29121 .615 -158.1905 23.7905 
(TCS)2Ni(H) -36.00000 26.29121 1.000 -126.9905 54.9905 
(TCS)2Ni(L) -115.20000* 26.29121 .003 -206.1905 -24.2095 
(TCS)2Cu(H) 
(TCS)2Cu(L) -2.40000 26.29121 1.000 -93.3905 88.5905 
negative control -1433.20000* 26.29121 .000 -1524.1905 -1342.2095 
positive control -163.20000* 26.29121 .000 -254.1905 -72.2095 
TCS(H) -258.00000* 26.29121 .000 -348.9905 -167.0095 
TCS(L) 4.80000 26.29121 1.000 -86.1905 95.7905 
(TCS)2Zn(H) -7.20000 26.29121 1.000 -98.1905 83.7905 
(TCS)2Zn(L) -64.80000 26.29121 .774 -155.7905 26.1905 
(TCS)2Ni(H) -33.60000 26.29121 1.000 -124.5905 57.3905 
(TCS)2Ni(L) -112.80000* 26.29121 .004 -203.7905 -21.8095 
(TCS)2Cu(L) 
(TCS)2Cu(H) 2.40000 26.29121 1.000 -88.5905 93.3905 
*. The mean difference is significant at the 0.05 level.    
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3. TNS 
 
Descriptive 
Treatment         
 95% Confidence Interval for 
Mean 
 N Mean Std. Deviation Std. Error Lower Bound Upper Bound Minimum Maximum 
negative control 6 1438.0000 143.44895 58.56279 1287.4596 1588.5404 1238.00 1638.00 
positive control 6 168.0000 12.06648 4.92612 155.3370 180.6630 150.00 184.00 
TNS(H) 6 3.6000 .48580 .19833 3.0902 4.1098 3.00 4.20 
TNS(L) 6 3.6000 .46043 .18797 3.1168 4.0832 2.90 4.20 
(TNS)2Zn(H) 6 36.0000 1.08628 .44347 34.8600 37.1400 34.60 37.30 
(TNS)2Zn(L) 6 42.0000 1.36382 .55678 40.5688 43.4312 40.00 43.60 
(TNS)2Ni(H) 6 7.2000 .77460 .31623 6.3871 8.0129 6.00 8.10 
(TNS)2Ni(L) 6 26.4000 1.32212 .53975 25.0125 27.7875 24.50 28.00 
(TNS)2Cu(H) 6 27.6000 .90774 .37059 26.6474 28.5526 26.70 29.00 
(TNS)2Cu(L) 6 16.8000 1.43248 .58481 15.2967 18.3033 14.60 18.30 
Total 60 176.9200 428.46392 55.31445 66.2360 287.6040 2.90 1638.00 
 
 
 
 
ANOVA 
treatment      
 Sum of Squares df Mean Square F Sig. 
Between Groups 1.073E7 9 1191959.904 574.940 .000 
Within Groups 103659.560 50 2073.191   
Total 1.083E7 59    
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Multiple Comparisons 
Treatment 
Bonferroni 
      
95% Confidence Interval 
(I) group (J) group 
Mean Difference 
(I-J) Std. Error Sig. Lower Bound Upper Bound 
positive control 1270.00000* 26.28809 .000 1179.0203 1360.9797 
TNS(H) 1434.40000* 26.28809 .000 1343.4203 1525.3797 
TNS(L) 1434.40000* 26.28809 .000 1343.4203 1525.3797 
(TNS)2Zn(H) 1402.00000* 26.28809 .000 1311.0203 1492.9797 
(TNS)2Zn(L) 1396.00000* 26.28809 .000 1305.0203 1486.9797 
(TNS)2Ni(H) 1430.80000* 26.28809 .000 1339.8203 1521.7797 
(TNS)2Ni(L) 1411.60000* 26.28809 .000 1320.6203 1502.5797 
(TNS)2Cu(H) 1410.40000* 26.28809 .000 1319.4203 1501.3797 
negative control 
(TNS)2Cu(L) 1421.20000* 26.28809 .000 1330.2203 1512.1797 
negative control -1270.00000* 26.28809 .000 -1360.9797 -1179.0203 
TNS(H) 164.40000* 26.28809 .000 73.4203 255.3797 
TNS(L) 164.40000* 26.28809 .000 73.4203 255.3797 
(TNS)2Zn(H) 132.00000* 26.28809 .000 41.0203 222.9797 
(TNS)2Zn(L) 126.00000* 26.28809 .001 35.0203 216.9797 
(TNS)2Ni(H) 160.80000* 26.28809 .000 69.8203 251.7797 
(TNS)2Ni(L) 141.60000* 26.28809 .000 50.6203 232.5797 
(TNS)2Cu(H) 140.40000* 26.28809 .000 49.4203 231.3797 
positive control 
(TNS)2Cu(L) 151.20000* 26.28809 .000 60.2203 242.1797 
negative control -1434.40000* 26.28809 .000 -1525.3797 -1343.4203 
positive control -164.40000* 26.28809 .000 -255.3797 -73.4203 
TNS(L) .00000 26.28809 1.000 -90.9797 90.9797 
(TNS)2Zn(H) -32.40000 26.28809 1.000 -123.3797 58.5797 
(TNS)2Zn(L) -38.40000 26.28809 1.000 -129.3797 52.5797 
(TNS)2Ni(H) -3.60000 26.28809 1.000 -94.5797 87.3797 
(TNS)2Ni(L) -22.80000 26.28809 1.000 -113.7797 68.1797 
(TNS)2Cu(H) -24.00000 26.28809 1.000 -114.9797 66.9797 
TNS(H) 
(TNS)2Cu(L) -13.20000 26.28809 1.000 -104.1797 77.7797 
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95% Confidence Interval 
(I) group (J) group 
Mean Difference 
(I-J) Std. Error Sig. Lower Bound Upper Bound 
negative control -1434.40000* 26.28809 .000 -1525.3797 -1343.4203 
positive control -164.40000* 26.28809 .000 -255.3797 -73.4203 
TNS(H) .00000 26.28809 1.000 -90.9797 90.9797 
(TNS)2Zn(H) -32.40000 26.28809 1.000 -123.3797 58.5797 
(TNS)2Zn(L) -38.40000 26.28809 1.000 -129.3797 52.5797 
(TNS)2Ni(H) -3.60000 26.28809 1.000 -94.5797 87.3797 
(TNS)2Ni(L) -22.80000 26.28809 1.000 -113.7797 68.1797 
(TNS)2Cu(H) -24.00000 26.28809 1.000 -114.9797 66.9797 
TNS(L) 
(TNS)2Cu(L) -13.20000 26.28809 1.000 -104.1797 77.7797 
negative control -1402.00000* 26.28809 .000 -1492.9797 -1311.0203 
positive control -132.00000* 26.28809 .000 -222.9797 -41.0203 
TNS(H) 32.40000 26.28809 1.000 -58.5797 123.3797 
TNS(L) 32.40000 26.28809 1.000 -58.5797 123.3797 
(TNS)2Zn(L) -6.00000 26.28809 1.000 -96.9797 84.9797 
(TNS)2Ni(H) 28.80000 26.28809 1.000 -62.1797 119.7797 
(TNS)2Ni(L) 9.60000 26.28809 1.000 -81.3797 100.5797 
(TNS)2Cu(H) 8.40000 26.28809 1.000 -82.5797 99.3797 
(TNS)2Zn(H) 
(TNS)2Cu(L) 19.20000 26.28809 1.000 -71.7797 110.1797 
negative control -1396.00000* 26.28809 .000 -1486.9797 -1305.0203 
positive control -126.00000* 26.28809 .001 -216.9797 -35.0203 
TNS(H) 38.40000 26.28809 1.000 -52.5797 129.3797 
TNS(L) 38.40000 26.28809 1.000 -52.5797 129.3797 
(TNS)2Zn(H) 6.00000 26.28809 1.000 -84.9797 96.9797 
(TNS)2Ni(H) 34.80000 26.28809 1.000 -56.1797 125.7797 
(TNS)2Ni(L) 15.60000 26.28809 1.000 -75.3797 106.5797 
(TNS)2Cu(H) 14.40000 26.28809 1.000 -76.5797 105.3797 
(TNS)2Zn(L) 
(TNS)2Cu(L) 25.20000 26.28809 1.000 -65.7797 116.1797 
negative control -1430.80000* 26.28809 .000 -1521.7797 -1339.8203 
positive control -160.80000* 26.28809 .000 -251.7797 -69.8203 
TNS(H) 3.60000 26.28809 1.000 -87.3797 94.5797 
TNS(L) 3.60000 26.28809 1.000 -87.3797 94.5797 
(TNS)2Ni(H) 
(TNS)2Zn(H) -28.80000 26.28809 1.000 -119.7797 62.1797 
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(TNS)2Zn(L) -34.80000 26.28809 1.000 -125.7797 56.1797 
(TNS)2Ni(L) -19.20000 26.28809 1.000 -110.1797 71.7797 
(TNS)2Cu(H) -20.40000 26.28809 1.000 -111.3797 70.5797 
(TNS)2Cu(L) -9.60000 26.28809 1.000 -100.5797 81.3797 
negative control -1411.60000* 26.28809 .000 -1502.5797 -1320.6203 
positive control -141.60000* 26.28809 .000 -232.5797 -50.6203 
TNS(H) 22.80000 26.28809 1.000 -68.1797 113.7797 
TNS(L) 22.80000 26.28809 1.000 -68.1797 113.7797 
(TNS)2Zn(H) -9.60000 26.28809 1.000 -100.5797 81.3797 
(TNS)2Zn(L) -15.60000 26.28809 1.000 -106.5797 75.3797 
(TNS)2Ni(H) 19.20000 26.28809 1.000 -71.7797 110.1797 
(TNS)2Cu(H) -1.20000 26.28809 1.000 -92.1797 89.7797 
(TNS)2Ni(L) 
(TNS)2Cu(L) 9.60000 26.28809 1.000 -81.3797 100.5797 
negative control -1410.40000* 26.28809 .000 -1501.3797 -1319.4203 
positive control -140.40000* 26.28809 .000 -231.3797 -49.4203 
TNS(H) 24.00000 26.28809 1.000 -66.9797 114.9797 
TNS(L) 24.00000 26.28809 1.000 -66.9797 114.9797 
(TNS)2Zn(H) -8.40000 26.28809 1.000 -99.3797 82.5797 
(TNS)2Zn(L) -14.40000 26.28809 1.000 -105.3797 76.5797 
(TNS)2Ni(H) 20.40000 26.28809 1.000 -70.5797 111.3797 
(TNS)2Ni(L) 1.20000 26.28809 1.000 -89.7797 92.1797 
(TNS)2Cu(H) 
(TNS)2Cu(L) 10.80000 26.28809 1.000 -80.1797 101.7797 
negative control -1421.20000* 26.28809 .000 -1512.1797 -1330.2203 
positive control -151.20000* 26.28809 .000 -242.1797 -60.2203 
TNS(H) 13.20000 26.28809 1.000 -77.7797 104.1797 
TNS(L) 13.20000 26.28809 1.000 -77.7797 104.1797 
(TNS)2Zn(H) -19.20000 26.28809 1.000 -110.1797 71.7797 
(TNS)2Zn(L) -25.20000 26.28809 1.000 -116.1797 65.7797 
(TNS)2Ni(H) 9.60000 26.28809 1.000 -81.3797 100.5797 
(TNS)2Ni(L) -9.60000 26.28809 1.000 -100.5797 81.3797 
(TNS)2Cu(L) 
(TNS)2Cu(H) -10.80000 26.28809 1.000 -101.7797 80.1797 
*. The mean difference is significant at the 0.05 level.    
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Appendix (C)  
Gastric lesions and flattening of the folds inside rats stomachs  
(a) 
     
  
Gross appearance of the gastric mucosa in a rat pre-treated with 5 ml/kg of 10% Tween 
20 (ulcer control). Severe injuries are seen in the gastric mucosa. 
 
(b) 
   
 
Gross appearance of the gastric mucosa in a rat pre-treated with 5 ml/kg of Cimedine (50 
mg/kg). Injuries to the gastric mucosa are milder compared to the injuries seen in the 
negative control rat. 
 
 
 
Gastric lesion 
Gastric lesions 
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(c) 
   
 
Gross appearance of the gastric mucosa in a rat pre-treated with 5 ml/kg of synthesized 
Schiff bases and complexes (60 mg/kg). No injuries to the gastric mucosa are seen, and 
showed flattening of gastric mucosa. 
Flattening of gastric 
mucosa 
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Appendix (D) Histology 
 
(d) 
 
    
 
Histological section of gastric mucosa in a rat pre-treated with 5 ml/kg of 10% Tween 20 
(ulcer control) only. There is severe disruption to the surface epithelium, and edema of 
the submucosa layer with leucocyte infiltration. 
 
(e)    
 
 
Histological section of gastric mucosa in a rat pre-treated with 5 ml/kg of Cimedine (50 
mg/kg). There is mild disruption to the surface epithelium with mild edema and 
leucocytes infiltration of the submucosal layer. 
Edema with 
leucocytes  
Mucosal 
lesions 
Mucosal 
lesions  
Edema with 
leucocytes 
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(f) 
   
 
Histological section of gastric mucosa in a rat pre-treated with 5 ml/kg of Synthesized 
Schiff base t (250 mg/kg). There is no disruption to the surface epithelium with no edema 
and no leucocytes infiltration of the submucosal layer. 
Intact mucosa 
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Appendix (E)  
 
Standard curve for DPPH assay (TS series):  
 
G raph % DP P H inhibition vs  S tandard
y =  1.8631x
R 2 =  0.9784
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Standard curve show the percent inhibition of DPPH with various concentrations of 
Vitamin C.  
 
Dose response curves for TS series:  
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Standard curve for DPPH assay (THAP series): 
 
G raph % DP P H inhibition vs  S tandard
y =  1.984x
R 2 =  0.9444
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Standard curve show the percent inhibition of DPPH with various concentrations of 
Vitamin C. 
 
Dose response curves for THAP series: 
 
 
Percent inhibition of DPPH in different concentrations
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Percent inhibition of DPPH in different concentrations
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Pecent inhibition of DPPH in different concentrations
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Pecent inhibition of DPPH in different concentrations
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FRAP standard curves:  
 
F rap S tandard C urve
y = 0.0004x
R2 = 0.9801
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Standard curve shows the variation of absorbance of the FRAP reagent with changing the 
concentration of ascorbic acid (Vit. C) (Used in calculations of FRAP values for TS 
series) 
F R AP  S tandard C urve
y =  0.0006x
R ² =  0.946
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Standard curve shows the variation of absorbance of the FRAP reagent with changing the 
concentration of ascorbic acid (Vit. C) (Used in calculations of FRAP values for THAP 
series) 
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Table 4.3: Observed ulcer area, mucus weight, pH and inhibition percentage in rats for TNS and its complexes: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All values are expressed as mean ± standard error mean. Means with different superscripts are significantly different. The mean   
difference is significant at the p<0.05 level. 
HD (High dose: 60 mg/kg), LD (Low dose: 30 mg/kg) 
 
Compound Total ulcer area(mm2) 
(Mean ± S.E.M) 
Mucus weight 
(g) 
pH % inhibition 
Tween-20 
(-ve control) 
1438 ± 58a 
 
0.58 7.00 - 
Cimetidine 
(+ve control) 
168 ± 5b 
 
0.61 7.00 88 
TNS (HD) 
 
3.6 ± 0.2c 1.33 4.22 100 
TNS (LD) 
 
3.6 ± 0.2c 1.60 4.11 100 
(TNS)2Zn (HD) 
 
36.0 ± 0.4c 1.13 3.92 97 
(TNS)2Zn (LD) 42.0 ± 0.5c 
 
1.10 3.15 97 
(TNS)2Ni (HD) 
 
7.2 ± 0.3c 1.65 3.68 100 
(TNS)2Ni (LD) 26.4 ± 0.5c 
 
2.00 3.05 98 
(TNS)2Cu (HD) 27.6 ± 0.4c 
 
1.63 6.03 98 
(TNS)2Cu (LD) 
 
16.8 ± 0.6c 4.00 3.81 99 
Table 4.2: Observed ulcer area, mucus weight, pH and inhibition percentage in rats for TCS and its complexes: 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All values are expressed as mean ± standard error mean. Means with different superscripts are significantly different. The mean 
difference is significant at the p<0.05 level. 
HD (High dose: 60 mg/kg), LD (Low dose: 30 mg/kg) 
 
 
 
Compound Total ulcer area(mm2) 
(Mean ± S.E.M) 
Mucus weight 
(g) 
pH % inhibition 
Tween-20 
(-ve control) 
1438 ± 58a 
 
0.58 7.00 - 
Cimetidine 
(+ve control) 
168 ± 5b 
 
0.61 7.00 88 
TCS (HD) 262.8 ± 0.8c 1.10 6.06 81 
TCS (LD) Zerod 1.22 3.68 100 
(TCS)2Zn (HD) 12.0 ± 0.1d 1.44 3.66 99 
(TCS)2Zn (LD) 69.6 ± 0.4d 1.20 3.19 95 
(TCS)2Ni (HD) 38.4 ± 0.2d 1.58 3.69 97 
(TCS)2Ni (LD) 117.6 ± 1.0ad 1.18 4.02 92 
(TCS)2Cu (HD) 2.4 ± 0.3d 2.84 2.35 100 
(TCS)2Cu (LD) 4.8 ± 0.4d 2.04 2.80 100 
Table 4.1: Observed ulcer area, mucus weight, pH and inhibition percentage in rats for TS and its complexes:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All values are expressed as mean ± standard error mean. Means with different superscripts are significantly different. The mean 
difference is significant at the p<0.05 level. 
HD (High dose: 60 mg/kg), LD (Low dose: 30 mg/kg) 
 
Compound Total ulcer area(mm2) 
(Mean ± S.E.M) 
Mucus weight 
(g) 
pH % inhibition 
Tween-20 
(-ve control) 
1438 ± 58a 
 
0.58 7.00 - 
Cimetidine 
(+ve control) 
168 ± 5b 
 
0.61 7.00 88 
TS (HD) Zeroc 0.88 3.61 100 
TS (LD) Zeroc 0.71 5.28 100 
(TS)2Zn (HD) Zeroc 1.31 5.00 100 
(TS)2Zn (LD) Zeroc 0.58 3.44 100 
(TS)2Ni (HD) 9.6 ± 0.2c 1.50 6.25 99 
(TS)2Ni (LD) 20.4 ± 0.2c 0.86 4.77 98 
(TS)2Cu (HD) 2.4 ± 0.1c 1.43 3.54 100 
(TS)2Cu (LD)  52.8 ± 0.2c 1.33 4.54 96 
